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Abstract 
 
Background: The retina responds to light over a wide range of operational conditions, 
surpassing 10 units in a logarithmic scale. Adaptation of the retina to the particular presenting 
light conditions relies considerably on modulation of retinal pathways by dopamine, which is 
released in response to light or circadian rhythms exclusively from dopaminergic amacrine 
cells.  Rods, cones and intrinsically photoresponsive retinal ganglion cells (ipRGCs) have all 
been shown to input into dopaminergic amacrine cells. However, the pathways that these 
photoreceptors employ to ultimately trigger dopamine release in response to light remain 
unclear.   
Methods: Ultra-high performance liquid chromatography separation and tandem mass 
spectrometry detection was used to quantify dopamine, and its primary metabolite 3,4-
dihidroxyphenylacetic acid (DOPAC). Retinal dopamine release was assessed under various 
conditions, in a variety of mouse models, using two complementary experimental designs: in 
vivo anaesthetised mice and ex vivo explanted retinae. 
Results: In wild-type mice, significant light-induced dopamine release compared to dark-
adapted retinae occurred only at bright light intensities, within one minute and after postnatal 
day 18. Conversely, dopamine turnover was suppressed by dim red light when compared to 
infrared light dissection. These results occurred in both in vivo and ex vivo preparations with 
analogous results, although in vivo provided a more “instantaneous” measurement when time 
courses were compared. Under pharmacological modulation, a reduction in light-evoked 
responses occurred when sodium channels or gap-junctions were blocked, and the response 
was nearly abolished by inhibiting glutamate receptors (mGluR type III, AMPA/kainate or 
NMDA). In the dark, dopamine turnover was upregulated by blocking GABA receptors, 
xiii 
 
increasing overall retinal excitability (with high K+ solution), or activating NMDA receptors. 
The use of transgenic mice models (Gnat2A518G, Opn4Cre/Cre, Opn1mwR and rd/rd) of altered 
photoreception revealed that rods were responsible for both, driving the suppression of 
dopamine release under dim red light and triggering light-induced dopamine release under 
bright light conditions. The contribution of ipRGCs was tested in i) rd/rd animals, ii) by 
chemogenetic activation in Opn4Cre/+ mice, and iii) in Opn4Cre/Cre mice. The contribution of 
cones was tested i) before cone degeneration in rd/rd animals, ii) in Gnat2A518G mice, and iii) 
by spectrally segregating the activation of different photoreceptors in Opn1mwR mice. 
Surprisingly, despite the electrophysiological input from cones and ipRGCs into dopaminergic 
amacrine cells, these photoreceptors did not elicit widespread dopamine release in any 
experimental approach, and using mouse models associated with their inactivation did not show 
differences in dopamine release compared to wild-types. Lastly, density and morphology of 
microglia were characterised for the first time in a mouse model of chronic neuroinflammation, 
GFAP-IL6, exhibiting increased numbers and reactive phenotype. Surprisingly, light-induced 
dopamine release in GFAP-IL6 animals was not different compared to wild-types. 
Conclusions: This thesis provides novel evidence about dopamine dynamics in a variety of 
light conditions, transgenic mouse models and presence of pharmacological agents.  
Surprisingly, I found that rod input is both necessary and sufficient to evoke light-induced 
release dopamine across a wide range of light intensities, without quantifiable contribution 
from cones or ipRGCs, suggesting that electrophysiological inputs do not match dopamine 
release. Further, this data suggests that the main pathway that drives this increase in light-
induced dopamine release at light intensities where rods should be saturated is the primary rod 
pathway (with smaller contributions from the secondary and tertiary pathways) and involves 
bleaching adaptation of rods. 
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1.1. Vision 
The earliest evidence of life on Earth can be traced nearly 4 billion years ago1. Since then, 
sunlight has been a primordial force leading the evolution of living organisms. Fossil record, 
embryological development and comparative genetics on extant species allows traceability 
from the simplest to the most sophisticated mechanisms to detect light2. Simply, light sensing 
is advantageous to the survival of organisms in most environments3, even in the deepest and 
“darkest” places in the ocean4. Thus, the ability to respond to light is spread across all biological 
kingdoms. In many species light sensing occurs in the eye, a direct channel that allows the 
brain to interact with a portion of the electromagnetic spectrum.  
The eye is often considered as an optical instrument similar to a camera, it is capable of 
detecting and transforming photons contained in light into interpretable biochemical signals 
under a wide range of operational conditions. Anatomically, the eye is mostly covered by the 
sclera, a protective and connective tissue that helps to maintain the shape of the organ. The 
cornea is a curved and transparent tissue continuous to the sclera that transmits light, and 
protects the iris and the pupil. The pupil is a hole by which light passes through and whose size 
is regulated by the iris, a set of pigmented muscles that also provides our eye colour. The 
crystalline lens is located beneath the iris, suspended by ligaments attached to ciliary muscles 
that change the shape of the lens to alter the refractive index of the eye. This allows 
accommodation of the eye to view objects in focus over a wide range of distances. On the 
posterior part of the eye lays the retina, which is nourished by the retinal pigmented epithelium 
(RPE) and oxygenated by the choroid. 
The retina is a multi-layered photoreceptive tissue that triggers a cascade of chemical and 
electrical events in response to light (or its absence) and sends the information contained in 
light patterns to higher areas of the brain through the optic nerve. In adult humans the retina 
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spreads ~1,200 mm2 in surface area and ~400 µm in thickness5 (~15 mm2 and ~200 µm in 
mice6), which covers two-thirds of the posterior inner part of the eye. Retinal circuits are built 
from five types of neurons: photoreceptors, bipolar cells, ganglion cells, horizontal cells and 
amacrine cells; and three types of glia: Müller cells, astrocytes and microglia.  
The macula is a pigmented and rounded area (~20 mm2 in humans) located near the centre of 
the retina and responsible for central vision. This area provides great visual acuity compared 
to the rest of the retina that contributes to peripheral vision. The centre of the macula is called 
the fovea, and it consists of a depression in the inner retina with a high population of cones 
(~200,000 per mm2)7 and an absence of rods8, in contrast to the rest of the retina which is rod-
dominated. Cones are the photoreceptors responsible for colour, high-temporal and high-
resolution vision under bright light, whereas rods specialise in low-light conditions. This 
strategic adaptation of the eye allows humans to exhibit high acuity day-time vision, despite 
possessing a nocturnal retina by definition with ~95% rods and ~5% cones5. Rodents exhibit a 
similar retinal composition (~97% rods; ~3% cones) but lack any foveal specialisation9.  
As shown in Figure 1.1, the retina is organized in five distinct layers: three nuclear, and two 
synaptic layers. Bordering the innermost edge of those layers resides the RPE, which is a 
pigmented (melanin) cuboidal monolayer of cells essential for the maintenance and survival of 
the adjacent photoreceptor cell layer. The RPE performs a wide range of visual-maintaining 
functions, including: recycling of photoreceptor pigments, light absorption and protection 
against free radicals, transepithelial transport, spatial buffering of ions, production of growth 
factors, and immune modulation10.  
In the outer nuclear layer, rods and cones (also known as classical photoreceptors) convert 
photons from light into synaptic outputs that can be passed to second and third order neurons 
of the retina. In humans, three types of cones can be found depending on the wavelength 
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sensitivity range: short (blue), medium (green) and long (red); and only one type of rods 
(green). In the outer plexiform layer, photoreceptors synapse onto specific types of bipolar 
cells, rods generally synapse with rod bipolar cells whereas cones contact with cone bipolar 
cells. Horizontal cells laterally interact with photoreceptors to regulate and integrate their 
signals.  
Bipolar cell bodies are located in the inner nuclear layer, and transmit the signals from 
photoreceptors to retinal ganglion cells directly, or indirectly via amacrine cells, which are 
interneurons that mainly project their dendrites into the inner plexiform layer and interact with 
bipolar cells, ganglion cells and other amacrine cells. Further, a small percentage of ganglion 
cells (~1%) function as photoreceptors and are named intrinsically photoresponsive retinal 
ganglion cells (ipRGCs). 
Lastly, the axons of retinal ganglion cells form the optic nerve and send the visual information 
from the retina to higher areas of the brain11.  
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Figure 1.1. Vertical section of a human retina. Five main layers constitute the thickness of the retina, 
three nuclear and two synaptic or plexiform layers; from top to bottom: outer nuclear layer, outer 
plexiform layer, inner nuclear layer, inner plexiform layer, ganglion cell layer. Five types of neurons 
are discretely distributed across the retina, and the information flows vertically from classic 
photoreceptors (rods and cones) to bipolar cells, and then to ganglion cells. Lateral regulatory synapses 
occur at the outer and inner synaptic layers from horizontal and amacrine cells respectively. The retinal 
pigmented epithelium (RPE) is adjacent to the outermost part of the retina performing supportive 
functions. Image adapted from Mader, S & Windelspecht, M. Human Biology 13th edition, McGrawHill 
(2016). 
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1.2. Photoreceptors 
Photoreceptors are the specialised neurons that convert photons into biochemical signals, and 
three different types of photoreceptors are found in the retina: rods, cones and ipRGCs. 
Photoreceptors differ from each other in the visual pigment they contain, distribution across 
the retina, morphology and light-response properties. These variations reflect that each 
photoreceptor is specialised for different aspects of vision. 
 
1.2.1. Visual pigments 
Visual pigments are light-absorbing molecules that mediate vision, made of an opsin 
apoprotein (membrane-bound G-protein coupled receptor) covalently bound (through a Schiff-
base) to a chromophore retinal molecule (normally vitamin A or retinal). Once visual pigments 
absorb light, an isomerisation of the chromophore from -cis to –trans (or –trans to –cis if it is 
a photoisomerase) triggers a conformational change in the opsin, which activates the G-protein 
coupled receptor and initiates a downstream signalling known as phototransduction cascade. 
The chromophore retinal absorbs light at a maximum spectral sensitivity (λmax) of 380 nm when 
the Schiff-base linkage to the opsin is not protonated, although visual pigments can be activated 
at different wavelengths since the protonation state of the Schiff-base linkage change their 
spectral absorption properties12. 
Human rods and cones possess rod opsin and cone opsins respectively, which cause these cells 
to have different wavelength sensitivity: 498 nm (rods), 420 nm (S-cones), 530 nm (M-cones) 
and 560 nm (L-cones). Mice have similar rod opsins to humans, but they only possess S-cones 
(λmax = 359 nm) and M-cones (λmax = 505 nm). However both can be co-expressed within the 
same cone13–16. Melanopsin (λmax = 479 nm) is found in ipRGCs, and surprisingly for an opsin 
found in vertebrates, it displays several hallmarks of invertebrate opsins17. The major 
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difference between vertebrate and invertebrate opsins is that after activation by light, 
invertebrate opsins do not need to release the retinal from the opsin pocket. Melanopsin is a 
tristable18 pigment  that can bind both 11-cis-retinal or all-trans-retinal, acting as light sensor 
or photopigment regenerator respectively. Another important aspect of melanopsin is its 
activation profile, distributed by light across one active (blue light) and two silent (violet and 
red light) signalling states. Furthermore, pre-stimulation with red light enhances responses 
elicited with blue light18. 
 
1.2.2. Phototransduction cascade   
The process by which a photon triggers a biochemical cascade in photoreceptors is known as 
phototransduction. Rods and cones are in a continuous depolarised state during darkness, 
continually releasing glutamate at the ribbon synapse pre-synaptic to bipolar and horizontal 
cells. In response to light, rods and cones enter into a hyperpolarised state by a graded change 
in membrane potential, causing a reduction in glutamate release that is proportional to light 
intensity. Rod and cone photoresponses exhibit different speeds, photosensitivity and 
adaptation features in any given species, yet both are stable and reproducible within species. 
Phototransduction in rods and cones starts when the visual pigment absorbs a photon. Then, 
the opsin molecule becomes active, following a sequence of intermediaries states19 it triggers 
the activation of the protein transducin. Transducin is a heterotrimeric G-protein with different 
but similar α-subunits in rods and cones20 (the subunits are encoded by different genes, but can 
be interchanged artificially21). Transducin activates the enzyme phosphodiesterase, which 
hydrolyses free cGMP in the cytoplasm. This reduction in cGMP results in the closure of 
cGMP-gated channels located in the membrane, which reduces cation influx and 
hyperpolarises the membrane at the outer segment of the photoreceptor causing a reduction in 
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glutamate release from the synaptic terminal. An important principle present at different stages 
of the phototransduction cascade is amplification, which is the process by which the activation 
of a small number of G protein coupled receptors triggers a robust downstream signalling event. 
Following light exposure, for the photoreceptor to return to the initial dark-adapted state in a 
process known as dark adaptation, free levels of cGMP must be increased and all-trans-retinal 
needs to be released from the binding pocket and isomerised back to 11-cis-retinal in the RPE, 
so the photoreceptor can keep the responding to further light stimuli.  
Rods and cones can operate in a dynamic range of light intensities because both can modulate 
their sensitivity to light responses in a process known as light adaptation, which is intimately 
related with variations at the phototransduction cascade level. While rods are classically known 
to have a limited ability to adapt to high light intensities, cones exhibit an almost limitless 
capacity to adapt to bright light conditions. However, some authors recently argued against the 
popular belief of rods being functional only at scotopic light levels22–28. Furthermore, a recent 
paper found that after the initial reduction of rod responses caused by bright light exposure, 
rods slowly recover, and the more light given the more robust the rod response. The 
mechanisms suggested for these observations were adjustments in gain and bleaching 
adaptation28, explained in more detail below.  
In rods, long exposures to light decrease the probability of photon absorption because some of 
the rod opsins are bleached, as a result cGMP channels close, Ca2+ influx is reduced, and Ca2+ 
dissociates from Ca2+-binding proteins necessary for the functioning of the phototransduction 
cascade. The intracellular decrease in Ca2+ reduces three amplification steps of the 
phototransduction cascade and accelerates its termination by increasing the synthesis of cGMP, 
leading to a partial reopening of cGMP channels, the recovery of some circulating currents of 
cations, and therefore recovery of the operating range of the photoreceptor under increased 
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light conditions.Cones exhibit an additional resistance to saturation because their high rate of 
photopigment regeneration, low amplification of the signal, and fast termination of the 
phototransduction cascade29.  
In contrast to rods and cones, light activation of melanopsin causes depolarisation of the 
ipRGCs as opposed to hyperpolarisation in classical photoreceptors. The elements of the 
phototransduction cascade of melanopsin differ from rods and cones and closer resemble 
invertebrate opsins, and determination of some of the elements are still active areas of research. 
Light-activated melanopsin interacts with a G protein (Gq) that in turn activates phospholipase 
C, which leads to the generation of inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 
increases intracellular Ca2+, while DAG activates protein kinase C, and is further metabolised 
into arachidonic acid and other polyunsaturated fatty acids that lead to the opening of non-
selective cation channels30. It has been widely speculated that these channels are transient 
receptor potential (TRP) due to similarities with Drosophila phototransduction, 
immunoreactivity in ipRGCs, and blockage of the photoresponse with TRP antagonists31–33. 
Very recently, Jiang et al.34 proposed the involvement of hyperpolarisation-activated cyclic 
nucleotide-gated (HCN) channels in specific ipRGC subtypes. Adaptation of ipRGCs is 
modulated by the background light level, neuromodulators and circadian rhythms. Similar to 
rods and cones, light adaptation follows Weber-Fechner’s law (constancy in object perception 
regardless background illumination) and is partially dependent on Ca2+ 35. When ipRGCs are 
stimulated by bright steady light, the voltage response transiently rises before relaxing and 
shortening the peak time36,37, and under flickering bright light the amplitude of the response is 
also attenuated37. Further, ipRGCs receive negative feedback from dopamine38, adenosine39 
and melatonin40, which are neuromodulators associated with light adaptation and circadian 
rhythms. 
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1.2.3. Morphology, properties and functions 
Rods and cones differ in shape, type of photopigment they contain, distribution across the 
retina, and pattern of synaptic connections. However, both are located in the photoreceptor 
layer, stratify in the outer plexiform layer, and exhibit homologous structures with similar 
functions such as the outer segment, inner segment and synaptic terminal.  
The outer segment is a structure, conical in cones and cylindrical in rods, filled with a dense 
pile of discs made of cell membrane that contain densely packed transmembrane visual 
pigments (~25,000 molecules/μm2 41). Thus, the total number of pigments can be assessed using 
the outer segment volume, which is larger in rods compared to cones41. Additionally, rod discs 
are disconnected from the outer membrane, whereas in cones, the plasma membrane of the 
discs and the outer membrane are continuous. This fact accounts for the morphological 
difference in the surface area of rods, which is larger and more efficient than cones for photon 
detection. In rods, the noise (spontaneous chromophore isomerisation) present during the dark 
conditions is very low, and therefore single events can be detected above noise threshold due 
to the high stability of rod opsin and the large surface area of densely packed pigments. Rod 
opsin pigments exhibit high thermal stability and low spontaneous activation42 compared to 
cone pigments43, which improves the response accuracy at very low light intensities and allows 
a reliable single photon detection when dark-adapted44,45. Conversely, cones exhibit faster 
responses due to the fluidity in trafficking proteins and ions (such as Ca2+) provided by the high 
surface to volume ratio in their outer segment due to the connected discs. This fluency increases 
the termination of the phototransduction cascade and the traffic of regenerated photopigment, 
allowing cones to signal much faster than rods without undergoing saturation. For example, 
when 90% of the visual pigment is bleached, the current amplitude of cones is only half than 
the one measured in the dark46. These properties make rods perfect for high sensitivity and low 
acuity vision, whereas cones cover colour vision, high acuity and low sensitivity scenarios. 
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The outer segment is connected to the inner segment through a cilium, which is a bottled-neck 
point where all the proteins destined to the outer segment must pass through. The inner segment 
is filled with mitochondria that maintain the huge demand of energy required to maintain the 
membrane potential, especially in the dark. 
Rods and cones make ribbon synapses onto bipolar and horizontal cells, which consists of a 
configuration known as a triad with two lateral processes from a horizontal cell and one central 
process from a bipolar cell that lies in an invagination at the photoreceptor terminal. This 
structure allows synaptic vesicles to be densely localized and released continuously under dark 
conditions47. At this point, many rods converge into a single rod bipolar cell, which makes the 
rod system more sensitive to light detection because signals can be pooled, but at the cost of a 
lower resolution. Conversely, the less convergent relationship of cones to cone bipolar cells 
maximises acuity by sacrificing sensitivity. The most extreme example with least convergence 
to maximise resolution occurs in the midget system in central fovea of human or monkey 
retinae, where connections are as low as one to one. Additionally, rods and cones can 
communicate via gap junctions at the synaptic endings48 and share downstream pathways. 
At the ganglion cell layer, six populations of ipRGCs (M1-M6) can be distinguished in rodents 
and two in primates (M1 and M249–51), based on morphology, stratification, melanopsin 
expression level, and electrophysiological properties52–55. In contrast with classical 
photoreceptors, ipRGCs can stratify at different levels in both ON and/or OFF sublamina of 
the inner plexiform layer. While M1 cells solely stratify in the OFF sublamina; M2, M4, M5 
stratify in the ON sublamina; and M3, M6 stratify in both ON and OFF sublaminae55,56. All 
populations express melanopsin in soma and dendrites (~3 molecules/μm2)57 and despite being 
only ~900 cells in the entire mouse retina (~1% of total retinal ganglion cells),  ipRGCs produce 
a photoreceptive net across the retina due to their large dendritic fields58 with different kinetics 
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and sensitivities among the different ipRGCs populations56 (light response properties from the 
different ipRGCs subtypes are summarised in Table 1.1). 
As previously mentioned, ipRGCs depolarise in response to both flash and steady light, in 
contrast with the hyperpolarising response of rods and cones59, with a transient inward current 
proportional to the intensity of the flash57. Under dim steady light, ipRGCs respond with a slow 
integration time (~8 s) that allows summation of photons arriving at different times57 (once the 
light intensity increases, the small signals sum creating larger and more sustained responses). 
Particularly, the M1 subtype exhibits the fastest, largest and most sensitive responses among 
ipRGCs populations60, probably due to their high level of melanopsin expression61,62. 
Surprisingly, M1 ipRGCs often enter into depolarization block, which significantly reduces 
their spiking rate as the stimulus gets above a threshold. However, this does not affect their 
overall efficiency at coding the stimulus intensity as many subsets of M1 cells exhibit different 
depolarisation block light thresholds meaning the population as a whole cover a very wide 
range of light intensities63,64. 
In addition to intrinsic responses, ipRGCs can respond extrinsically to light stimulus via rod 
and cone inputs65. As previously mentioned, M1 stratify in the OFF sublamina and receive 
strong ectopic synapses from cone63,66,67 and rod63,68 ON bipolar cells . The role of OFF bipolar 
cells signalling into ipRGCs is minor and only evident after pharmacological manipulation of 
the retina63. Further, ipRGCs synapse with different amacrine cells50,69,70, and receive 
inhibitory inputs mediated by GABAA but not by glycine receptors
71. Specifically, the M1 
subtype establishes a reciprocal synapse with dopaminergic amacrine cells68,70,72 and it is 
suggested that some of these inhibitory inputs comes from dopaminergic amacrine cells since 
they co-release GABA and dopamine73–77, and in turn ipRGCs activate dopaminergic amacrine 
cells via glutamate release. While GABA inhibition seems to reduce the depolarisation block 
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at high irradiances and creates more transient responses at low light levels63, dopamine 
upregulates melanopsin expression78 and is suggested to improve the sensitivity of ipRGCs 
(because the more melanopsin molecules the more chances of capturing photons) during 
daytime (dopamine levels are higher in the daytime), although the increase in excitability is 
modest79. Interestingly, exclusive and artificial acute activation of ipRGCs can be assessed 
using chemogenetic tools such as designer receptors exclusively activated by designer drugs 
(DREADDs), which have been expressed exclusively in ipRGCs and activated with a designer 
drug that only targets that specific receptor during dark. Activation of ipRGCs using 
DREADDs resulted in a decrease in both a and b waves of the scotopic electroretinogram 
(ERG), suggesting that the modulation that ipRGCs exert onto the retina affects photoreceptors 
and, potentially, downstream pathways80.  
Table 1.1. Physiological properties of ipRGCs subtypes. Adapted from Schmidt et al. 201156 
The axons from ipRGCs project to several brain areas such as the suprachiasmatic nuclei (SCN) 
of the hypothalamus for circadian rhythms, the olivary pretectal nuclei (OPN) for pupillary 
light reflex (PLR), the lateral geniculate nucleus for vision forming, the superior colliculus for 
contrast and motion, the ventral subparaventricular zone for masking behaviour and the 
ventrolateral preoptic nucleus for sleep52,61,84–89. 
 
 Intrinsic light response Extrinsic light response 
M1 Large and high sensitivity81 
● ON-predominant, small and sustained 
● Vey weak OFF with pharmacology82 
M2 Small and low sensitivity81 ON-predominant, large and sustained81 
M3 Small and intermediate sensitivity83 ON-predominant, large and sustained83 
M4 Small and insensitive52 Small and sustained60 
M5 Small and insensitive52 Small and sustained60 
M6 Small and insensitive55 ON-predominant, small and sustained55 
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Despite different functions attributed to ipRGCs in the recent years, circadian entrainment and 
PLR are the most well-known and are mediated by the SCN and OPN respectively. Several 
melanopsin functions have been discovered using Opn4-/- mutants, the transgenic mouse model 
for melanopsin knockout that replaces the opsin with a tau-lacZ sequence. Mice show no 
morphological changes or number or projections of ipRGCs, but loss of photosensitivity84. The 
main functions of melanopsin are discussed below:  
Constriction of the pupil reduces light saturation, increases the depth of field and improves 
resolution. Although Opn4-/- mutants retain similar PLR responses as wild-types at low 
irradiances, they show incomplete (~80% 90)  and brief91 constriction at high light intensities. 
Further, animals lacking not only the photopigment melanopsin but all the ipRGCs65,92,93 
completely lack PLR responses meaning ipRGCs form the principal conduits conveying this 
light information to the OPN. 
Daily physiological and behavioural rhythms are a ubiquitous feature of mammals, and these 
are controlled by a molecular-based clock located in the SCN (central peacemaker) and in some 
organs94. However, the SCN needs a periodical reset based on environmental cues, and light is 
by far the most reliable. The process by which these rhythms repeat in a period of 24 hours 
under a light/dark cycle is known as photoentrainment, and ipRGCs are the main cells 
responsible for carrying the signal into the SCN95 (rods24 and cones96 also play a role in 
photoentrainment signalling through ipRGCs). Retinae themselves also possess a 
photoentrainable circadian oscillator and its photoentrainment, surprisingly, is not dependent 
on rods, cones or melanopsin, but neuropsin, a UV-sensitive opsin expressed in a subset of 
ganglion cells97.  
While melanopsin is well known for its role in other non-image forming processes such as 
alertness98, melatonin suppression99, sleep modulation100 or photophobia101, increasing 
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evidence suggests that ipRGCs contributes to many aspects of image-forming vision such as 
environmental illuminance discrimination86,87,102,103, contrast89 and adaptation of visual 
responses104. In addition, melanopsin photoreception has been shown to influence circuits 
involved in colour discrimination (in primate49), spatial information (M2-M5)60 and motion 
detection (M1-M4)60. Furthermore, when rod and cone phototransduction is knocked out but 
ipRGCs are still functional, an elementary form of pattern vision is suggested based on an 
improved performance in water maze tests102 and c-fos activation in visual cortex52. 
 
1.2.4. “Earliest photoreception” 
The development of the retina starts during the embryonic period and comprises several phases 
until retinal maturation is achieved in adult organisms. Retinal cell types originate from 
common multipotent progenitors, known as retinal progenitor cells (RPC). The purpose of 
RPCs is to expand the tissue during development, and stop their cycle at a certain point to start 
differentiation towards the mature form of a retinal neuron and establish synaptic connections. 
Birthdates are different for every retinal cell, generally it is as follows: retinal ganglion cells 
→ horizontal cells → cones → amacrine cells → rods → bipolar cells and Müller cells. The 
differentiation initiates in centre of the retina and spreads to the periphery105.  
Consequently, the three types of photoreceptor are born at different dates. In mice, retinal 
ganglion cells and cones are born at embryonic day 10 (E10), whereas rods appear at E12106. 
The outer segments of rods and cones both arise around postnatal day 4-6  (~P4-6) and reach 
adult length ~P19 – 25107. Similarly, dendrites from ipRGCs are clearly organized ~P6 and 
have adult-like stratification ~P19101. Melanopsin is the first opsin expressed in the retina 
~E10.5, followed by S-opsin ~P1, rod opsin ~P5, and M-opsin ~P7108. Further, ipRGCs become 
photosensitive before birth109 in contrast with photoreception of rods and cones ~P10110,111. 
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The maturation of ipRGCs involve a drop in density ~70% from P0 to P14, while the dendritic 
arbour size, sensitivity and sustained responses increase112,113. 
Proteins found at synaptic sites are a good indicator of the structural development of the retina. 
In the outer plexiform layer glutamate transporters are expressed ~P2 in cones and ~P8 in 
rods114, and the proteins that form ribbon synapses anchor ~P10. Even though ribbon synapses 
are not mature at this stage, glutamatergic transmission is active and plays a role in 
synaptogenesis115. mGluR6 receptors from ON bipolar cells start their development ~P5-P8116, 
and ON bipolar cells release glutamate to propagate retinal waves from P10-P15117–119. In the 
inner plexiform layer, amacrine cells develop synapses with other amacrine cells and ganglion 
cells prior to bipolar cells120. Around eye-opening the density of ribbon synapses in the inner 
plexiform layer reaches half of those present in an adult retinae121 and photoreceptor signalling 
becomes essential for maintaining healthy synapses with bipolar cells ~P14122,  causing retinal 
waves to cease123. Alterations from the photoreceptor flow of neurotransmitter into 
postsynaptic neurons (such as in rd/rd mice where classical photoreceptors degenerate) will 
cause sprouting of postsynaptic neurons into the outer nuclear layer124,125. Rd/rd mice are used 
as a model of human retinitis pigmentosa where rods and cones start degenerating during 
development until they are virtually gone ~P30126. Greferath et al.127 time-lined this 
degeneration in a double-mutant mouse rd-FTL, where a β-galactosidase reporter system was 
under the promoter of the c-fos gene. In photoreceptors c-fos is expressed before programmed 
cell death occurs128, which allows photoreceptor loss to be tracked. Until P8 no differences 
between wild-type and rd mice were observed, but rods started to degenerate ~P9-P18. Rods 
were virtually gone  ~P18 (~2% of rods remained129) and cones started to degenerate ~P19, 
with a maximum peak between P22 - P26. In adult mice (>P60) no trace of rods could be found 
and only 5% of the original population of cones was still present in the periphery129, although 
they are thought to be non-functional.  
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1.3. Retinal pathways 
Once classical photoreceptors respond to light triggering the phototransduction cascade and 
modulating the glutamate release at the post-synaptic site, the change in the gradient of 
neurotransmitter is sensed by second-order neurons in the visual pathway, bipolar cells, which 
in turn modulate their own glutamate release to feed information into third-order neurons, 
ganglion cells, that connect to the brain. Conversely to this flux of vertical information, 
horizontal and amacrine cells transmit information laterally between neurons in the same layer. 
All these fluxes of information are explained in more detail in the following sections. 
 
1.3.1. Cone pathways 
Rods and cones synapse onto bipolar cells in the outer plexiform layer. Bipolar cells are 
classified into rod and cone bipolar cells, depending if they make contact with rods or cones 
predominately. In addition, bipolar cells can be categorized in subclasses depending on their 
response to light: depolarising (ON) or hyperpolarising (OFF), determined by the expression 
of different glutamate receptors on the bipolar cells. From the 13 types of bipolar cells that 
have been found so far, 12 belong to ON and OFF cone bipolar cells, whereas only one ON 
rod bipolar cell has been found130. Therefore, after the photoreceptor level, light signals diverge 
in two distinct pathways: ON or OFF, which are conserved across species131. The axon 
terminals of cone bipolar cells stratify in the ON or OFF sublamina of the inner plexiform layer 
innervating either ON or OFF retinal ganglion cells respectively (except M1 ipRGCs whose 
dendrites stratify within the OFF sublamina and receive en passant synapses from ON bipolar 
cells66,132). 
All ON bipolar cells express mGluRs (mainly mGluR6 subtype133) on their presynaptic 
processes, which are essential for communication between photoreceptors and bipolar cells. 
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Signals onto mGluRs are called “sign-inverting” because ON bipolar cells depolarise in the 
presence of light contrary to photoreceptors. This modulation of polarity is caused by an 
associated ion channel (thought to be TRPM1134) that is coupled to a second messenger 
pathway triggered upon activation of the mGluR. mGluR6 responds to 2-amino-4-
phosphonobutyric acid (APB or L-AP4) completely blocking ON bipolar cell responses, which 
mimics the increase in glutamate release from photoreceptors in the dark135.  
Conversely, signals onto iGluRs are known as “sign-preserving” because OFF bipolar cells 
hyperpolarise in the presence of light as photoreceptors. In contrast with mGluRs, iGluRs are 
ligand-gated ion channels whose aperture is directly modulated by glutamate (without 
downstream signalling cascade). Two kinds of iGluRs are present in the dendrites of OFF 
bipolar cells (with distinct patterns of expression across species136–142): α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) and kainate (named due to the ability to respond to 
the glutamate agonists AMPA and kainate respectively), with different resensitization rates that 
confer preference for transient and sustained components of the visual stimulus respectively143 
(but see144). 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) is a competitive antagonist of 
AMPA and kainate receptors that completely blocks the responses of OFF-bipolar cells145.  
Another type of iGluR are N-methyl-D-aspartate (NMDA) receptors (named due to the ability 
to respond to NMDA), which are assembled by different combinations of subunits (NR1, 
NR2A through NR2D, and  NR3A and NR3B in mice146–148), each conferring specific 
properties.  NMDA receptors are non-selective cation channels that are especially permeable 
to Ca2+ and are unique in that at resting membrane potentials Mg2+ is bound to the receptor 
causing the blockage of the cation channel149,150. Only following membrane depolarisation, 
which displaces Mg2+ from the channels, allows it to open in response to glutamate151 (with 
slower kinetics than AMPA and kainate receptors). Additionally, both glycine and glutamate 
are necessary to activate NMDA receptors containing NR2 and NR1 subunits152–154. 
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Interestingly, NR1 and NR2 subunits have been found in photoreceptor terminals155,156, (cone) 
outer segments157 and bipolar cells158–163, although NMDA-mediated currents cannot be 
induced164–170 (except in isolated rod bipolar cells171). This suggests that NR1 subunits serve 
as glutamate autoreceptors, whereas NR2 subunits might provide a pathway for Ca2+ into the 
cone outer segments.  
The outer retinal synapses between photoreceptors and bipolar cells are modulated by lateral 
synapses from horizontal cells (mice only have one subtype that contacts both rods and 
cones172,173, but different subtypes with input preference for rods and cones exist in fish and 
macaque174–176), which are laterally interconnecting neurons with huge receptive fields177 (~6 
dendritic fields overlap at any given point of the retina178) made of gap junctions (Cx57 
subtype179). Gap junctions (or electrical synapses) are clusters of intracellular channels that 
allow direct diffusion of ions and small molecules (up to 1KDa) between adjacent cells and are 
regulated by circadian rhythmicity and light-driven neuromodulators such as adenosine, 
dopamine and nitric oxide180–184. These neuromodulators trigger intracellular signalling 
pathways, and among the most observed regulatory mechanisms, phosphorylation controls 
tasks related to the lifecycle of the gap junctions such as assembly, trafficking, degradation and 
channel aperture185,186. For instance, the modulation that light exerts on the coupling of 
horizontal cells187–190 starts with the light-induced release of dopamine and nitric oxide 
(explained in more detail in section “1.4. Dopamine in the retina”) that diffuses throughout the 
retina and causing an intracellular decrease of cAMP191,192 and cGMP193–195 concentration 
respectively, which results in a decrease in coupling196. However, the light-dependent  
modulation of coupling is more complex, exhibiting an n-shape with dark and light adapted 
retinae showing uncoupling between horizontal cells197–199, whereas mesopic (intermediate 
light intensities between photopic and scotopic) conditions exhibits maximum coupling200,201.  
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Horizontal cells provide a gain control system that improves the acuity of signals202–204 and 
contrast205,206 by measuring the environmental light illumination in a determined area and 
subtracting a proportional part by providing inhibitory input to rods and cones. Horizontal cells 
hyperpolarise in response to light causing γ-aminobutyric acid (GABA) release207,208 and 
activating GABA receptors located in photoreceptors209, bipolar cells137 and other horizontal 
cells210. GABA acts as an inhibitory neurotransmitter through Cl- mediated channels, and 
therefore activation of GABA receptors inhibits depolarisation of the neuron where these are 
expressed (different GABA receptor subtypes are suggested to mediate different signal 
properties, GABAA transient and GABAC sustained
211,212). The retina uses this lateral 
inhibition to create spatially opposing centre-surround receptive fields in order to increase the 
coding efficiency of the signal at an early stage of the visual process. An additional regulatory 
mechanism is caused by glutamate spillover from cones that receive negative feedback from 
horizontal cells, which triggers the activation of a glutamate-transporter associated Cl- current 
in neighbouring cones that increase their membrane potential213,214. 
Axon terminals of cone bipolar cells exhibit ribbon synapses215–217 with the dendrites of 
ganglion cells within the inner plexiform layer, which is further divided in five sublaminae 
based on the stratification of OFF (1st and 2nd sublaminae) or ON (3rd to 5th sublaminae) neurons 
(in complex retinae where bistratified ganglion cells218–220 and bipolar cells221–223 is common, 
the classification only applies to monostratified neurons). Retinal ganglion cells are positive 
for non-NMDA 224,225 and NMDA147,170,226,227 glutamate receptor subunits, whose combination 
mediates the final physiological responses of ganglion cells228–234. Transient responses235 and 
quantal release of glutamate236–238 is associated with non-NMDA receptors, whereas sustained 
responses145 and regulation of glutamate overflow238–241 is associated with NMDA receptors. 
These distribution suggest that NMDA receptors are often localized extra-synaptically and 
those postsynaptic to bipolar cells are activated by glutamate spillover240. 
21 
 
Similar to the lateral regulation that horizontal cells exert, amacrine cells receive glutamatergic 
input from bipolar cells  and regulate ganglion cell excitability either directly or indirectly 
through bipolar cells or additional amacrine cells using GABA and/or glycine as 
neurotransmitters242 (in fact, amacrine cells are commonly divided in wide/medium-field 
GABAergic243,244 and narrow-field glycinergic245–247 amacrine cells, which present preference 
for ON or OFF pathways respectively248–250). Amacrine cells express subunits of both mGluRs 
and iGluRs with certain preference for rod or cone signalling. For example, NR1 and NR2 
NMDA subunits, and mGluR7 are exclusive to cone bipolar cells155,156,159,251. On the inhibitory 
side, both GABA242,252,253 and glycine254–257 receptors are expressed in a variety of amacrine 
cells, and ON and OFF ganglion cells. Pharmacologically inhibiting GABA and glycine (with 
picrotoxin and strychnine respectively) modulates ganglion cell responses and provides 
information about the pattern of synaptic connections: GABAergic amacrine cells tend to do 
feedback (to bipolar cells) or feedforward inhibition (to ganglion cells) in reciprocal inhibitory 
circuits258–260 whereas glycinergic amacrine cells tend to do crossover inhibition261–264 
(different neuronal populations inhibit each other’s activation). Conversely, excitatory 
amacrine cells such as vGluT3 has been shown to contact both ON and OFF bipolar cells265 
and play a role in crossover and lateral excitation266, causing an increase in glutamate release 
in response to light267. Additionally, acetylcholine is released from starburst amacrine cells in 
response to light268,269 and has been suggested to modulate responses from other amacrine cells, 
bipolar cells and ganglion cells through nicotinic acetylcholine receptors270–273.  
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1.3.2. Rod pathways 
Rod signals are highly dependent on the cone pathway at different levels to ultimately feed 
information into ganglion cells. Thus, three different rod pathways are known depending on 
environmental light demands (pink arrows, Figure 1.2). 
The first and most sensitive pathway consists of rods → rod bipolar cells → AII amacrine cells 
→ ON or OFF cone bipolar cell → ON or OFF ganglion cell. The ribbon synapse between rod 
spherules and rod bipolar cells is densely filled with glutamate vesicles that excite the 
postsynaptic glutamate receptors located on the dendrites of the bipolar cells. Then, rod ON 
bipolar cell makes a glutamatergic synapse with AII amacrine cells274 (rod bipolar cells respond 
to continuous light with maintained depolarisation, whereas the AII amacrine cells respond 
with a  transient depolarisation275), which in turn communicate sign-conserving signals to ON 
cone bipolar cells (preferentially subtype CBb7)276 through gap junctions or sign-inverting 
signals to OFF cone bipolar cells through glycinergic synapses274. Additionally, A17 amacrine 
cells strongly modulate the kinetics of the synapse between rod bipolar cells → AII amacrine 
cells277,278 by releasing GABA onto the rod bipolar cell terminals279,280. Further, acetylcholine 
has been shown to trigger GABA released from A17 amacrine cells to rod bipolar cells281. 
These connections are suggested to help setting the sensitivity level over a large area of rods 
and rod bipolar cells282. Gap junction permeability at this level affects the signalling 
distribution of rod bipolar cells to ON and OFF cone pathways, as signal transmission to ON 
bipolar signals will be eliminated by gap junction closure but OFF bipolar signal transmission 
will persist. For instance, dopamine and nitric oxide are light-induced neuromodulators that 
decrease electrical coupling between AII amacrines283,284 and AII amacrine to cone ON bipolar 
cells285,286 (explained in more detail in section “1.4. Dopamine in the retina). Artificially, 
meclofenamic acid (MFA) is a potent (non-selective) gap junction blocker that blocks AII → 
AII and AII → cone bipolar electrical synapses287, in addition to others. AII amacrine cells are 
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the most abundant subtype of amacrine cells in the retina, they can be coupled with each other 
(Cx36 subtype288) or to cone bipolar cells (Cx36 and Cx45 subtypes288–291, but see292) serving 
as an electrical bridge for rods to utilise one of the cone pathways293 AII-AII coupling seems 
to synchronise signals transmitted from rods using the primary pathway and maintains the 
sensitivity of the signal294. Similar to horizontal cells, bright light or dark adaptation results in 
a decrease of coupling whereas mesopic conditions increases conductance295,296. This 
adaptation occurs because detection of photons in low light conditions requires an uncoupling 
of AII amacrine cells to prevent a diffusion of the small signals from rods (which can be down 
to a single photon), whereas in mesopic conditions summing small and synchronised signals 
reduces the background noise. Under bright light conditions limiting lateral interactions 
enhances high acuity cone signals as rod input to cone ON bipolar cells is removed by closure 
of AII → cone ON bipolar cell gap junctions285,297. AII amacrine cells exhibit both NMDA and 
non-NMDA receptor-mediated responses to kainate, AMPA251 and NMDA298, that can be 
blocked with CNQX, but not L-AP4251. AII amacrine cells are also responsive to exogenous 
application of GABA, glycine and tetrodotoxin (TTX)251.  
The second rod pathway is ~1 log unit less sensitive than the first299 and consists of rods 
coupling with cones through gap junctions at their spherules and pedicles respectively (via 
Cx35/36300,301), and deletion of Cx36 results in a loss of signal transmission through primary 
and secondary rod pathways302. These gap junctions allow rods to have access to both ON and 
OFF cone bipolar cells, and therefore ON and OFF ganglion cells. This pathway is used in high 
scotopic conditions and when the primary pathway is saturated303.  
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The third pathway is ~1 log unit less sensitive than the second299, and arose after finding direct 
connections between rods and OFF cone bipolar cells in different mammals304–311 although 
only one in five rods makes this synapse306. Rods involved in  these connections exhibit high 
electrical coupling between them306, which suggests pooling of signals and therefore decreased 
sensitivity of the signal. The third rod pathway is consistent with reports of OFF ganglion cells 
responses after blockage of the first rod pathways using L-AP4 (blocking rod → rod bipolar 
signal) and strychnine (blocking AII → OFF cone bipolar signal). Further, depletion of cones 
showed that they are not necessary for function of the tertiary pathway304, which is used in 
backlight object detection during dusk or dawn306. 
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Figure 1.2. Possible routes conveying light signals to dopaminergic amacrine cells.  Rod pathways 
are shown with pink arrows: Rod (dark grey) signals can enter cone ON bipolar cells (yellow) via three 
routes, rod → rod bipolar (white) → AII amacrine (dark green) → cone ON bipolar (primary rod 
pathway); rod → cone (light grey) → cone ON bipolar (secondary rod pathway); or rod → cone ON 
bipolar (tertiary pathway). The first two pathways require gap junction connectivity (red cylinders). 
Intrinsically photoresponsive retinal ganglion cells (ipRGCs; dark blue), may input directly or indirectly 
to dopaminergic amacrine cells (DA amacrine; bright green). PRL: photoreceptor layer, OPL: outer 
plexiform layer, INL: inner nuclear layer, IPL: inner plexiform layer, GCL: ganglion cell layer.  
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1.4. Dopamine in the retina 
George Barger and James Ewens synthesised dopamine for the first time in 1910 at Wellcome 
Laboratories in London, England312. During the following years research in biosynthesis and 
physiological actions of dopamine escalated313 until a remarkable finding occurred in 1957, 
Arvid Carlsson demonstrated the role of dopamine as a neurotransmitter in the nervous 
system314. Today, we know that dopamine is involved in a broad range of functions as a brain 
neurotransmitter: mood, reward, cognition, locomotion, attention and sleep315. In the retina, 
adaptation to presenting light conditions relies considerably on modulation of retinal pathways 
by dopamine. In this section, the neuromodulatory roles of dopamine in the retina and the 
different inputs that trigger retinal dopamine release will be discussed. 
Retinal monoamine presence was first observed in 1963 (using Falck-Hillarp’s method316) 
between the inner plexiform layer and the inner nuclear layer317. Most likely, researchers were 
looking at dopaminergic amacrine cells, which later would be found in that region in many 
different species318. Dopaminergic amacrine cells are the only neurons in the retina capable of 
synthetising and releasing dopamine, although they also co-release GABA319,320 and ATP321. 
Tyrosine hydroxylase (TH) is the rate limiting enzyme to produce dopamine, noradrenaline 
and adrenaline, and has been extensively used to label dopaminergic amacrine cells. However, 
two types of cells express TH: type 1 and type 2 catecholaminergic amacrine cells, which differ 
in soma size (type 1 have larger somas than type 2), plane of arborisation in the inner plexiform 
layer (type 1 arborizes in stratum 1, whereas type 2 arborizes in stratum 3), levels of TH (type 
1 contain ~3.5-fold more than type 2) and cell density (type 2 is more dense than type 1)322. 
From these, type 1 is thought to be dopaminergic and type 2 noradrenergic323, which was 
assessed using different staining strategies in mouse models discussed below: 
27 
 
Human placental alkaline phosphatase (PLAP), an enzyme located on the outer surface of the 
cell membrane, was linked to a TH promoter to allow visualisation of these cells with indolyl 
phosphate324. The visualisation of PLAP is correlated with the amount of TH that the cell 
contains, which results in type 1 but not type 2 cell staining at short incubation times325. Further 
characterisation can be assessed with longer incubation times, revealing the aforementioned 
differences between both types in morphology, plane of arborisation and cell density. 
Additionally, when TH antibody was applied in TH-PLAP retinae only the same type 1 cells 
were immunostained in both cases324, providing an extra manner of staining type 1 cells. 
Isolated TH-PLAP+ cells were shown to release dopamine319, which provides further evidence 
to confirm their dopaminergic profile. However, a disadvantage TH-PLAP retina staining 
present is that cells can only be stained and visualised in dispersed cell culture. In order to 
visualise dopaminergic cells in living retinae, a transgenic mouse line was generated where red 
fluorescent protein (RFP) was driven by the TH promoter326. In TH-RFP retinae both types of 
catecholaminergic amacrine cells were stained and clearly exhibited previously described 
differences in morphology, plane of arborisation and cell density. This mouse model is 
probably the most used to characterise physiological responses from dopaminergic amacrine 
cells in the murine retina77,327–333. In contrast, transgenic models generated with a Cre 
recombinase and a reporter fluorescent protein system do not label type 1 catecholaminergic 
cells consistently, but GABAergic, glycinergic and few ganglion cells334. Some examples of 
these models are TH-BAC-Cre, TH-CRE and DAT-CRE animals, which are not suitable to 
study retinal dopaminergic amacrine cells. In addition, the Gensat retina project (founded by 
the National Institutes of Health) produced various BAC transgenic mice for general use within 
the neuroscience community335. For instance, in Drd2-eGFP mice the promoter for dopamine 
receptor 2 drives the expression of green fluorescent protein (GFP). However, one drawback 
of this model is that the expression of this specific subtype of dopamine receptor is not 
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exclusive of dopaminergic amacrine cells (all dopamine receptors subtypes are explained in 
further detail later in this section), and thus additional staining (for example TH) is needed to 
be certain of the cell identity. Further, to perform in vivo experiments, a two-photon microscope 
is needed in order to visualise the GFP+ cells and avoid excitation of the retina336.  
In summary, dopaminergic amacrine cells (or type 1 catecholaminergic cells) are regularly 
distributed across the retina in a range of 10 to 200 cells per mm2 depending on species, and 
their dendrites form a dense network that virtually covers the entire retina324,326,337–339. The 
stratification of dopaminergic amacrine cells occurs mainly in the stratum 1 (OFF) of the inner 
plexiform layer, but axon-like processes can be emitted to the stratum 3 (ON) of the inner 
plexiform layer, ganglion cell layer or into the outer plexiform layer77,326,340–345. In fact, 
dopaminergic amacrine cells do not make morphologically defined synapses outside stratum 
166,325, which are GABAergic since there are no dopaminergic synapses in the retina due to its 
propagation by volume transmission.  
Dopaminergic amacrine cells respond to light inputs77,181,350–359,327,360–369,330,370,333,336,346–349 and 
circadian rhythms371–380 in several species due to the inputs received from rods, cones and 
ipRGCs (whether these inputs cause actual dopamine release or not is discussed in detail in this 
thesis). Three subtypes of dopaminergic amacrine cells can be identified depending on their 
electrophysiological responses to light: insensitive, transient elevation of spike frequency and 
sustained elevation of spike frequency77. Additionally, dopaminergic amacrine cells fire action 
potentials spontaneously75,324 that can be increased with kainate, and decreased with GABA or 
glycine324. Dopaminergic amacrine cells specifically express NR2A and NR2B NMDA 
subunits, the latter being sensitive to dopamine and causing NMDA receptor hypofunction381. 
Since dopaminergic amacrine cells receive inputs from GABAergic and glycinergic amacrine 
cells (that in turn receive synapses from OFF bipolar cells330), authors suggested that 
29 
 
dopaminergic amacrine cells are inhibited during dark, and light removes that inhibition and 
triggers action potentials received from ON bipolar cells and ipRGCs330,336.  
Apart from light influence, fluctuations in dopamine release at different times of day are 
strongly related to melatonin rhythms. Melatonin is a hormone synthesised in photoreceptors 
and controlled by a circadian rhythm modulated by dopamine and light. Contrary to dopamine 
rhythmicity, melatonin levels increase under darkness and decrease in the light382–384. Despite 
dopaminergic amacrine cells expressing the core circadian clock genes385–388, the ability to 
generate circadian rhythms of dopamine metabolism is dependent on the melatonin feedback 
loop and retinal dopamine is not able to follow a circadian rhythm in mice incapable of 
synthesising melatonin374,389. However, the reverse is not true and disruption of dopamine 
signalling does not stop the circadian rhythm of the enzyme responsible for melatonin 
production in photoreceptors390.  
Dopamine, acting on dopamine receptors (D1-like; D2-like), mediates multiple trophic roles 
and physiological adaptation mechanisms across the entire retina. The metabolic pathway for 
dopamine formation initiates with L-tyrosine (an essential amino acid from the diet) gaining a 
hydroxyl group by the action of tyrosine hydroxylase, and becoming L-3,4-
dihydroxyphenylalanine (L-DOPA), which is decarboxylated by DOPA-decarboxylase, finally 
becoming dopamine. Once synthesised, dopamine can be stored in vesicles, further 
metabolised or released extracellularly. Dopamine undergoes reuptake by dopaminergic 
amacrine cells themselves through dopamine transporters181,374,391 and 3,4-dihydroxyphenyl-
acetic acid (DOPAC) is one of the major intermediaries of dopamine metabolism formed by 
monoamine oxidase followed reuptake392. The ratio of DOPAC to dopamine content is thought 
to be a good indicator of dopamine turnover extensively used in the literature181,368,400–403,370,393–
399, as it is generally only formed following dopamine release181.  
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As previously discussed, dopamine acts through dopamine receptors, which belong to the 
superclass of G-protein coupled family, and can be classified in two different families: D1-like 
(D1 and D5) and D2-like (D2, D3 and D4)404 that enhance or inhibit internal cAMP production 
respectively by modulating the activity of adenylyl cyclase405. This suggests that dopamine has 
differential neuromodulatory effects depending on which receptors are expressed at its target. 
Using immunocytohistochemistry, dopamine receptors have been identified in all types of 
retinal cells (Table 1.2), and the distribution of both families of dopamine receptors throughout 
different cell types on the entire retina provides a global fine-tuned modulation based on the 
exposure and concentration of dopamine181,406. In fact, despite the confined production and 
release of dopamine in the inner nuclear layer, dopamine spreads by volume transmission and 
travels tens of micrometers across the entire retina407. Thus, both families exhibit different 
sensitivity thresholds depending on the distance to the dopaminergic source181, D1-like being 
lower (~10 nM408) than D2-like (~1 nM409).  
Localisation Dopamine receptor subtype 
RPE D2 (in mouse410 and human411) and D5 (in cow412 and human cell line413) 
Rods and cones D2 (in salamander and frog414) and D4 (in mouse415) 
Cone bipolar, 
horizontal, amacrine 
and ganglion cells 
D1 (in rat416, mouse, hamster and macaque417) and D2 in dopaminergic 
amacrine cells418 to auto inhibit TH activity419 
Müller cells D2 (in rat420) 
Table 1.2. Dopamine receptor subtypes across the retina.  
In photoreceptors, dopamine modulates light responses, melatonin synthesis, retinomotor 
movements, disc shedding and gap junction conductivity421–424. Since photoreceptors possess 
D2-like receptors, dopamine leads to a decrease in cAMP (observed in chicken425, rat426, 
mouse415,427,428 and frog429) and a decreased capacity in further responses to light due to a 
downregulation of the phototransduction cascade429. Overall, dopamine modulates 
photoreceptor physiology to favour cone activity during daytime or high light intensities181, 
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and rod enhancement at night or dim light intensities430. Post-synaptic to photoreceptors, 
dopamine decreases coupling among horizontal cells431–433 by either a change in gap-junction 
permeability434 or number of channels435, and inhibits GABA release436. In bipolar cells, 
dopamine plays a role in gain control mechanism437, modulates the receptive field surround of 
ON cone bipolar cells 438, enhances light responses of rod-driven bipolar cells (by controlling 
a sustained Cl- current via GABAC receptor modulation, with horizontal cells as the suggested 
source of GABA430,439) and potentiates iGluRs of OFF cone bipolar cells440. In ganglion cells, 
dopamine modifies the spontaneous activity of ganglion cells, centre-surround balance of their 
receptive field441,442, and augments firing synchronisation between ganglion cells by increasing 
gap junction coupling (mouse443–445, but reduced in rat446 and cat447). In addition, dopamine 
modulates the photoresponsive activity of ipRGCs by attenuating melanopsin-based currents53. 
 
1.4.1. Light inputs to dopaminergic amacrine cells  
Dopaminergic amacrine cells respond to light via inputs from rods, cones and 
ipRGCs327,329,330,333,336, although their activation  (assessed with electrophysiology and c-fos 
staining of TH+ cells) does not always correlate with actual dopamine release368,448–450. In this 
section, I review the different pathways that light information uses to travel from 
photoreceptors to dopaminergic amacrine cells that were assessed using various techniques, 
and upcoming experimental chapters will address which of these pathways trigger actual 
dopamine release using several mouse models under different light conditions. 
Rods are thought to rely on cone pathways to reach dopaminergic amacrine cells in three 
pathways, the primary uses AII amacrine cells as a bridge between both photoreceptor 
circuitries: rod → rod bipolar → AII amacrine → cone ON bipolar cell → dopaminergic 
amacrine cells, the secondary uses gap junctions at photoreceptor level: rod → cone → cone 
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bipolar → dopaminergic amacrine, and the tertiary consists in a direct input from rod → cone 
bipolar cell → dopaminergic amacrine cell. Rod bipolar cells should not be directly involved 
in an excitatory input because they project to stratum 5 and dopaminergic amacrine cells 
stratify in stratum 1 (but see451). Rod bipolar cells however are suggested to be involved 
indirectly by inputting into glycinergic amacrine cells (different from AII) that inhibit 
dopaminergic amacrine cells upon illumination452.  
Zhao et al. showed that under steady or flickering dim to intermediate light conditions, rods 
provide an excitatory electrophysiological input into dopaminergic amacrine cells mainly 
through pathways that involve gap junctions (primary and secondary), and that rods alone are 
responsible for stimulation of dopaminergic amacrine cells at low light intensities333 (with 
similar responses in both dorsal and ventral retina). Unfortunately, Zhao and colleagues did not 
test rods inputs at bright light intensities because for their preparations the RPE was removed 
and this would cause irreversible bleaching of rod opsins resulting in an experimental bias 
(although months later, Tikidji-Hamburyan et al. recorded rod responses under bright light 
without the RPE attached to the retina28). Nonetheless, they suggest that rods could signal to 
some dopaminergic amacrine cells via the tertiary pathway at high light intensities. Indeed, the 
hypothesis of rods driving the majority of light-induced dopamine release was tested in Gnat1-
/- mouse model, that lack functional rods (although a small response is retained453–455). Those 
mice exhibited ~3-fold lower (although still significant) increase in dopamine turnover 
compared to wild-type mice in response to bright steady light, and activated ~5% of 
dopaminergic amacrine cells in contrast with ~100% in light-pulsed wild-type animals 
(determined by c-fos staining)368. Additionally, Gnat1-/- animals also showed a decreased 
dopamine turnover overall during both day and night399. These results together suggest that 
rods are a main contributor to actual dopamine release even at bright light intensities. 
33 
 
Under intermediate and bright light conditions (both steady and flickering), cones provide an 
excitatory electrophysiological input into dopaminergic amacrine cells (with more pronounced 
responses in the dorsal retina) via cone ON bipolar cells → dopaminergic amacrine cells66 
(which in fact is a reciprocal synapse with release of glutamate and GABA respectively that 
creates a balance of excitatory and inhibitory signals to potentially inhibit an excessive input345) 
or indirectly through ipRGCs330 (with more pronounced responses in the dorsal retina). Further, 
two inhibitory pathways are suggested to be cone-driven, an ON inhibition at light onset: cone 
→ OFF bipolar cell → glycinergic amacrine cell → dopaminergic amacrine cell (mediated by 
AMPA receptors) and an OFF inhibition at light offset: cone → OFF bipolar cell → 
GABAergic/glycinergic amacrine cell → dopaminergic amacrine cell (mediated by kainate 
receptors). Indeed, Qiao et al. generated a “cone-only” mouse model (double knock-out Gnat1-
/- and Opn4-/-) and found that after light pulsing, cones evoke three different 
electrophysiological responses in dopaminergic amacrine cells: one ON excitatory current 
(mediated by cone ON bipolar cells and ipRGCs), and an OFF and a delayed ON inhibitory 
currents (mediated by OFF bipolar cells; Figure 1.3). From those, ~70% of the tested 
dopaminergic amacrine cells exhibited exclusively ON responses, ~20% ON and OFF, and 
~10% all three. However, these “cone-only” mice only caused ~1.2-fold increase in DOPAC: 
dopamine ratio after bright light exposure, in agreement with the results from Gnat1-/- mouse 
previously discussed330,368 and in contrast with ~3.5-fold increase in wild-type mice368. These 
results suggest that cones provide a balanced combination of excitatory and inhibitory inputs 
to dopaminergic amacrine cells, and that they contribute to dopamine release (at intermediate 
to bright light intensities) much less than rods. Interestingly, spiking from dopaminergic 
amacrine cells decline rapidly at the onset of a strongly depolarising synaptic input (caused by 
either steady or low rate flicker) and dopaminergic amacrine cells enter into depolarisation 
block, which is relieved when the depolarising input decays336.  
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Figure 1.3. Proposed cone pathways conveying cone signals to dopaminergic amacrine cells.  
Excitatory ON responses are mediated by ON bipolar cells directly (red) and ipRGCs (violet). OFF 
inhibition is mediated by type 2 and 3a OFF bipolar cells through GABAergic/glycinergic amacrine 
cells (cyan), whereas ON inhibition (d-ON response) is mediated by type 1 OFF bipolar cells via 
glycinergic amacrine cells (orange). a: sublamina a / OFF layer; b: sublamina b / ON layer; AC: 
amacrine cell; C: cone; DA: dopaminergic amacrine cell; GC: ganglion cell; GCL: ganglion cell layer; 
INL: inner nuclear layer; IPL: inner plexiform layer; ipRGC: intrinsically photoresponsive retinal 
ganglion cell; ONL: outer nuclear layer; OPL: outer plexiform layer. Image adapted from Qiao et al. 
Multiple cone pathways are involved in photic regulation of retinal dopamine. Scientific Reports (2016). 
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As previously mentioned, morphological evidence suggests that M1 ipRGCs and dopaminergic 
amacrine cells exhibit reciprocal synapses and these connections are glutamatergic from 
ipRGCs456 and act on AMPA/kainate receptors of dopaminergic amacrine cells457, whereas 
these in return inhibit ipRGCs458. The intrinsic electrophysiological input from ipRGCs to 
dopamine amacrine cells is independent from rods or cones signals327,328,330,333,339,458. Indeed, 
dopaminergic amacrine cells exhibited a light-induced robust and sustained response in rd1 
animals327 mediated by AMPA and NMDA currents331. Signalling from ipRGCs provides 
sustained responses in dopaminergic amacrine cells of wild-type mouse in presence of L-AP4 
(which blocks rod and cone ON pathways)327 and rd/rd animals (which lack rods or cones, but 
intact ipRGCs are preserved)329. However, when assessing actual dopamine release in Opn4-/- 
mice, those exhibit similar dopamine turnover levels as wild-type368. Further, rd/rd cl mice are 
not able to release dopamine in response to the same bright light stimulus as the one received 
by Opn4-/- and wild-type mice368. These results suggest that 1) dopamine release does not 
correlate with dopaminergic amacrine cells activation assessed via nuclear c-fos (although c-
fos+ dopaminergic amacrine cells are reduced in rd/rd animals compared to wild-type) or 
depolarisation of the soma via electrophysiology, and 2) ipRGC signalling does not seem to be 
sufficient to elicit light-induced dopamine release despite the clear electrophysiological inputs. 
In summary, responses from dopaminergic amacrine cells are the consequence of the 
integration of several intensity-dependent stimuli originating in the three types of retinal 
photoreceptors that result in a balance of excitatory and inhibitory inputs. Surprisingly 
however, actual light-induced dopamine release is mainly dependent on rod inputs with minor 
contribution from cones and/or ipRGCs, and occurs towards the photopic range. Table 1.3 
summarises the current understanding of the pharmacological modulation that common drugs 
exert on retinal pathways that input into dopaminergic amacrine cells. 
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Table 1.3. Pharmacological modulation of dopamine release. AP5: (2R)-amino-5-phosphonovaleric 
acid; (2R)-amino-5-phosphonopentanoate, CNQX: 6-cyano-7-nitroquinoxaline-2,3-dione, D2R: 
Dopamine subtype 2 receptor, DA: dopamine, DAC: dopaminergic amacrine cell, GABA: γ-
aminobutyric acid, ipRGCs: intrinsically photoresponsive retinal ganglion cells, L-AP4: L-2-amino-4-
phosphonobutyric acid, MFA: meclofenamic acid, TH: tyrosine hydroxylase, TTX: tetrodotoxin 
 
Drug Effects on dopaminergic amacrine cells 
AP5 
(NMDA antagonist) 
Reduces ipRGC-based responses331 
CNQX 
(AMPA/kainate 
antagonist) 
Blocks ipRGC, ON bipolar cell328 and OFF bipolar cell inputs330 and thus, 
light-induced transient responses in wild-type324,328 and rd/rd  animals327 
Dopamine 
DACs themselves are inhibited by DA via D2R398,414,417,459. Attenuates rod 
inputs by uncoupling AII amacrine cells283 and photoreceptors398, and 
attenuates DAC responses via reduction of melanopsin-based 
photocurrent38 and NMDA-gated currents381.  
NMDA 
Induces GABA release from amacrine cells that can be reversed with 
dopamine460,461 and increases AII gap junction connectivity462. Causes 
DAC depolarisation331 
GABA 
Hyperpolarises DAC324 and (muscimol, a GABA agonist) inhibits light-
induced DA release356,463. Co-released GABA from DACs in natural 
conditions, prevents excessive input from ON bipolar cells319,320. 
Glycine Hyperpolarises DAC324 and reduces light-induced DA release464 
L-AP4 
(mGluR6 agonist) 
Abolishes light-induced transient responses309,328 and DA release362,364 
MFA 
(gap junction blocker) 
Blocks AII electrical synapses and prevents rod signals into DACs287, in 
Cx36-/- mouse, DACs exhibit reduced responses to scotopic light333  
Picrotoxin 
(GABAA/C antagonist) 
Stimulates TH activity in dark and has no effect on active TH. Increases 
DA turnover188,350,354,356,362, the effects can be reversed with L-AP4362350,465 
Strychnine 
(Glycine R antagonist) 
Abolishes hyperpolarisation triggered by glycine324 and suppresses the 
OFF response of DACs330, increases DOPAC in dark (but see466) but not 
additionally in light467 
TTX 
(Na-channel blocker) 
Blocks ipRGC direct and indirect (via ON bipolar cells) inputs into 
DACs329, DAC themselves324,457 and reduces responses of ~50% DAC 
(the ones that receive input generated from ipRGCs)330 
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1.5. Aims 
In the retina, dopamine is exclusively synthesised and released by dopaminergic amacrine cells 
and plays multiple roles in physiological functions such as light adaptation, circadian rhythms, 
development and cell survival. Dopaminergic amacrine cells are activated in response to light 
because of the inputs they receive from the three types of photoreceptors: rods, cones and 
ipRGCs. However, given the discrepancy in the literature between electrophysiological and/or 
nuclear activation of dopaminergic amacrine cells and actual release of the neurotransmitter 
dopamine, a systematic approach clarifying this disagreement seems necessary. Therefore, the 
work undertaken in this thesis aimed to: 
1) Optimise an analytical protocol to reliably quantify dopamine and its primary 
metabolite DOPAC in the murine retinae. 
2) Determine the conditions that trigger light-induced dopamine release in the retina. 
3) Determine the photoreceptive origin (rods, cones or ipRGCs) and pathways employed 
of the inputs that trigger light-induced dopamine release in the retina. 
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CHAPTER 2:                                                  
Materials and Methods 
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2.1. Animals  
All procedures were conducted in accordance with the Australian Code for the Care and Use 
of Animals for Scientific Purposes and were approved and monitored by the Western Sydney 
University Animal Care and Ethic Committee under protocols A10396, A11900 and A12402. 
Mice were bred at our animal facility (Campbelltown Campus, Western Sydney University, 
Australia) and maintained under a 12 h light (~300 lux): 12 h dark cycle. Males and females ≥ 
60 days (unless specified otherwise) were used. Prior to experiments and with the purpose to 
dark-adapt retinae, mice were kept in complete darkness ≥ 18 h for CT6 (midday) or ≥ 6 h for 
CT18 (midnight). Several mouse genotypes were used: wild-type C57BL/6J (Animal 
Resources Centre, Canning Vale, Australia), Gnat2A518G (University of Melbourne, 
Australia468; backcrossed to C57BL/6J), rd/rd (Animal Resources Centre, Canning Vale, 
Australia), Opn4Cre/Cre (Johns Hopkins University52, USA), Opn1mwR (Dr. Jeremy Nathans469) 
and GFAP-IL6 (University of Sydney470, Australia). Mouse models are explained in more 
detail below: 
C57BL/J6 animals are used as wild-type control in this project due to significant prior literature 
using them as a background strain for transgenic lines. However, these mice exhibit non 
detectable melatonin levels471, an important consideration when assessing retinal circadian 
rhythms because its absence affects both the regulation of retinal rhythmicity and inhibition of 
dopamine389. 
Gnat2A518G mice are used as model for cone photoreceptor inactivation since they have a natural 
missense mutation (due to a single base pair substitution of adenine for guanine), that causes 
misfolding of the  cone specific α-transducin subunit468. Indeed, ERGs from these animals 
show normal rod responses and no appreciable cone responses468. A reduction in the total 
number of cones occurs at 3 months of age compared to wild-type controls, accompanied by a 
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progressive remodelling at bipolar and horizontal cell synapses468. While more models for cone 
inactivation are available (such as Gnat2cpfl3, cpfl1 or CNGA3-/-), these suffer too much retinal 
degeneration or still exhibit ERG cone responses at young ages472–474.  
rd/rd is a mouse model used to study retinitis pigmentosa in humans. These animals possess a  
natural nonsense mutation in the rod phosphodiesterase475 that leads to rod and then cone 
degeneration within a month. Moreover, these animals suffer one of the most severe 
remodelling among retinal degenerate models476. After photoreceptor degeneration, the 
remaining cells in the retina (horizontal, amacrine, bipolar and retinal ganglion cells) form a 
tangle where new synapses are formed. Additionally, Müller cells and RPE migrate and disrupt 
the lamination of both plexiform layer477. 
Opn4Cre/Cre is a transgenic mouse model of melanopsin inactivation created by expressing Cre 
recombinase in the place of melanopsin gene (OPN4)52. The ipRGCs of these animals do not 
show changes in number, morphology or projections478, but these cannot respond intrinsically 
to light.  On the other hand, the activity of rods and cones remains unaltered.  
Opn1mwR is a transgenic mouse model where the opsin of M-cones has been substituted by the 
one in human L-cones469, resulting in a ~45 nm red shift in spectral sensitivity. Other than that, 
the retinae of these animals seems as functional as wild-type animals with robust ERG 
responses, indistinguishable patterns of immunostained cones, and ganglion cell responses 
originated in “red cones”469. 
GFAP-IL6 is a transgenic mouse model whose interleukin 6 (IL-6) is under the regulatory 
control of the glial fibrillary acidic protein (GFAP)479. This means that IL-6 is constitutively 
expressed in the central nervous system, causing severe neurologic symptoms and advanced 
neurodegeneration due to a lifelong inflammatory responses from microglia and astrocytes480.  
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2.2. Dopamine release experiments 
2.2.1. Light sources 
Dim red light (>650 nm) from a head torch or infrared light (>800 nm) from night-vision 
goggles were used for injections and dissections under dark conditions. A LED lamp (EDGE 
SAD Lightbox, Litebook) was used for light pulsing, and different light intensities were 
achieved by adding 0.9 log unit neutral density (ND) film (Lee) to the lamp. For specific 
wavelength pulses, another LED lamp (MCWHLP1, Thor Labs) was coupled with a red (624 
nm) or blue (434 nm) filter. All the light intensities used are summarised in Table 2.1, and the 
spectrograms presented in Figure 2.1. The measurements of the light source were conducted 
using different methodologies:  
A photometer (L202 PMS, Macam) measured the light intensities displayed in lux units, and a 
spectrometer (USB2000+XR1-ES, Ocean Optics) measured the light spectrum. Effective 
photons were calculated using the relative photopigment absorption spectra by Govardovskii481 
multiplied by the spectrum of the light source and the specific energy (in µW/cm2) of a single 
photon at each wavelength. Rod isomerisations were assessed by converting effective rod 
photons to corneal and retinal irradiance based on Lyubarsky calculations482, which included 
corrections that considered the wavelengths transmitted through the ocular tissues483, and the 
size of a dilated pupil with mydriatics (3.2 mm2). Corrections applied to the ex vivo experiments 
were conducted considering corneal and lens absence (since the retina is facing the light source 
directly), and the aperture of the pupil was considered to be the diameter of the eye, 8 mm2. 
Effective photons are used in this thesis so that activation can be compared between 
photoreceptors. For publications, however, I have used Rh*/rod/s. 
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Light source + filter type W/m2 Lux Log rod photons cm-2 s-1 Log R*rod-1s-1 
LED (max. intensity) 36.14 10369.21 15.99 7.34 
LED + 1 0.9 ND Filter 4.54 1305.40 15.09 6.44 
LED + 2 0.9 ND Filters 0.57 164.34 14.19 5.54 
LED + 3 0.9 ND Filters 0.07 20.68 13.29 4.64 
Head torch (>650 nm) 0.05 0.2 8.79 0.01 
Infrared goggles (>800 nm) 0.6 <0.001 5.82 -2.47 
Table 2.1. Intensity of light sources expressed in different units.  
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Figure 2.1 Light sources relative spectrograms. Normalised spectrograph of the raw LED light 
source (grey) or with the 434 nm filter (blue) or 624 nm filter (red). 
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Figure 2.2 Opsin nomograms of the murine retina. L-cones (which belong to human and are present 
only in the genetically engineered Opn1mwR mice) in red (λmax= 556 nm), M-cones in green (λmax= 508 
nm), S-cones in purple (λmax= 360 nm), rods in black (λmax= 498 nm) and melanopsin in blue (λmax= 480 
nm).  
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2.2.2. Light pulsing, sample preparation and analysis 
For in vivo experiments, mice were handled under “dark” conditions (either dim red or 
infrared), anaesthetised with an intraperitoneal injection of 70 mg/kg Ketamine + 7 mg/kg 
Xylazine (Troy Laboratories), and their eyes dilated with Tropicamide 1% (Alcon) before light 
pulsing. Light pulses were conducted with the light source ~1.5 cm above the animal (meaning 
retinal illuminance was likely brighter in the ventral region). Unless specified otherwise, light 
pulses were 15 min in duration and maximum intensity (see Table 2.1). After light pulsing, 
mice were sacrificed by cervical dislocation, eyes were enucleated (under the same light 
conditions) and retinae extracted through a lateral incision along the ora serrata by adding 
pressure to both sides of the cut. Each retina was put into a 0.5 mL plastic tube and immediately 
frozen in liquid nitrogen (except postnatal day 0 and 7 animals where the whole eye was placed 
in the tube due to technical difficulties of extracting the retina). For dark-adapted mice, this 
process was conducted under dim red or under infrared light conditions (specified in each 
experiment). The tubes containing the retinae were stored at -80 C until analysed. 
For ex vivo experiments, after adaptation to the dark, mice were sacrificed by cervical 
dislocation, their eyes enucleated, and the cornea and lens removed under dim red light 
conditions. The remaining eyecup was placed, with the retina facing up, into a 0.5 mL plastic 
tube with 40 µL of oxygen-bubbled, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES)-buffered artificial cerebrospinal fluid (aCSF) at room temperature, and either light-
pulsed or kept in the dark. The supernatant aCSF was then removed and frozen in liquid 
nitrogen and stored at -80 C until analysed. 
Retinal homogenisation of in vivo experiments was completed with a pellet pestle cordless 
motor inside a 40 µL solution consisting of: 1% formic acid (Sigma-Aldrich), 0.5 mM ascorbic 
acid (Sigma-Aldrich) and 10 ng/mL the deuterated standards dopamine-d4 (CDN Isotopes) and 
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DOPAC-d5 (Cambridge Isotope Laboratories). For the ex vivo vials, media was supplied until 
1% formic acid, 0.5 mM ascorbic acid, 10 ng/mL deuterated standards and drug (specified in 
each experiment) concentrations were reached. Then, for both in vivo and ex vivo preparations, 
samples were centrifuged at 14,000 r.p.m. for 10 min at 4 C and the supernatant placed in 
clear glass total recovery vials (Waters) for chromatographic analysis.  
Mass spectrometry was performed using a Waters Xevo TQ-MS triple quadrupole mass 
spectrometer, fitted with an electrospray ionization source. The desolvation gas flow (nitrogen) 
was 800 L/h, desolvation temperature was 450 °C, cone gas 0 L/h, and collision gas (argon) 
flow of 0.15 mL/min, which gave a collision cell pressure of 2.6 × 10−3 mbar. In positive ion 
mode the capillary voltage was set at 1.2 kV and in negative mode 1.0 kV. Liquid 
chromatography was performed using a Waters Acquity UPLC, working at a flow rate of 0.20 
mL/min. A Waters Acquity UPLC BEH C18 column of 1.7 μm particle size and dimensions 
2.1 × 150 mm was used, operating at 40 °C. Solvent A consisted of 0.1% formic acid in 
ultrapure water and solvent B was 0.1% formic acid in methanol. A 20 min run was employed, 
commencing at 5% B for 1 min, increasing linearly to 100% B by 10 min, then returning 
immediately to 5% B at 15 min. The sample manager was kept at 4 °C and injections of 10 μL 
were made in full loop mode. Retention times for dopamine and dopamine-d4 were 2.1 and 
2.04 min respectively and were analysed in positive ion mode. DOPAC and DOPAC-d5 were 
5.09 and 5.01 min respectively and were analysed in negative ion mode. 
Dopamine only (ex vivo) or dopamine and DOPAC (in vivo) for each retina were quantified 
using MassLynx software. Dopamine per retina (ex vivo) or DOPAC: dopamine ratio (in vivo) 
are expressed as mean ± S.E.M. in graphical data.  
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2.2.3. Viral injections (Methods conducted by Dr. Morven A. Cameron) 
Intravitreal injections of AAV2-hSyn-DIO-hM3Dq-mCherry vector (2.3 x 1013 genomic 
particles/mL; The UNC Vector Core) were performed as previously reported80 and hyaluronan 
lyase and heparinase III (200 U each) was employed to maximise retinal penetration (total 
volume of 2.5 µL injected over 1 min). Control eyes underwent the same procedure, with 
injections including glycosydic enzymes but with the virus replaced by phosphate saline buffer 
(PBS) as vehicle. Mice were allowed at least 6 weeks to recover before being used in in vivo 
studies.  
For dopamine release assessment Opn4Cre/+ mice expressing hM3Dq in the right eye only, were 
dark-adapted overnight. Clozapine N-oxide (CNO, 5mg/kg) was administered intraperitoneally 
under dim red light and animals were then kept for 1 h in the dark. Both retinae were removed 
under dim red light and the left eye served as a control for the hM3Dq expressing eye. Pupil 
constriction in response to CNO was quantified 2 weeks before using the same methods and 
visualised using an infrared webcam (DCS-930L; D-Link) illuminated by a custom-made 
infrared LED array (> 950 nm). Animals with pupil constriction of less than 80% in response 
to CNO injection were excluded. 
 
2.2.4. Statistical Analysis 
All graphs and statistical analysis were performed with GraphPad Prism 7. Significance was 
defined as p-value smaller than 0.05. In vivo, both eyes were analysed separately and the 
average of the two was taken for each biological replicate reported. In contrast, for ex vivo 
experiments each retina was treated as an individual replicate as, once removed from the 
animal, retinae could be separated and subjected to different light conditions. 
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Student’s t-test was used to compare dopamine release between the two different “dark” 
conditions (dim red and infrared), between dark-adapted and light-pulsed mice at different 
development points, and between pharmacological treatments and controls. One-way ANOVA 
with Tukey’s post-test was used to test overall differences in the same light conditions across 
different genotypes. One-way ANOVA with Dunnett’s post-test was used to compare a range 
of increasing light intensities or exposures to dark-adapted controls. 
To find the threshold of light-induced dopamine release across genotypes, irradiance response 
curves were fit to the data for each genotype using the following equation: 
 
𝑌 =
𝐵𝑜𝑡𝑡𝑜𝑚 + (𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚)
1 + 10(log 𝐸𝐶50−𝑋) 𝐻𝑖𝑙𝑙 𝑆𝑙𝑜𝑝𝑒
 
 
Where: 
Y =   Mean of dark-adapted value + 2 standard deviations  
Bottom = Mean of lowest value 
Top =  Mean of highest value 
EC50 = X where the Hill Slope is half 
Hill Slope = Slope of the sigmoidal curve that fitted the data 
 
Threshold was defined as the point at which the curve exceeds the mean of the “dark” condition 
(dim red) + 2 standard deviations for the corresponding genotype. 
To test differences across fitted sigmoidal curves, Extra sum-of squares F test was applied. 
Significant differences are expressed with the p-value and the F value in the graphs. 
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2.3. Microglia characterisation 
2.3.1. Immunohistochemistry 
Mice were transcardially perfused with 4% paraformaldehyde (Merck Millipore) in 0.1 M PBS 
(Sigma-Aldrich); eyes were enucleated and stored in 0.1 M PBS until used. Wholemount 
retinae were extracted and blocked in a 96-well plate with 5% donkey serum (Sigma-Aldrich) 
in a 0.1 M PBS and 3% Triton-X (Sigma-Aldrich) solution for 45 minutes at room temperature. 
Retinae were placed in a solution containing 1:1000 rabbit-anti-Iba-1 primary antibody 
(Wako), 1 % donkey serum, 0.1 M PBS and 3% Triton-X solution overnight at 4 C. Retinae 
were washed with 0.1 M PBS three times for 15 minutes, and transferred to a solution 
containing 1:200 tetramethylrhodamine (TRITC) secondary antibody (Jackson 
ImmunoResearch), 2% donkey serum, 0.1 M PBS and 3% Triton for 90 minutes, washed with 
0.1 M PBS three times for 15 minutes. Retinae were mounted in vectashield and maintained in 
a dark-proof box at 4 C until imaged. 
 
2.3.2. Cell Counting and 3D Reconstruction 
Mounted retinae were examined using a Zeiss ApoTome microscope. The number of Iba-1+ 
cells counted through the entire thickness of the tissue was divided by the area of the retina 
(calculated by contouring the whole retina at 10X magnification) to obtain a density value. 
For reconstruction, Z-stack images of 1 µm thickness/stack were taken in a Zeiss LSM 5 
confocal microscope.  Images were examined using Neurolucida 360 software and the 
processes were reconstructed using directional kernels interaction mode (Figure 2.3). Nuclei 
were drawn in two-dimensions. 
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2.3.3. Statistical Analysis 
All graphs and statistical analysis were performed with GraphPad Prism 7. Significance was 
defined as p-value smaller than 0.05.  
One-way ANOVA with Tukey’s post-test was used to test the following morphological 
differences of microglia between ages (4 or 24 months) and genotypes (wild-type or GFAP-
IL6): cell density, soma area, soma perimeter, convex area, convex perimeter, dendritic length, 
primary dendrites, branching points and shift in maximum complexity in relation with the 
soma. The latter was assessed by comparing the coordinates of the highest point of the curve, 
obtained from Sholl Analysis.  
Sholl Analysis consists in drawing concentrical circles on the top of a reconstructed microglial 
cell with increasing radius of 3 µm starting in the centre of the soma (Figure 2.3 C) and plotting 
the size of the radius in the X axis and the different morphological variables (interactions, 
branching points, length, area, volume and endings) confined between that circle and the next 
in the Y axis.  
Bivariate correlation of soma area, soma perimeter, convex perimeter, dendritic length, primary 
dendrites and branching points were plotted against convex area484. Correlation was tested 
using Pearson r test, and the slope of the linear regression compared among groups using extra 
sum of squares F test.  
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Figure 2.3 3D reconstruction and analysis using Neurolucida 360 software. A) Z-stack confocal 
image of a single Iba1+ cell (red) at 40X magnification. B) Reconstruction of the dendritic arbour using 
directional kernels interaction mode (yellow). C) Sholl analysis consists of drawing concentrical circles 
(red) with a fixed increasing radius on top of the reconstructed dendritic arbour of the cell 
  
25 µm 
A    B     C 
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CHAPTER 3:                                                  
Optimisation of a method to accurately quantify 
dopamine turnover in the retina 
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3.1. INTRODUCTION 
Several methods have been used to determine the activity of dopaminergic amacrine cells, 
however most of them were based on indirect measurements such as tyrosine hydroxylase or 
c-fos staining, which do not always correlate with actual dopamine release368. Thus, a 
quantitative method for measuring dopamine and its metabolites appeared: high performance 
liquid chromatography coupled with electrochemical detection (HPLC-ECD)485, which is still 
widely used. Since the main aim of this thesis was to comprehensively describe the release of 
dopamine in the mouse retina, a reliable and sensitive analytical method for measuring 
dopamine turnover needed to be developed. In contrast with HPLC, ultra-high performance 
liquid chromatography (UHPLC) operates under higher pressure (which allows better 
chromatographic separation) and mass spectrometry tandem (MS/MS) detects analytes of 
interest based on the molecular weight and fragmentation rather than the electrochemical 
properties of the molecule (which might be similar among different analytes). Overall, 
UHPLC-MS/MS is faster, more sensitive and more selective. 
The following paper comprehensively describes optimisation of each step during the sample 
preparation and analysis of dopamine and DOPAC in the mouse retina. The section “3.2. 
Extended results” provides further results not included in the original paper relating to 
circadian changes in dopamine turnover, comparison between different dissection techniques 
and the impact of ethylenediaminetetraacetic acid (EDTA) addition to the sample before 
analysis. 
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available free of charge on the ACS Publications website at DOI: 10.1021/acs.analchem.7b03216.
63 
 
 
 
64 
 
3.2. Extended RESULTS 
Most of the information necessary to perform an understandable and reliable quantification of 
dopamine release is already explained in great detail the article. However, this extended section 
of the results provides even more fine-tuned characterisation of the elements that might impact 
dopamine quantification, such as the method of extracting the retina, addition of EDTA to the 
sample to prevent enzyme activation or influences of different circadian times.  
First, I examined the best method for extracting retinal tissue, based on the maximum number 
of counts provided by the integration peak of both dopamine and DOPAC (Figure 3.1). This 
was done in two ways: 1) “popping” out the retina through a lateral cut along the ora serrata 
and squeezing the eye with the fingertips, and 2) dissecting the retina under the scope by first 
piercing the eyeball on the ora serrata, then cutting along the ora serrata with a pair of small 
surgical scissors, and finally removing the cornea and the lens, and detaching the RPE with a 
pair of surgical forceps. The “popping” method had increased counts for both dopamine and 
DOPAC compared to retinae dissected under the scope (Figure 3.1). Since dopamine and 
DOPAC oxidise rapidly under environmental oxygen without antioxidants (as previously 
shown in the article), it is likely that the method that involves the least time from extraction to 
snap freezing (“popping”) provides the best method to preserve these analytes.  
Since EDTA has been previously used to stop enzyme activation in retinal samples (Table 3.2), 
I examined the effect of adding EDTA in the homogenised sample containing each retina. 
However, the use of EDTA is not entirely justified because the addition of the acid (either 
formic or perchloric) lowers the pH to a range where retinal enzymes are not active. Further, 
the addition of EDTA (or any salt) into samples analysed via UHPLC-MS/MS is not 
recommended because salts such as EDTA precipitate inside the conduits of the UHPLC 
instrument and remain there interacting with the mobile phase and further incoming samples 
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increasing ion suppression. Indeed, addition of EDTA to dopamine and DOPAC standards 
diluted in 0.1M perchloric acid and 0.01% of sodium metabisulfite did not increase the counts 
of integrated peak areas. In fact, dopamine counts were significantly lower compared to the 
solution of perchloric acid and sodium metabisulfite without EDTA (Figure 3.2). 
Dopamine is released in a circadian manner due to the interaction with melatonin, with more 
dopamine being released during the day and less dopamine being released during the night. 
Even though C57BL/6 mice are genetically incapable of synthetising melatonin, they do show 
significant circadian rhythmicity in retinal function368,389 meaning the light input to 
dopaminergic amacrine cells may undergo circadian modulation. Indeed, Cameron et al.368 
reported more dopamine release at CT18 than CT6 in free-moving animals. While I showed in 
the article that anaesthesia did not alter the concentration of dopamine nor DOPAC, under dark 
or light conditions at CT6, I extended the analysis to examine dopamine release at subjective 
midnight (CT18). Surprisingly, dopamine turnover ratios (both dark-adapted and light-pulsed) 
were not statistically different when comparing CT6 to CT18 in either free-moving or 
anaesthetised mice (Figure 3.3).  However, a trend of more dopamine released at CT18 than 
CT6 in free-moving mice was abolished after application of anaesthesia, which provides a 
consistent reduction in the standard deviation of every measurement. This may be explained 
due to the animals’ behavioural circadian rhythms, presumably spending more time with their 
eyes open during their active phase (~CT12 - CT23) and not because of an actual increase in 
dopamine turnover in response to the same light stimulus. Therefore, it is likely that anaesthesia 
standardises the amount of light reaching the mice between circadian time points.  
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Figure 3.1 “Popping” the retina from the eye-cup provides increased dopamine and DOPAC 
counts instead of scope dissection.  Under dim red light, A) dopamine absolute peak integration counts 
are significantly increased when “popping” is used over conventional dissection scope. B) DOPAC 
counts are also increased by using “popping” over scope dissection (t-test, **p < 0.01, mean ± SEM, n 
= 12 each). 
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Figure 3.2 Both sodium metabisulfite and EDTA cause a significant reduction in dopamine 
counts. A) Absolute peak integration counts of standard dopamine (100 ng/mL) dissolved in 0.1M 
perchloric acid show significantly reduced signal when 0.01% sodium metabisulfite (SMBS; black 
stripes) alone, or in combination with 0.5mM EDTA (black and grey stripes) are added. B) DOPAC 
standard (100 ng/mL) dissolved in perchloric acid do not exhibit any difference compared to the 
addition of SMBS or EDTA (one-way ANOVA with Tukey’s post-test, ***p < 0.0001, mean ± SEM, 
n ≥ 6 each group). 
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Figure 3.3 Anaesthesia reduces behavioural variation. Free-moving (A) and anaesthetised (B) mice 
exhibit significant light-induced dopamine release at both CT6 and CT18. No statistical differences are 
observed in light-pulses between CT6 and CT18 (t-test, p ≥ 0.22) in either condition. However, a trend 
of increased dopamine turnover is observed in free-moving mice at CT18, which is eliminated by 
anaesthesia (one-way ANOVA with Tukey’s post-test, ***p < 0.0001, mean ± SEM, n ≥ 6 each group). 
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3.3. Extended DISCUSSION 
Measurement of retinal dopamine and DOPAC over the years has varied greatly from lab to 
lab. To illustrate the extent of the variety of analytical techniques, I took recent papers (~5 
years old on average) that measured both DOPAC and dopamine and summarised the animal 
methods employed in Table 3.1. Most of the steps gathered in Table 3.1 are shown in this 
chapter to have an impact on dopamine turnover measurements, which makes comparisons 
between labs problematic. In addition, most of the papers report DOPAC: dopamine levels 
under extended environmental conditions, while others specifically compare dark-adapted vs 
light-pulsed retinae. For example, in DOPAC: dopamine column, basal values range from 0.02 
to 1.2, with increases from 2 to 6-fold when comparing dark-adapted against light-pulsed 
animals. Also, it is difficult to reach a consensus on which light is better to use during the 
“dark” dissections (dim red or infrared), as well as the collection method (retinal dissection 
under the scope, whole eye analysis or isolation of the retinae by “popping” it out of the eye). 
Further, both light exposure times and intensities are very variable, (although a trend to use 
ZT1 exists). Age does not seem to have an obvious correlation with increased or decreased 
dopamine turnover (but see486). Table 3.2. summarises the analytical methodology used in the 
same selection of papers from Table 3.1. Here, it is conspicuous the extent of the diversity in 
the solutions used to homogenise the sample, the flow rate, both mobile and stationary phases 
and internal standards. 
From the conclusions obtained during our comprehensive method optimisation (including the 
extended results), it is recommended: 
1. To reduce (when possible) strong acids such as perchloric acid, since it is more 
hazardous to both the researcher and the sample compared to weaker acids such as 
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formic acid, which performs the same functions of lowering the pH to obtain both 
protein precipitation and enzyme inactivation.  
2. Not to add sodium metabisulfite or EDTA significantly since they reduced absolute 
peak integration of dopamine likely due to an increased ion suppression while DOPAC 
remained unchanged (Figure 3.1), meaning that DOPAC: dopamine ratio would be 
significantly affected.  
3. The flow rate determines the elution times of the metabolites meaning that if it were 
too fast the analytes would co-elute with small molecules or if too slow analytes may 
co-elute with lipids. This co-elution would likely impact the detection of the analytes. 
Indeed, the peaks of the analytes are optimally distributed when the flow rate is kept 
between 0.2 and 0.3 mL/min).  
4. Acidified water and acidified methanol performed well compared to more complex 
mobile phases.  
5. The use of C18 columns since these exhibited stable performances across a variety of 
sizes and models, although the cleaning of the column highly impacts on the quality of 
the chromatogram, and is rarely mentioned on the literature. Overnight cleaning with a 
low flow rate (~0.2 mL/min) of 100% acetonitrile significantly increased the half-life 
of the column, as well as removed lipids and proteins.  
In conclusion, I recommend the use of each of the steps followed in this article as a 
comprehensive troubleshooting guideline to improve or solve problems related with dopamine 
release quantification using UHPLC-MS/MS. 
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Euthanasia Dark light Collection DOPAC/DA Age 
Light 
intensity 
Light 
exposure 
Ref. 
n.s. infrared Dissection 0.02-0.08 42-56 170 lux From 1 to 12 h 389 
n.s. dim red Dissection 0.06-0.13 70 100 lux 4 and 8 h 487 
n.s. n.s. Whole eye 0.4 42 300 lux 4.5 h 402 
Cervical 
dislocation 
infrared Whole eye 0.15-0.3 40-120 n.s. 5 and 11 h 398 
“humanely 
killed” 
dim red n.s. 0.1-0.2 40-120 100 lux 15-20 min 488 
n.s. dim red n.s. 1.2 18 200 lux 1 h 489 
Cervical 
dislocation 
dim red n.s. 0.2 105 300 lux 2 and 14 h 490 
Cervical 
dislocation 
dim red Dissection 0.2 35-50 200 lux 1 h 401 
Cervical 
dislocation 
n.s. Dissection 0.1-0.3 84 n.s. n.s. 491 
Cervical 
dislocation 
dim red "Popping" 0.1-0.6 70-120 1300 lux 90 min 368 
Table 3.1. Light-pulsing methods across literature. Different features that affect dopamine turnover 
quantification are gathered in this table: euthanasia, light used during dissection in the dark, collection 
of the retinae, DOPAC: dopamine ratio, age, environmental illuminance in the dark: light cycle and 
time of exposure to light. (n.s.: not specified in the source) 
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Acid Antioxidant Additions Flow Mobile phase Column Standard 
0.1M 
HClO4 
n.s. 
20% 
ACN 
1.0 
mL/min 
75mM PB, 25mM EDTA, 1.7mM 
OA, 0.01% TEA, 7.5% ACN, pH 3 
C18, 3µm, 
2.8 x 10 cm 
DA, 
DOPAC 
0.1M 
TCA 
0.01M SA 
10mM 
EDTA 
0.6 
mL/min 
89.5% 0.1M TCA, 0.01M SA, 
0.1mM EDTA, 10.5% MeOH, pH 
3.8 
C18, 
2.6µm, 4.6 
x 10 cm 
IP 
0.2M
HClO4 
0.01M 
SMBS 
0.1mM 
EDTA 
0.6 
mL/min 
89.5% 0.1M TCA, 0.01M SA, 
0.1mM EDTA, 10.5% MeOH, pH 
3.8 
C18, 
2.6µm, 4.6 
x 10 cm 
n.s. 
0.1M 
HClO4 
0.5mM AA - - 
50mM KP, 0.02% OSS, 15% 
MeOH, 0.1mM, EDTA, pH 3.1 
C18, 5µm, 
4.6 x 15 cm 
DA, 
DOPAC 
0.1M 
TCA 
0.01M SA 
10mM 
EDTA 
0.6 
mL/min 
89.5% 0.1M TCA, 0.01M SA, 
0.1mM EDTA, 10.5% MeOH, pH 
3.8 
C18, 
2.6µm, 4.6 
x 10 cm 
IP 
0.1M 
HClO4 
10µM AA 
0.1mM 
EDTA 
0.2 
mL/min 
95% PB, 0.05mM EDTA, 1.7mM 
OSA, 90mM NP, 50mM CA, 5% 
ACN 
C18, 
2.2µm, 2.1 
x 10 cm 
3,4-
DHBA 
0.1M 
HClO4 
- - 
0.3 
mL/min 
50mM KP, 15 mg/ml EDTA, 
0.26mM NOS, MeOH 8%, pH 4.5 
C18, 5µm, 
4.6 x 25 cm 
DA, 
DOPAC 
0.1M 
HClO4 
10µM AA 
0.1mM 
EDTA 
0.2 
mL/min 
95% PB, 0.05mM EDTA, 1.7mM 
OSA, 90mM NP, 50mM CA, 5% 
ACN 
C18, 
2.2µm, 2.1 
x 10 cm 
3,4-
DHBA 
0.1M 
HClO4 
0.01% 
SMBS 
- 
1.5 
mL/min 
0.1M PA, 0.1mM EDTA 0.45mM 
NOS, 6% ACN, pH 2.7 
C18, 5µm, 
4.6 x 25 cm 
3,4-
DHBA 
0.2M 
HClO4 
0.01% 
SMBS 
- 
1.5 
mL/min 
0.1M NP, 0.1mM EDTA, 0.35mM 
NOS, 5.5 % ACN, pH 2.7 
C18, 5µm, 
4.6 x 25 cm 
3,4-
DHBA 
Table 3.2. Analytical methods across the literature. Different methods to assess dopamine 
quantification: acid, antioxidant and other elements added during the homogenisation of the retinae (or 
whole eyes); flow rate; mobile and stationary phase (column); and internal standards. AA: ascorbic 
acid, ACN: acetonitrile, CA: citric acid, 3,4-DHBA: 3,4-dihydroxybenzilamine, EDTA: 
ethylenediaminetetraacetic acid, HClO4: perchloric acid, IP: isoprotenerol, KP: potassium phosphate, 
MeOH: methanol, NOS: sodium octyle sulfate, NP: sodium phosphate, n.s.: not specified, OA: 
octanesulfonic acid, OSA: orthosilicic acid, OSS: octyl sodium sulphate, PA: phosphoric acid, PB: 
phosphate buffer, SA: sodium acetate, SMBS: sodium metabisulfite, TCA: trichloroacetic acid, TEA: 
triethylamine. 
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CHAPTER 4:                                                        
Light-induced dopamine release in wild-type mice 
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4.1. INTRODUCTION 
Dopamine is the main light-driven neuromodulator of the retina and thus it is important to 
understand which environmental light conditions and pathways are involved to ultimately 
trigger its release. Approaches such as electron microscopy or immunohistochemical studies 
have contributed to the discovery of direct synaptic inputs into/from dopaminergic amacrine 
cells, while electrophysiological studies revealed the physiology of dopaminergic amacrine 
cells in response to light-driven inputs from all photoreceptors classes. However, the 
electrophysiological activation of dopaminergic amacrine cells does not always correlate with 
actual dopamine release368,449 and thus provides an incomplete picture of the role of dopamine 
in light adaptation. Quantitative studies helped to determine the effect of different drugs on the 
overall release of dopamine in the retina in several species, providing a valuable but still 
incomplete piece of the story. Further, as previously discussed in “Chapter 3. Optimisation of 
a method to accurately quantify dopamine turnover in the retina”, different laboratories use a 
huge diversity of methodologies and it is sometimes challenging to assume comparisons 
between results and yet, from all the extensive literature not a single study has fully 
characterised actual dopamine release in a single species with a consistent methodology both 
in vivo and ex vivo under a wide range of light conditions and/or pharmacological modulation. 
Thus, the aim of this chapter is to fill the gap in the literature to better comprehend dopamine 
dynamics, release threshold and differences between in vivo and ex vivo preparations in wild-
type mice. In this chapter I assessed retinal dopamine release in two complementary ways: in 
vivo with DOPAC: dopamine ratio from the entire homogenised retina, and ex vivo with 
dopamine released from the explanted retina into the media where the retina was submerged. 
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4.2. RESULTS 
4.2.1. Dim light suppresses dopamine release 
True dark conditions in retinal experiments are generally very rare, frequently “dark” refers to 
dim or near infrared illumination. Previous experiments examining dopamine release have used 
dim red light as the “dark” control for mouse experiments, taking advantage of their blue-
shifted retinal sensitivity. However, while mouse rods are maximally sensitive to 498 nm 
wavelength light, they are ~4 log units more sensitive than cones under dark-adapted conditions 
meaning a significant rod signal is produced even under 8.79 log rod photons cm-2 s-1 
illumination (equivalent to dim red light dissection). Despite the limited time spent on the 
dissection procedure (< 1 minute), surprisingly retinae dissected under dim red light (8.79 log 
rod photons cm-2 s-1) showed a significant decrease (t-test, p ≥ 0.02) in dopamine turnover 
compared to those dissected under infrared light (5.82 log rod photons cm-2 s-1) conditions at 
both CT6 (subjective midday) and CT18 (subjective midnight; Figure 4.1 A). Further, no 
differences between equivalent time points were observed at those circadian times (one-way 
ANOVA with Tukey’s multiple comparison test, p ≥ 0.68). This suggests that rod input actually 
supresses dopamine release at dim light intensities. Dim red light would be subsequently used 
as the preferred dark-adapted control condition for further experiments (until specified 
otherwise) to compare with light-driven dopamine release as it offered the lowest basal level. 
The ex vivo preparation exhibited a similar result with more dopamine released under infrared 
dissection conditions (Figure 4.1B), although it is not statistically significant (t-test, p = 0.059). 
 
4.2.2. Light-induced dopamine release is high threshold 
Dopamine is strongly released by bright light in a variety of species and yet the exact light 
threshold to elicit an increase in dopamine turnover remains mostly unknown. In fact, only one 
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article measured  actual dopamine release along an irradiance-response curve in rabbit444. Since 
mice are such a pivotal model used in neuroscience and most of the literature contains 
experiments conducted with mice, I performed an irradiance-response curve to elucidate the 
threshold of dopamine release in wild-type mice in both in vivo and ex vivo approaches. In vivo, 
light-induced dopamine release was tested in mice exposed to different steady light conditions, 
and compared to dark-adapted mice dissected under dim red light (Figure 4.2). Experiments 
were conducted from 16 log rod photons cm-2 s-1 decreasing in 0.9 log units until no difference 
between the “dark” conditions were observed. Surprisingly, only the two highest irradiances 
(~15 and 16 log rod photons cm-2 s-1; 15 min) caused a significant increase in light-induced 
dopamine release (one-way ANOVA with Dunnett’s multiple comparison test, p < 0.0001). 
Further, mice were tested at different circadian points either CT6 or CT18, and no differences 
were observed between equivalent irradiance points (Figure 4.2), which can be fitted with the 
same curve (extra sum-of-squares F test, p = 0.83; F = 0.37). In the literature, flickering light 
has been reported to increase dopamine release in a number of species359,360,363,364,444,492,493 but 
I show that dopamine release levels were the same (t-test, p = 0.18) in response to either steady 
or flickering light just below the release threshold (Figure 4.2). 
Similarly, light-induced dopamine release in the supernatant of ex vivo eyecups (cornea and 
lens were removed but the retina remained attached to the RPE) exposed to different light 
intensities (from dark-adapted to 16 log rod photons cm-2 s-1, 15 min) at CT6 (Figure 4.3) 
exhibited a significant increase in light-induced dopamine release only at the two highest 
irradiances (one-way ANOVA with Dunnett’s multiple comparison test, ***p < 0.0001). The 
point of this experiment was to validate an alternative method to determine dopamine release 
with easier accessibility for further pharmacological manipulation (i.e. addition of inhibitory 
drugs in the media instead of intravitreal injections in vivo). The data illustrates that the two 
methods report the same, despite one measuring dopamine turnover based on the entire retinal 
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tissue in vivo (often used for dopamine quantification) and the other based on an ex vivo retinal 
preparation that releases dopamine into a small volume. Despite the light source and the 
distance of the retina was the same in both in vivo and ex vivo approaches, the lack of cornea 
and lens causes an increased aperture that causes a slight increase in the illuminance reaching 
the retina that was corrected (explained in section “2.2.1. Light sources”). Ex vivo results 
showed a very similar pattern to the in vivo methodology and both curves overlap (extra sum-
of-squares F test, p = 0.57; F = 0.72) when plotted together (Figure 4.3). In fact, dopamine 
release thresholds (calculated by increasing two standard deviations to each irradiance point 
until it is above to the previous) are identical in vivo (CT6 = 14.59; CT18 =14.61) and ex vivo 
(CT6= 14.59). The main conclusion from the irradiance response curve experiments is that 
light-induced dopamine release is very high threshold.Altogether, this data supports the use of 
either in vivo or ex vivo methodologies as a complementary assessment of dopamine release in 
the mouse retina. However, an increased inter-experiment variability in the baseline levels of 
the ex vivo preparation occurs, perhaps due to further manipulation of the retina and lower 
dopamine levels released into the supernatant compared to the amount of dopamine in the 
retinal tissue. Despite the variability between experiments, the intra-experiment variability 
(assessed with the standard deviation) is similar to the in vivo results (~10% of the mean), and 
relative comparisons within the same experiments and dark-adapted controls provided reliable 
results. 
Since many retinal experiments tend to remove the RPE from the retina, I tested the effect of 
both leaving the RPE attached or removing it from the retina (Figure 4.4). Removing the RPE 
prior to challenging the retina to bright light (16 log rod photons cm-2 s-1, 15 min) resulted in 
an impairment not only to the ability of the retina to produce significant light-induced 
dopamine release (comparing dark-adapted to light-induced RPE-detached retinae), but also 
lowered significantly the overall levels of dopamine released in the media by ~58.3% 
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(comparing RPE-attached to RPE-detached retinae at equivalent conditions, t-test, **p ≥ 
0.007). Thus, all experiments were performed keeping the RPE attached (as described in 
section “2.2.2. Light pulsing, sample preparation and analysis”).  
The existing literature does not provide comprehensive details of the dynamics of dopamine 
release in mice. While changes in basal levels of dopamine turnover after several hours of dark- 
or light-adaptation have been measured, electrophysiological experiments record light-evoked 
responses of dopaminergic amacrine cells in response to very short light-pulses. Thus, little 
evidence provides information between seconds and hours of light exposure. Here, I measured 
dopamine release in response to bright light (16 log rod photons cm-2 s-1) at different exposure 
times from 30 seconds up to 1 hour in vivo or up to 15 minutes ex vivo (Figure 4.5). Further, 
after 1 hour of light-adaptation I switched off the lights to determine the time required for 
dopamine turnover to go back to overnight dark-adapted levels. Significant dopamine release 
occurred within 1 minute of light exposure from overnight dark-adapted mice (one-way 
ANOVA with Dunnett’s multiple comparison test, ex vivo: *p = 0.03; in vivo: ***p < 0.0001), 
and remained constant through the following time points up to 15 or 60 minutes for ex vivo and 
in vivo preparations respectively. Importantly, while the ex vivo data can be fitted with a 
logarithmic function, the DOPAC: dopamine ratio showed a much more dynamic profile: it 
rapidly increased within 30 seconds and peaks at 1 minute, after which a reduction occurred 
between 1 to 15 minutes, and then stabilised at 15 minutes without further changes up to 1 
hour. Conversely, once the lights were switched off from a light-adapted state, DOPAC: 
dopamine ratio quickly dropped within 5 minutes of darkness, and it continued decreasing for 
60 minutes until overnight dark-adapted levels were reached (fitted with a logarithmic function; 
Figure 4.4B). These data suggest that, in vivo and ex vivo approaches reflect different aspects 
of dopamine temporal dynamics: while the former seems to reflect a more instantaneous 
measurement, the latter reflects dopamine slowly accumulating in the media over time. 
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4.2.3. Dopamine release is modulated via excitatory and inhibitory 
inputs 
Much is known about dopaminergic retinal responses to a wide variety of drugs in both in vivo 
and ex vivo approaches. However, drawbacks arise with some of these methods: 1) the RPE is 
removed in most of these experiments ex vivo (which impairs both dark-adapted light-induced 
dopamine levels, Figure 4.4), 2) when intravitreal injections are performed in vivo the final 
retinal concentration is at best an estimate, and 3) the half-life of some drugs are not exactly 
known. Here, I tested a range of drugs that modulate inputs into dopaminergic amacrine cells 
in wild-type mice, under both dark-adapted (with dim red dissection and extraction of the 
retinae) and light-pulsed conditions. Together, this summary of dopamine release in response 
to a battery of drugs provides further evidence to elucidate the pathways involved in light-
induced dopamine release (Figure 4.6). I divided this summary of drug responses into different 
sections: inhibitory inputs, excitatory inputs, spiking and blocking of rod input into canonical 
cone pathways via gap junctions.  
The activity of inhibitory pathways was tested by the addition of either strychnine (glycine 
receptor antagonist) or picrotoxin (GABAA/C receptor antagonist). Application of 10 µM 
strychnine significantly reduced dark levels of dopamine (t-test, **p-value = 0.009), but had 
no effect on light-pulsed retinae compared to dark and light controls respectively. Comparing 
between both strychnine conditions, retinae were still able to significantly release light-induced 
dopamine (t-test, #p-value = 0.02). Conversely, addition of 50 µM picrotoxin significantly 
raised dopamine levels in dark-adapted retinae (t-test, ***p-value < 0.0001) up to control light 
levels, but no further increase occurred by light-pulsing retinae while picrotoxin was present, 
and therefore dark-adapted retina resembled light-pulsed retinae when picrotoxin was present 
in the media (t-test, p-value = 0.75). This suggests that constitutive GABAergic inputs inhibit 
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dopaminergic amacrine cells in the dark and are relieved by the GABA antagonist causing 
dopamine release equivalent to a bright light pulse (as previously suggested75,465), while 
glycinergic inputs might regulate dopamine release at lower light levels and are overwhelmed 
at bright light intensities.  
Signalling of excitatory pathways was assessed by addition of the following set of drugs 
individually: L-AP4 (mGluR type III agonist), CNQX (AMPA/kainate antagonist) and AP5 
(NMDA antagonist). In accordance with previous experiments464, addition of 50 µM L-AP4 
significantly reduced both dark and light levels (t-test, **p-value ≤ 0.008) of dopamine 
compared to their respective control groups and prevented light-induced dopamine release, 
suggesting that ON bipolar cells must be involved in the pathway governing light-induced 
dopamine release. Also, 10 µM CNQX significantly blocked light-induced dopamine release 
back to dark-adapted levels (t-test, **p-value = 0.002), but had no further reduction effect on 
dark-adapted retinae (t-test, p-value = 0.5). Surprisingly, 10 µM AP5 significantly decreased 
light-pulsed dopamine (t-test, ***p-value = 0.0002) back to dark-adapted levels, and further 
reduced dark-adapted dopamine release (t-test, *p-value = 0.02). A small but significant 
difference (t-test, #p-value = 0.04) could still be observed between AP5-treated dark-adapted 
and light-pulsed retina. These results suggest that light-inputs causing dopamine release must 
travel through ON bipolar cells and are mediated by both AMPA/kainate receptors at a certain 
point in the circuitry, and extrasynaptic NMDA receptors are activated by glutamate spillover 
from bipolar cells at bright intensities. A positive trend in dopamine turnover was observed in 
dark-adapted retinae treated with 50 µM NMDA, although removal of Mg2+ from the media to 
facilitate the activation of NMDA receptors did not further enhance the response (t-test, p = 
0.77).  
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4.2.4.  Gap junction coupling is required to drive the majority of light-
induced dopamine release 
Since rod signals use gap junctions to feed information into cone circuitry (through primary 
and secondary pathways), I used 200 µM MFA to non-selectively block gap junctions and 
study the effect of the remaining signalling pathways into dopaminergic amacrine cells. MFA-
treated retinae significantly reduced dopamine release in both dark-adapted and light-treated 
conditions (t-test, **p-value ≤ 0.003). However, significant light-induced dopamine release 
remained when comparing between MFA-treated conditions (t-test, ##p-value ≤ 0.005) 
suggesting that this input could come from cone photoreceptors.   
 
4.2.5. Dopamine release is enhanced with depolarisation  
Next, the depolarisation-dependence of dopamine release was tested by either enhancing (with 
high potassium in the medium) or blocking (with TTX) overall excitability in the retina 
(including dopaminergic amacrine cells themselves and ipRGCs). On the one hand, 10 µM 
TTX caused a significant decrease in dopamine release in both dark-adapted and light-pulsed 
retinae (t-test, *p-value ≤ 0.01) compared to untreated controls. TTX-treated retinae were not 
able to drive significant light-induced dopamine release, although a trend was apparent (t-test, 
p-value = 0.22). On the other hand, when increasing KCl from 3 mM (basal level) to 15 mM 
(considered to cause neuronal hyperexcitability494), dopamine release showed a positive trend 
in dark-adapted and a significant increase in light-pulsed retinae (t-test, *p-value = 0.04) 
compared to their respective controls. This suggests that dopamine release correlates with 
increased depolarisation by increasing extracellular potassium, although this is further 
enhanced by light. 
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4.2.6. Light-induced dopamine release occurs as early as P18 
Taking advantage of the different development timelines of retinal photoreceptors, I explored 
light-induced dopamine release at different developmental time points to elucidate the relative 
contribution of each photoreceptor to dopamine release at different developmental ages. These 
results also provide valuable information for groups that study retinal development and myopia 
since low levels of dopamine are associated with this visual impairment495, and a better 
understanding of dopamine release might provide alternative approaches to treat the symptoms 
at early stages. Light-induced (16 log rod photons cm-2 s-1, 15 min) dopamine release was tested 
at different time points during development and compared to dark-adapted retinae of the 
correspondent post-natal days: P0, P7, P18, P22 and P26 (Figure 4.7).  From these time points, 
the earliest age when light-induced dopamine release significantly differed to the dark-adapted 
control occurred at P18 (t-test, **p-value = 0.045). This difference was maintained at P22 (t-
test, **p-value = 0.001), P26 (t-test, ***p-value = 0.0004) and as far as I know until P60, which 
is the age used for the rest of mice in this thesis (unless stated otherwise). Suggesting that 
circuit maturity (regarding dopaminergic amacrine cells inputs) is reached ~P18. 
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Figure 4.1 Dim light supresses dopamine turnover. A) A significant decrease in dopamine turnover 
occurs in dark-adapted mice dissected under dim red light (8.79 log rod photons cm-2 s-1, >650 nm) 
compared to those dissected under infrared light (5.82 log rod photons cm-2 s-1, >800 nm) at both CT6 
and CT18 (t-test, *p < 0.05, ***p < 0.001, mean ± SEM, n ≥ 6 each).  No statistical differences are 
observed between equivalent irradiance points at CT6 and CT18 (one-way ANOVA with Tukey’s 
multiple comparison test, p ≥ 0.68). B) Ex vivo preparation showed similar results at CT6 with increased 
dopamine release under infrared light (t-test, p = 0.059, mean ± SEM, n ≥ 3 each) 
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Figure 4.2 In vivo light-induced dopamine release occurs only at bright intensities. In an irradiance-
response curve, significant light-induced dopamine release occurs at the two highest light intensities 
(>15 log rod photons cm-2 s-1, 15 min) compared to dark-adapted mice dissected under dim red light 
(one-way ANOVA with Dunnett’s multiple comparison test, ***p < 0.0001, mean ± SEM). No 
statistical differences are observed between equivalent irradiance points at CT6 (n ≥ 11 each) and CT18 
(n ≥ 3 each; one-way ANOVA with Tukey’s multiple comparison test, p > 0.99; one curve can fit both 
data sets extra sum-of-squares F test, p = 0.83; F = 0.37). Flickering light (0.5 sec ON, 1.5 sec OFF) 
does not increase dopamine turnover near the threshold for significant dopamine release (~14 log rod 
photons cm-2 s-1, 15 min) compared to its equivalent irradiance point of steady light (t-test, p = 0.18, n 
= 4) 
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Figure 4.3 Ex vivo light-induced dopamine release occurs only at bright intensities and matches 
the in vivo approach. In an irradiance-response curve, significant light-induced dopamine release 
occurs at the two highest light intensities (>15 log rod photons cm-2 s-1, 15 min) compared to dark-
adapted retinae dissected under dim red light, similarly to the in vivo irradiance-response curve (Figure 
4.2; one-way ANOVA with Dunnett’s multiple comparison test, ***p < 0.0001, mean ± SEM, n ≥ 5 
each; one curve (dotted line) can fit both datasets extra sum-of-squares F test, p = 0.57; F = 0.72). 
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Figure 4.4 Light-induced dopamine release is reduced in retinae without RPE. Significantly lower 
levels dopamine release in both dark and light (~16 log rod photons cm-2s-1, 15 min) conditions occur 
in retinae without the RPE attached compared to controls (t-test, p ≥ 0.007, mean ± SEM, n ≥ 3 each). 
Retinae without RPE attached are incapable of releasing light-induced dopamine (t-test, p = 0.06,). 
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Figure 4.5 Light-induced dopamine release occurs within 1 minute from a dark-adapted state. A) 
Significant light-induced dopamine release occurs after 30 s (in vivo) or 1 minute (ex vivo) of bright 
light exposure (~16 log rod photons cm-2s-1) compared to dark-adapted mice dissected under dim red 
light (one-way ANOVA with Dunnett’s multiple comparison test, *p < 0.05, ***p < 0.0001, mean ± 
SEM, n ≥ 5 each). This difference is maintained as long as 60 min (in vivo) or 15 min (ex vivo). B) 
When lights are turned off from a light-adapted retina in vivo, a significant decrease in dopamine release 
results after 10 min. The decrease continues for 60 min until overnight dark-adapted levels are reached 
(one-way ANOVA with Dunnett’s multiple comparison test, **p < 0.001, ***p < 0.0001).              
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Figure 4.6 Pharmacological modulation of retinal pathways. Bars filled with colour represent dark-
adapted retinae, while white-filled, border-coloured bars represent light-pulsed retinae (~16 log rod 
photons cm-2s-1, 15 min). When two bars match in colour, the same drug treatment is applied in both. 
Stars indicate comparison between dark and light controls with dark or light treated retinae respectively. 
Hashtags indicate comparison between dark and light-pulsed retina with the same treatment. Strychnine 
(glycine antagonist) reduces dopamine in the dark while leaving light-induced dopamine intact. 
Picrotoxin (GABAA/C antagonist) has no effect on dopamine release in the light while it causes a 
significant increase in the dark similar to light-pulsed controls. Overall, inhibition of excitatory inputs 
into dopaminergic amacrine cells with L-AP4 (mGluR agonist), CNQX (AMPA/kainate antagonist) 
and AP5 (NMDA antagonist) reduce dopamine levels under light conditions, L-AP4 and CNQX 
completely abolish light-inducible responses whereas retinae with the AP5 treatment exhibit a reduced 
but still significant response to light. NMDA show an increasing trend in dopamine release under dark 
conditions independently from addition of Mg2+. Blockage of gap junctions with MFA reduce both dark 
and light dopamine release with a small light-inducible response remaining possible Spiking reduction 
with TTX and depolarisation increase with high KCl concentration dramatically reduce or increase 
dopamine release respectively (only modestly in the dark with KCl). (t-test, *p < 0.05, **p < 0.001, 
***p < 0.0001; t-test, #p < 0.05 ##p < 0.001, ###p < 0.0001 mean ± SEM, n ≥ 3 each condition). 
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Figure 4.7 Significant light-induced dopamine release occurs as early as P18. Significant light-
induced (~16 log rod photons cm-2s-1, 15min) dopamine release compared to dark-adapted mice 
dissected under dim red light at equivalent development points starts at the age of 18 days and is 
maintained at least until P26. Mice under P18 do not exhibit light-inducible dopamine release in 
response to bright light. No differences are observed (one-way ANOVA with Tukey’s multiple 
comparison test, *p < 0.05, **p < 0.01, mean ± SEM, n = 5 each time point). 
90 
 
4.3. DISCUSSION 
4.3.1. Dopamine is released under both “dark” and bright light  
In this chapter I show that the irradiance profile of dopamine turnover in the retina is a U-
shaped curve with more dopamine being released under dark and bright light, and less under 
intermediate light conditions. A significant increase in dopamine turnover under infrared light 
conditions compared to dim red light (Figure 4.1) might appear counterintuitive since 
dopamine is thought to be a light-adaptive neuromodulator. Further, this increase is very fast 
since the amount of either infrared or dim red light the mice are exposed to during the retinal 
extraction does not exceed 1 minute (after being dark-adapted for ≥ 6 hours). Here, I propose 
two hypotheses that might explain this phenomenon: First, rods exert a suppressive effect under 
dim red light. Although a direct measurement of global dopamine release has not been reported 
in the dark (except in fish and only during night-time363), indirect evidence based on the 
coupling of both horizontal cells and AII amacrine cells (which are suggested to be regulated 
by dopamine) showed increased coupling during dim and bright light, and decreased coupling 
at intermediate light conditions200,296. In addition, at the dim red light intensity (8.79 log rod 
photons cm-2 s-1) rods are active (~ 2 log units above its threshold) and thus are a likely 
candidate to be driving this suppressive effect under dim light. However, the application of L-
AP4 reduced dopamine release under dim red light suggesting that this suppression is not 
mediated by ON bipolar mechanisms, but rather rod synapses into OFF bipolar cells304.  
The second hypothesis implies that this unnatural exposure to such low-light levels of light, 
such as experienced by the animal under infrared, might make the retina more excitable as a 
consequence of receiving inputs beyond the response capacity of the retinal system. This 
increased excitability could lead to a general increase in depolarisation of dopaminergic 
amacrine cells and subsequent dopamine release as shown in Figure 4.6. In the literature, 
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dopaminergic amacrine cells exhibited spontaneous activity (with at least four different 
profiles336) under dark conditions75,327,402,496, and these firing rates are correlated with release 
of dopamine vesicles (~40,000 molecules of dopamine per vesicle) via amperometry457.  While 
it is true that mice live in very low light levels, moonlight and starlight produce a photon flux 
of ~9 log photons cm-2s-1 at wavelengths that range 410-700 nm. These light intensities are 
higher than the experimental conditions reproduced under IR light. 
Moving to brighter light intensities, the literature often states that dopamine is released in 
response to bright light and yet only one article performed an irradiance response curve (in 
rabbit)497 that determined an actual dopamine release threshold (2 log units lower than the one 
I present in Figures 4.2 & 4.3), with a similar pattern that showed an abrupt increase towards 
the brightest light intensities. However, other papers reported light induced dopamine release 
at lower485, similar187,364,492 or brighter368,498 light in different mammal and non-mammal 
species compared to my release threshold in mice. Furthermore, flickering light at a light 
intensity just below the abrupt increase of dopamine release did not show any difference 
compared to steady light (Figure 4.1), although dopaminergic amacrine cells have been shown 
to trigger strong bursts of spikes in rodent retinae in response to flickering light336. An increase 
in dopamine release was reported in both non-mammal360,363,492,493,499 and mammal 
species364,450, although for mammal species the flickering stimuli was brighter compared to the 
steady light. 
While it is possible that the method I used to determine dopamine release is not sensitive 
enough to measure localised augments of dopamine, it is certainly able to statistically discern 
between two measurements whose dopamine release differs ~16 pg of dopamine/retina (Figure 
4.6). In addition, a lot of the experiments reported in the literature were conducted in vitro 
retinae without the RPE attached and it is very rare to see light intensities as high as those used 
in this thesis because a significant portion of the rod photopigments would be irreversibly 
92 
 
bleached. It may be that these experiments miss the abrupt increase at light levels above 14 log 
rod photons cm-2 s-1. Indeed, I highlight the importance of keeping the RPE attached to the 
retina in ex vivo preparations in Figure 4.4, as without it retinae release significantly less 
dopamine likely due to a decrease in the regeneration of all-trans-retinal to 11-cis-retinal from 
rod opsin during bright light treatment. Certainly, while cones can additionally count on Müller 
cells to obtain 11-cis retinal500–502 and  melanopsin can act as a photoisomerase with certain 
independence of the RPE503–505, rods strongly rely on the RPE506,507 suggesting that rods are 
necessary to drive light-induced dopamine release (as previously suggested by Cameron et 
al.368). Also, dopamine release occurred within a minute in response to bright light (Figure 
4.5A) and while other studies reported the earliest light-induced dopamine release over longer 
timescales (within 10 to 15 minutes after light exposure187,485,492), actual dopamine vesicles are 
released within 3 seconds after dopaminergic amacrine cell depolarisation508.  
Retinal dopamine was linked with eye growth a long time ago and hypothesised as a target for 
the regulation of myopia509. Since then, a number of studies showed that exposure to bright 
light (that cause light-induced dopamine release) reduced the risk of myopia, supporting the 
critical role of dopamine during development510–516. However, the contribution of each 
photoreceptor to light-induced dopamine release has not been treated in depth, although rods 
were considered to be involved ~P28 in mice399. In my experiments, overall light-induced 
dopamine release did not occur before P18 (Figure 4.7), even though all three photoreceptor 
types have been previously shown to be functional before that time. While it may be that the 
retinal circuitry is not mature enough at this age, dopaminergic amacrine cells can certainly be 
labelled as early as E19517, P7518, P10519 and P16520 in rat, and P6 in mouse, and those numbers 
increase until adult levels are reached ~P18 or ~P15 respectively338. Further, Arroyo et al.521 
suggested that dopaminergic amacrine cells are functional very early (~P4) and can be elicited 
to release dopamine by retinal waves. The first functional photoreceptors in the retina are 
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ipRGCs, which have been shown to elicit light-evoked responses at P0 via electrophysiology, 
calcium imaging and c-fos activation of brain projections85,112,522 and even regulate light-
induced retinal responses before birth521,523. However, no differences were observed between 
dopamine release in light-pulsed and dark-adapted retinae at that age (Figure 4.7), suggesting 
while melanopsin is active and signalling, its input alone is not enough to drive overall light-
induced dopamine release. Later, S and M cone opsins are expressed at ~P1 and~P7 
respectively, and rod opsin ~P5108,  but no literature is available regarding actual light responses 
from these photoreceptors or downstream pathways at these ages (although excitatory post 
synaptic potentials can be recorded from ganglion cells at P7524 matching the time of arrival of 
axons from bipolar cells525). However, my experiments confirmed similar levels of dopamine 
turnover between light and dark conditions at P7. At eye opening (~P10-P12) light provokes 
electrophysiological responses in both ON and OFF retinal ganglion cells526,527, which 
correlates with the time that rods become effectively responsive to light85,110 (assessed by c-fos 
and electrophysiology). Unfortunately, no intermediate point of dopamine turnover between 
P7 and P18 was tested, but one would expect at least a moderate increase in DOPAC: dopamine 
ratio in response to light ~P12-P15. In the literature, dopaminergic amacrine cells have been 
shown to respond to light ~P18127 (assessed with c-fos), correlating with the positive results in 
light-induced dopamine turnover between P18-P26 (Figure 4.7). 
 
4.3.2. In vivo and ex vivo approaches provide complementary results 
Treating retinae with in vivo or ex vivo approaches allows us to understand dopamine release 
from complementary perspectives. The in vivo approach of measuring DOPAC: dopamine ratio 
seems to provide an instantaneous picture of the moment when retinae were extracted and snap 
frozen. This is suggested by the fluctuation observed between 1 and 15 minutes after light 
exposure (Figure 4.5). For instance, at 5 minutes the animal has had more light exposure than 
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at 1 minute, but the DOPAC: dopamine ratio is smaller. These results may reflect the regulation 
of dopaminergic amacrine cells via different feedback mechanisms involving dopamine at 
different points of the visual pathways that input into dopaminergic amacrine cells, such as: 1) 
reducing rods activity under bright light amacrine cells528 and 2) reducing the amplitude and 
sensitivity of rod-driven depolarising bipolar cells via disinhibition of a GABAergic inhibitory 
input437 diminishes the excitatory input into dopaminergic amacrine cells; 3) increasing 
excitability of OFF bipolar cells440,529 reduces the inhibitory parallel inputs into dopaminergic 
amacrine cells330,336; 4) closing gap junctions284,445,530,531 reduces rod fed into cone pathways 
(primary and secondary rod pathways); 5) auto-inhibition of dopaminergic amacrine cells via 
D2 receptor decreases TH activity419. 
Further, an important consideration should be made to researchers using the DOPAC: 
dopamine ratio as a measure of overall turnover in the retina since the dissection conditions of 
the retina (e.g. ~1 minute of bright dissection light) could significantly change this ratio over a 
short time-scale. Consequently, animals were light-pulsed for 15 minutes in further 
experiments since responses were stabilised by this time.  
The ex vivo preparation is particularly useful for experimental designs that involve the use of 
drugs, since they can easily be added in the media without the troubleshooting of intravitreal 
injections. However, while the ex vivo measurements provide similar irradiance response 
graphs as the in vivo approach, the ex vivo time course shows a constant increase in dopamine 
release until a plateau is reached (Figure 4.5) without the oscillation observed in vivo. The 
differences in the reduction of temporal resolution can be explained because dopamine released 
in the supernatant (or pseudo-vitreous) is just accumulated over time taking longer to diffuse 
into a larger volume compared to the transmission within the retinal tissue. Also, dopamine 
molecules released from the ex vivo preparation might suffer from oxidation before the 
extraction (the artificial media was bubbling and/or atmospheric oxygen diffusion) and cause 
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a further reduction in the final quantification. Certainly, in “Chapter 3. Optimisation of a 
method to accurately quantify dopamine turnover in the retina”, I show that the standard counts 
of dopamine without an antioxidant such as ascorbic acid are significantly reduced compared 
to those with ascorbic acid. However, addition of ascorbic acid into the supernatant of the ex 
vivo preparation as an attempt to prevent dopamine oxidation was not possible because ascorbic 
acid affects both RPE532,533 and GABA receptors534 and might alter results of light-induced 
dopamine535. All these differences could account for the increased consistency in the in vivo 
baselines, compared to the variability in ex vivo baseline levels as previously discussed. 
Additionally, the ex vivo retinae suffer more manipulation and small variations in the timing of 
the procedure might compromise the viability of the tissue (e.g. part of RPE detaches). To 
reduce that variability, viability assays in conjunction with protein normalisation536 can be 
performed in the future after the collection of the supernatant. 
 
4.3.3. Dopamine release does not match electrophysiological inputs  
Interestingly, the electrophysiological responses of dopaminergic amacrine cells upon 
application of some of the drugs from Figure 4.6 (strychnine, picrotoxin, L-AP4, CNQX, AP5, 
TTX) did not correlate with dopamine quantification i.e. dopaminergic amacrine cells have 
electrophysiological light-induced responses after its application but not light-induced 
dopamine release77,327,330,333,336,458, suggesting a discrepancy between actual dopamine release 
and electrophysiological responses (as previously mentioned368). However, 
electrophysiological recordings are conducted at the soma of dopaminergic amacrine cells and 
actual dopamine release is suggested to occur at the processes451 that lack voltage-gated sodium 
channels537 suggesting they are electrically isolated from the soma. Even if the 
electrophysiological recordings were performed in the processes, in the striatum, the machinery 
necessary for dopamine release is only found ~20% of dopamine varicosities with the rest being 
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“silent”538. Therefore, it is possible that a similar scenario occurs in the retina and the 
recordings would still mismatch with dopamine release. However, stimulation of excitability 
with high potassium (15 mM KCl) increases dopamine release only under light stimulation 
compared to the control (3 mM KCl) similarly as reported in the literature, where a significant 
increase ~5-fold of dopamine release occurs with higher concentrations of KCl (between 25-
40 mM KCl)355,356,360,364,492,498,539. Depolarisation caused by high K+ presumably increases 
spiking, although there is the possibility that this depolarisation inactivates V-gated Na+-
channels and thus reduces spiking. This last hypothesis can be easily tested in future 
experiments combining KCl with TTX to check if the increase in dopamine is maintained in 
the presence of both compounds. Conversely, TTX blocks sodium channels and therefore 
prevents firing of action potentials540. Indeed, application of TTX ex vivo significantly reduced 
dopamine levels in both dark and light, and that dopamine could not be released in response to 
light if TTX was present in the media. Sodium channels are mainly located in third-order 
neurons such as amacrine537,541,542 (including dopaminergic amacrine cells324,537) and retinal 
ganglion cells543,544 (including ipRGCs329,330); although in humans they appear to be present in 
rods545 and  (controversially) in bipolar cells 546–549, which are suggested to be involved in the 
termination of a light response. Together these results (KCl and TTX) suggest that an increase 
in excitability is required for dopamine release at the specific discharge site. Alternatively, the 
increasing effect of KCl on dopamine release may be caused by a sustained depolarisation of 
dopaminergic amacrine cells rather than to an increase in spiking activity. Increasing 
extracellular K+ would shift the membrane potential to ~-50mV, potentially leading to Na+ 
channel inactivation but activating the voltage-dependent Ca2+ channels responsible for 
dopamine release. 
Overall changes in light-induced dopamine release from dopaminergic amacrine cells in the 
presence of strychnine or picrotoxin did not have any effect compared to untreated light 
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controls (Figure 4.6). Glycine is released by half of the amacrine cells of the retina, and the 
majority of them are at the post-synaptic side of AII amacrine cells, which connect rod bipolar 
signals to cone OFF pathways550. In addition, glycine receptors are found in distinct subsets of 
amacrine cells including AII and dopaminergic amacrine cells452, and 3 µM strychnine 
effectively blocks different glycinergic receptors256. Relieving an inhibitory input 
hypothetically should increase excitability in dopaminergic amacrine cells, and indeed 1 µM 
strychnine has been shown to increase excitability of dopaminergic amacrine cells77. However, 
my results showed no additional increase in dopamine release, either in the light or the dark, in 
response to 10 µM strychnine. This agrees with other measurements of dopamine release in the 
literature466, further demonstrating the lack of correlation between electrophysiological 
response and dopamine release. However, Morgan et al.467 showed a dose-dependent increase 
of L-DOPA in dark-adapted rats (up to 50 nM strychnine), whereas my results show the 
opposite. These differences could be related to differences in both dosage (which has opposite 
effects at low and high doses on bipolar cells551) and analytical techniques (mice ex vivo eyecup 
against rat in vivo intravitreal injections). Additionally, 10 µM strychnine has been shown to 
block acetylcholine receptors552,553 which may affect the suggested link between ON bipolar 
terminals and dopaminergic amacrine cells through starburst amacrine cells322. 
Picrotoxin has been shown to effectively block GABA-induced currents in GABAA and 
GABAC receptors, both of which are ligand-gated chloride channels
554–559. GABA is released 
from horizontal cells, A17 and dopaminergic amacrine cells, and receptors can be found in all 
retinal cell types including dopaminergic amacrine cells themselves560. My experiments 
showed that addition of 50 µM picrotoxin raises dark-adapted dopamine levels to equal those 
of light-pulsed retinae and light and picrotoxin had no synergistic effect. Similar results are 
found in the literature with additions ~30-100 µM picrotoxin in fish356,492,561, amphibian562 and 
mammal350,465 retinae. Ultimately, the effects on upregulation of dopamine release in the dark 
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are most likely explained due to the relief of a tonic GABA inhibition of dopaminergic 
amacrine cells, as has been previously suggested356,465,562. The GABA source for this inhibition 
could come from the A17 amacrine cells that contact rod bipolar cells563,564. Alternatively, the 
presence of GABA receptors in bipolar cells565,566 and the increase in the amplitude of b wave 
in the electroretinogram after picrotoxin exposure567 suggests an increase light responsiveness 
of ON bipolar cells that may increase the excitatory input received by dopaminergic amacrine 
cells. As previously mentioned mice are nocturnal animals and the exposure to such high light 
intensities are certainly triggering volume transmission of dopamine in response to a bright 
light from a dark-adapted state. My hypothesis is that the release machinery of dopaminergic 
amacrine cells gets saturated with bright light and picrotoxin, and therefore we cannot see any 
synergistic effect. An alternative hypothesis would be that light and picrotoxin trigger pathways 
that share a common mechanism of dopamine release (supposing that more than one exists) 
and perhaps the addition of light, picrotoxin and more drugs that trigger DA release (such as 
high KCl) could answer if dopaminergic amacrine cells reached their saturation. 
In contrast to the variability in responses from the relief of the inhibitory inputs to dopaminergic 
amacrine cells, the blockage of different excitatory inputs with L-AP4, CNQX and AP5 
eliminated widespread dopamine release (Figure 4.6). L-AP4 is a potent and selective agonist 
of group III mGluR receptors (subtypes 4,6,7 and 8), from those, mGluR8 are found in 
photoreceptors, mGluR6-8 on the ribbon synapse between photoreceptors and bipolar cells227, 
and mGluR4,7,8 in amacrine and ganglion cells568 (although mGluR7 & mGluR8 are not the 
most prevalent GluR receptors, they have been found at the photoreceptor-bipolar cell synapse 
sites. Protein of mGluR7 can be found in rat and goldfish bipolar cells, and in mouse cones; 
whereas protein and mRNA of mGluR8 can be found in mouse and rat photoreceptors, and 
mRNA in mouse bipolar cells). L-AP4 is mainly used in the retina to eliminate ON bipolar cell 
responses by hyperpolarisation of these cells. Application of 50 µM  L-AP4 in my experiments 
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was enough to prevent light-induced dopamine release and impact significantly on dopamine 
levels in the dark suggesting that basal dopamine release in the dark is mediated by a different 
circuitry than light-induced (possibly via rod →OFF bipolar cells304). In the literature, the same 
concentration of L-AP4 only abolished transient light electrophysiological responses in 
dopaminergic amacrine cells327,330 with the remaining sustained resistant component suggested 
to be driven by ipRGCs327. It may be that it is the transient, rather than sustained, 
electrophysiological response that ultimately elicits dopamine release. 
CNQX is a competitive antagonist that blocks all excitatory synaptic activity of AMPA and 
kainate iGluR receptors, which are present in horizontal, OFF bipolar, amacrine (including 
dopaminergic amacrine345), and ganglion cells251,569–574. Thus, CNQX could be blocking key 
synapses such as ipRGCs → dopaminergic amacrine cells328,330. However, it is difficult to 
discern where the block is occurring, although dopaminergic amacrine cells express AMPA 
and kainate receptors77,324 that could explain the reduction observed in light-induced dopamine 
in the presence of 10 µM CNQX.  
AP5 is a selective and competitive antagonist of NMDA receptors and, as previously 
mentioned, NMDA receptors are blocked by Mg2+ at resting membrane potentials below -65 
mV. Therefore, removing this ion from the extracellular solution allows these ion channels to 
be activated by synaptic glutamate without coincident membrane depolarisation575,576. Indeed, 
my results suggest an involvement of NMDA receptors since blocking NMDA receptors with 
10 µM AP5 reduced light-induced dopamine release, and enhancing NMDA receptor activity 
in a medium free of Mg2+ increased dopamine release. Further, different subunits that form 
NMDA receptors largely impact on their affinity577,578 and blockade sensitivity of Mg2+ 579–581, 
with NR2A and NR2B more strongly blocked than NR2C and NR2D582 and preferentially 
expressed in both amacrine and ganglion cells583. Perhaps an uneven relief of NMDA blockage 
at different points of the retinal circuitry prevented the triggering signal into dopaminergic 
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amacrine cells to release dopamine. Even though NMDA receptors (and its subunits) are 
expressed ubiquitously throughout the retina583, more specifically, NMDA receptors have been 
shown to increase light responses from AII and A17 amacrine cells584, which are specific 
amacrine cells of rod pathways. Thus, it may be that at bright light intensities glutamate 
spillover from rod bipolar cells activates NMDA receptors at these synapses.  
Finally, when gap junctions in the retina were non-specifically blocked with 200 µM 
MFA287,585, light-induced dopamine release was significantly reduced but not eliminated 
suggesting that the remaining signal must be from cones, ipRGCs or an alternative gap-junction 
independent rod pathway (the role of cones and ipRGCs will be further discussed with 
transgenic animal models in “Chapter 5.  Photoreceptive input driving light induced dopamine 
release”) or simply reflect an incomplete blockage of pathways. Certainly, the tonic light driven 
input that dopaminergic amacrine cells receive from ipRGCs is still present when MFA is 
applied544,586. Again, suggesting that spiking of the soma of dopaminergic amacrine cells does 
not equal widespread dopamine release. A more specific experiment performed by Zhang et 
al.333 knocking out specifically Cx36 (using a transgenic mouse model) to disrupt primary and 
secondary rod pathways (instead of all gap junctions with MFA), showed that light induced 
responses from dopaminergic amacrine cells were eliminated (in 5 out of 6 cells) at scotopic 
light levels, but responses recovered past the mesopic threshold. Therefore, they suggest that 
all three: primary (rods → rod bipolar cells → AII amacrine cells → cone bipolar cells), 
secondary (rods → cone bipolar cells) and tertiary (direct contact from rods to cone bipolar 
cells310,587) rod pathways involve rod signalling into dopaminergic amacrine cells. Since 
blockage of the electrical connection between AII and ON-bipolar cells287,585 still provided 
responses in dopaminergic amacrine cells, a remaining rod signal into dopaminergic amacrine 
cells may occur via chemical synapses through  rod → ON rod bipolar → AII amacrine cells 
→ OFF cone bipolar588,589 or ON rod bipolar  → A17 amacrine cells451,590.  
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In conclusion, this chapter provides evidence that dopamine turnover is U-shaped with more 
dopamine being released only under very dim scotopic and very bright photopic light 
intensities. Temporal dynamics of dopamine are studied in vivo showing an “instantaneous” 
measurement of dopamine turnover after any given light or dark exposures, which exhibits 
much faster dopamine increase in response to light rather than dopamine decrease during dark 
adaptation. The ex vivo preparation is used as a tool to assess dopamine turnover under 
pharmacological modulation of pathways involved in dopamine release, providing results in 
agreement with the literature, ultimately indicating that dopamine release is a balance between 
excitatory and inhibitory inputs. Also, the circuitry involved in light-induced dopamine release 
reaches its maturity ~P18, despite evidence showing the activation of different photoreceptors 
at earlier stages during development. Importantly, different experiments from this chapter show 
that widespread dopamine release does not correlate with electrophysiological activation of 
dopaminergic amacrine cells, suggesting that the assumption made in few articles from the 
literature that somatic activation of dopaminergic amacrine cells equals dopamine release may 
be wrong. However, each analytical technique has its own limitations and much smaller 
amounts of localised dopamine (that I was unable to quantify) may be released in response to 
electrophysiological activation. 
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CHAPTER 5:                                          
Photoreceptive input driving light-induced 
dopamine release 
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5.1. INTRODUCTION 
In the previous chapter I defined global light-induced dopamine release over a range of light 
intensities, exposure times and pharmacological modulation in wild-type mice. However, in 
order to determine the origin(s) of the input(s) that determine dopamine turnover, here, I used 
a range of mouse models with altered photoreception: Gnat2A518G mouse lacking cone 
phototransduction but without cone degeneration468; Opn4Cre/Cre mouse lacking melanopsin but 
without major ipRGCs reorganization52,478; rd/rd mouse whose rods and cones degenerate 
during development and suffer significant retinal remodelling, but have intact and functional 
ipRGCs; and Opn1mwR mouse that have a knock in (human) L-opsin substituting the (murine) 
M-opsin and present a shifted sensitivity towards red469, which is used to spectrally segregate 
the activity of cones from the other photoreceptors.  
The previous chapter showed that dopamine is released in response to bright light. Since both 
cones and ipRGCs are known to be functional at bright light intensities and present a well-
established electrophysiological input into dopaminergic amacrine cells, I characterised the 
putative input of both ipRGCs and cones to light-induced dopamine release. First, to test the 
role of cones I used three different approaches: 1) irradiance-response curve in Gnat2A518G 
mouse compared to wild-type from the previous chapter, 2) Opn1mwR mouse to preferentially 
activate cones using a red-shifted light stimulus, and 3) light pulses at developmental ages in 
rd/rd mice where rods are lost but cones are still functional.  
To determine the input of ipRGCs I relied on four different approaches: 1) irradiance-response 
curve in both Opn4Cre/Cre (no melanopsin) and rd/rd mouse (only ipRGCs active); 2) 
preferential activation of rods and cones but not melanopsin using distinct spectral stimuli in 
wild-type mice; 3) use of aged (>18 months) rd/rd mice to evaluate the impact of the reported 
increase in the number of dopaminergic amacrine cells activated by light at this age449,591 
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(presumably from ipRGCs); and 4) chemogenetic activation of ipRGCs (exclusively) using 
virally introduced Cre-dependent Designer Receptors Exclusively Activated by Designer 
Drugs (DREADDs) in the Opn4Cre/+ mouse80.  
Although rods are classically known to be active at low light intensities and become saturated 
under bright light, recent literature argues against this and suggests that rods might be 
functional at bright light intensities27,28. Therefore, to determine the input of rods in both dim 
and bright light conditions I performed three different experiments: 1) dissection of the retinae 
from all the aforementioned mutant mice under both dim red and infrared light to determine if 
the suppressive effect of dopamine turnover under dim red light was indeed caused by rods 
alone (Figure 4.1); 2) use of Gnat2A518G mouse light-pulsed with a red-shifted light to activate 
rods but not melanopsin above dopamine release threshold; and 3) use of MFA on light-pulsed 
Gnat2A518G mouse to assess if an increase in dopamine turnover was due to primary, secondary 
or tertiary rod pathways, or had any additional photoreceptive inputs. 
Further, I systematically provided complementary approaches to overcome the limitations of 
the experimental conditions and transgenic mice models themselves (discussed in detail 
throughout the chapter). Altogether these results suggest that rods alone are both sufficient and 
necessary to drive light-induced dopamine release at any given light intensity, and conversely, 
cones nor ipRGCs elicit significant changes in widespread light-induced dopamine release 
despite known electrophysiological input to dopaminergic amacrine cells. 
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5.2. RESULTS 
5.2.1. Rod input supresses dopamine release under dim light 
In the previous chapter I suggested that rods were responsible for suppression of dopamine 
release at dim light intensities, given the differences in dopamine turnover observed between 
dim red and infrared dissection in wild-type mouse (Figure 4.1). In order to clarify the 
photoreceptive origin that caused this reduction, I performed dissections under both dim red 
and infrared light in Gnat2A518G, Opn4Cre/Cre, Opn1mwR and rd/rd mice (Figure 5.2). Retinae 
from Gnat2A518Gand Opn4Cre/Cre dissected under dim red light exhibited a significant decrease 
in dopamine turnover compared to those dissected infrared light (t-test, **p-value ≤ 0.009). 
Further, comparison of Gnat2A518G and Opn4Cre/Cre with wild-type mouse showed no differences 
at equivalent irradiance points (one-way ANOVA with Dunnett’s multiple comparison test 
against wild-type dim red p-value ≥ 0.21, and wild-type infrared p-value ≥ 0.34). No significant 
differences were observed between dim red and infrared light dissections in Opn1mwR mice (t-
test, p-value = 0.32), although a trend of ~1.6-fold decrease under dim red light conditions was 
observed. However, no significant differences were observed when comparing equivalent 
irradiance points of Opn1mwR with wild-type mice (t-test, p ≥ 0.23). Given the red-shifted 
spectral activation of cones in this model, this result suggests that the increased activation of 
L-cones under infrared light may drive a small reduction in dopamine release, reducing the 
difference between dim red and infrared conditions. Last, rd/rd mice did not exhibit any 
difference between dissection conditions (t-test, p-value = 0.17), suggesting that rods are 
necessary to modulate dopamine turnover at these light intensities and that ipRGCs alone do 
not elicit any measurable effect on the modulation of dopamine release by dim light. 
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5.2.2. Rods are both sufficient and necessary to drive light-induced 
dopamine release 
In line with the rationale from the previous chapter, I tested dopamine release along an 
irradiance-response curve from dark-adapted (dim red) to 16 log photons cm-2 s-1, in both in 
vivo and ex vivo preparations. Here, I used three different genotypes (Gnat2A518G, Opn4Cre/Cre 
and rd/rd) to determine the role of each photoreceptor in light-induced dopamine release at 
given irradiance points. In agreement with wild-type in vivo data, only high irradiances (15 and 
16 log rod photons cm-2 s-1; 15 min) caused a significant increase in light-induced dopamine 
release in Gnat2A518G and Opn4Cre/Cre (Figure 5.1A, one-way ANOVA with Dunnett’s multiple 
comparison test, ***p-value < 0.0001) suggesting that neither cones nor ipRGCs are necessary 
to drive light-induced dopamine release even at bright light intensities. The irradiance response 
curves from Gnat2A518G, Opn4Cre/Cre and wild-type mice could be fitted in the same curve (extra 
sum-of-squares F test, p = 0.89, F = 0.44) and exhibited very similar thresholds of dopamine 
release (Table 5.1), suggesting that neither cones nor ipRGCs are necessary to set the dopamine 
release threshold. Conversely, rd/rd mice did not exhibit light-induced dopamine release at any 
given light intensity (one-way ANOVA with Dunnett’s multiple comparison test, p-value > 
0.99). However, the results obtained from rd/rd mice need to be interpreted with a degree of 
caution since those animals suffer severe retinal remodelling during development that might 
impair natural synaptic connections, and thus may not be the most reliable model to study 
isolated inputs from ipRGCs. Nonetheless, taken together these results suggest rods are both 
1) necessary and sufficient to drive light-induced dopamine suppression and release, and 2) 
define the thresholds at which those occur. 
I repeated these irradiance curves ex vivo and I observed very similar results as in vivo, with 
Gnat2A518G and Opn4Cre/Cre mice releasing light-induced dopamine at the two brightest light 
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intensities compared to dim red light (one-way ANOVA with Dunnett’s multiple comparison 
test, ***p-value ≤ 0.0007), and rd/rd being irresponsive to light throughout the entire given 
range of light intensities (Figure 5.2B). However, as was apparent in the previous chapter, ex 
vivo baseline levels were variable, and comparing absolute values of either the two highest 
irradiances of Gnat2A518G mice or 15 log rod photons cm-2 s-1 of Opn4Cre/Cre mice with 
equivalent irradiance points in wild-types, showed a significant decrease in dopamine release 
(one-way ANOVA with Tukey’s multiple comparison test, $$$p ≥ 0.0001). This may indicate 
that rods set the threshold for release, whereas cones and/or ipRGCs could play a role in 
amplitude modulation. However, this change in amplitude could also be a consequence of 
general morphological changes in the Gnat2A518G animals that prevents diffusion of dopamine 
out of the retina, or strain differences between the Opn4Cre/Cre animals (C57BL/6 and 129sv 
mix) compared to C57BL/6 wild-types. Despite this reduction in amplitude of responses, the 
absolute thresholds of dopamine release remain very close across genotypes (Table 5.1) and if 
the data is normalised one curve can fit all light-inducible genotypes ex vivo (wild-type, 
Gnat2A518G and Opn4Cre/Cre; extra sum-of-squares F test, p = 0.71, F = 0.67). Further, if in vivo 
and ex vivo irradiance curves of each genotype are normalised together, one curve can fit both 
datasets in all genotypes (Table 5.1). These results strongly support the use of ex vivo as an 
equivalent measure for dopamine release, and support the same hypothesis raised by the in vivo 
results that rods are both sufficient and necessary to drive light-induced dopamine release. 
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Genotypes p-value F value In vivo threshold (log rod 
photons cm-2 s-1) 
Ex vivo threshold (log rod 
photons cm-2 s-1) 
Wild-type 0.9788 0.1097 14.5966 14.5988 
Gnat2A518G 0.3888 1.051 14.5851 14.5624 
Opn4Cre/Cre 0.6623 0.6058 14.3854 14.2424 
rd/rd 0.9848 0.0153 N/A N/A 
Table 5.1. No difference between ex vivo and in vivo thresholds for dopamine release. F-test sum-
of-squares was applied to normalised (R/Rmax) data from in vivo and ex vivo irradiance curves from 
each genotype, and one curve coukd fit each pair of data from each genotype. This suggests that both 
measurements are complementary when assessing light-induced dopamine release at equivalent 
irradiance levels at the same time exposures (15 minutes). Light-induced dopamine release threshold 
(defined as 2 standard deviations above dark release) was not different between genotypes or method. 
 
While rd/rd mice might not be the best model to study circuitry due to the substantial 
remodelling they suffer, ipRGC inputs to dopaminergic amacrine cells are maintained in these 
animals327–329,592,593. Given that I did not observe any light-induced dopamine responses in 
rd/rd mice, I tested if the dopaminergic amacrine cells from rd/rd animals could indeed release 
dopamine. To assess this, I hypothesised two situations: 1) dopaminergic amacrine cells might 
be receiving additional glycinergic and/or GABAergic inhibition that cannot be relieved by 
ipRGC input, and 2) dopaminergic amacrine cells do not have the machinery necessary to 
synthesise and release dopamine as a consequence of degeneration and/or remodelling of the 
remaining retina. First, I inhibited inhibitory inputs into dopaminergic amacrine cells with 
either strychnine or picrotoxin as performed in the previous chapter. Application of 10 µM 
strychnine into the media did not affect dopamine levels of either dark-adapted or light-pulsed 
retinae compared to their respective untreated controls (t-test, p-value ≥ 0.17). However, 
addition of 100 µM picrotoxin caused a significant increase in light-induced dopamine release 
(t-test, *p-value = 0.02), but not in dark-adapted controls (t-test, p-value = 0.1). Suggesting that 
indeed, dopaminergic amacrine cells in rd/rd animals receive GABAergic but not glycinergic 
inhibitory input but that this can only be relieved by a combination of light and picrotoxin to 
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cause dopamine release. These results are in agreement with an enhanced GABA and 
melanopsin signalling in rd animals reported in the literature592, and suggests that the relief of 
both stimulates dopaminergic amacrine cells via both disinhibition from GABA and excitation 
from ipRGCs. 
Since depolarisation is correlated with dopamine release in the literature355,356,360,364,492,498 
(Chapter 4, Figure 4.6), I stimulated the excitability of rd/rd retinae in a medium with high 
potassium (15mM; Figure 5.3). Not surprisingly, high potassium caused a significant increase 
in dopamine release in both dark-adapted and light-pulsed conditions compared to their 
respective non-treated controls (t-test, *p-value ≤ 0.03). No differences were observed between 
dark and light treated conditions (t-test, p-value ≥ 0.61), suggesting that the increase was based 
exclusively on increased excitability or sustained depolarisation of  dopaminergic amacrine 
cells (as discussed in the previous chapter), and as opposed to wild-type mice (Chapter 4, Figure 
4.6), was not enhanced by light. While the basal rate of dopamine didn’t increase significantly 
with high KCl, it certainly had a synergistic effect when combined with light. Taken together, 
these results indicate that the dopamine release machinery is still capable of functioning and 
an increase in excitability alone does cause dopamine release in the rd/rd retinae. Further, to 
better understand if the release of dopamine is based specifically on spiking, an experiment 
combining KCl with TTX would shine some insight on this hypothesis. 
Using a Mg2+-free solution to disinhibit NMDA receptors and increase the excitatory inputs to 
dopaminergic amacrine cells did elicit significant dopamine release under both dark and light 
conditions (t-test, ***p-value ≤ 0.0001; Figure 5.3), suggesting that NMDA channels are 
necessary to trigger dopamine release. However, depletion of Mg2+ will cause an increase in 
the overall excitability of the retina in addition to unblocking NMDA channels. 
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However, these experiments were performed in young rd/rd mice (~P60), and paradoxically, 
aged rd/rd mice (~P720) are reported to have a wider activation pattern of dopaminergic 
amacrine cells in response to light driven by ipRGCs (~3% TH cells expressed c-fos at 3 months 
and ~36% at >14 months in response to light)593. Therefore, I examined light-induced 
dopamine release in aged animals to check if the increase in electrophysiological activation 
correlated with actual levels of dopamine release (Figure 5.4). Although aged animals exhibited 
an increased basal level of dopamine turnover under both dark and light conditions (t-test **p 
≤ 0.0056), they remained irresponsive to a bright light pulse (16 log rod photon cm-2 s-1, 15 
min) compared to dark-adapted retinae of an equivalent age. It is possible that increased 
innervation from ipRGCs in aged animals contributes to the increased basal release of 
dopamine rather than light-induced release. 
Further examination of rd/rd mice was conducted at different developmental points to test if 
they had light-inducible dopamine at any developmental point before photoreceptor 
degeneration. Thus, light-induced dopamine release was tested at the highest irradiance (16 log 
photons cm-2 s-1, 15 min) at P0, P7, P18, P22 and P26 (Figure 5.5), and no light-induced 
dopamine release occurred at any developmental time point (t-test, p-value ≥ 0.25). This results 
further support the hypothesis that ipRGCs cannot drive light-induced dopamine alone despite 
its electrophysiological input (since ipRGCs are active before birth), and that cones alone 
(present until P22) were not able to drive light-induced dopamine release at P18 (contrary to 
wild-types; Chapter 4, Figure 4.7).  
To further assess the input and circuitry exploited by each photoreceptor to dopamine release 
in non-degenerate retinae, I used three additional and different approaches: 1) chemogenetic 
activation of exclusively ipRGCs in the dark (DREADDs), 2) spectral activation of the three 
photoreceptors using different wavelengths (624 nm; 434 nm) and light intensities, and 3) 
pharmacological modulation of Gnat2A518G mice. 
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DREADDs can have several applications depending on the construction of the vector594, and 
recently much work has been done on ectopic activation of ipRGCs using hM3D-Gq 
receptors80,595–597. Our vector of choice was pAAV-hSyn-DIO-hM3Dq-mCherry, so the floxed 
receptor hM3Dq (G-protein coupled receptor) could be expressed only in the ipRGCs of 
Opn4Cre/+ mice. Depolarisation can be induced exclusively in ipRGCs with application of 
clozapine N-oxide (CNO). First, animals were unilaterally intravitreally injected with adeno-
associated virus (AAV) containing floxed hM3Dq fused to mCherry. After 6 weeks of 
incubation, it was then possible to activate ipRGCs expressing hM3Dq with an intraperitoneal 
injection of CNO (5mg/kg). To verify expression in ipRGCs, pupillary constriction of mice 
was tested under infrared light (> 950 nm) in response to CNO injection. Figure 5.6 shows a 
representative image of a mouse pupil before (left) and after CNO (right) injection; this 
response lasted > 3 hours before the pupil started to re-dilate. Animals with < 80% constriction 
were excluded as constriction is correlated with expression levels80. As AAV injections were 
unilateral, the contralateral eye was used as a control. CNO was injected, pupil constriction 
verified, and eyes removed under dim red light after 1 hour. No significant melanopsin-induced 
dopamine release occurred in the virus-injected eye compared to the contralateral control 
(paired t-test, p-value = 0.62) indicating that even sustained activation of ipRGCs in a non-
degenerate retina cannot drive dopamine release.   
Next, red and blue light pulses were tested on wild-type and Gnat2A518G mice to determine 
which photoreceptor is setting the threshold. Theoretical irradiance response curves were 
constructed for each photoreceptor based on their spectral sensitivity481 (Figure 5.7). These 
curves assume that the irradiance response to the white light stimulus given the threshold is set 
by each respective photoreceptor. As rods, M-cones, melanopsin and L-cones have similar 
sensitivity to white LED light (“Chapter 2. Materials and Methods”, Figure 2.2), effective 
photons cm-2 s-1 are very similar, however, as the white light does not contain UV light, if UV-
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cones were driving this response they would be activated by a lower number of effective 
photons. The aim of these experiments was to use blue- and red-light stimuli to selectively 
activate each photoreceptor above its theoretical threshold. The blue light (solid blue line) 
activates all photopigments above threshold, whereas the red light (solid red line) activates 
only rods and cones above their dopamine release thresholds. Since rods are the prime suspect 
to drive dopamine release, high intensity red and blue light input intensities (red and blue lines) 
were matched for effective activation for rods (15 log effective photons cm-2 s-1). Both wild-
type and Gnat2A518G mice were able to release light-induced dopamine in response to both red 
and blue light (Figure 5.8A; t-test, ***p < 0.0001), suggesting that the input of neither 
melanopsin nor cones was necessary to set the threshold. Further, comparing dopamine 
turnover levels in conditions where only rods were active above dopamine release threshold 
(red light in Gnat2A518G) against activation of rods plus an additional photoreceptor, such as 
rods + melanopsin (blue light in Gnat2A518G) or rods + cones (red light in wild-type), showed 
no differences in dopamine turnover levels (one-way ANOVA with Dunnett’s multiple 
comparison test, p ≥ 0.87). These results suggest that rods alone set and define dopamine 
release. I also utilised a similar method in Opn1mwR mice to spectrally activate cones but neither 
rods nor ipRGCs above the dopamine release threshold (Figure 5.8B). The red pulse used here 
(dotted line) is of a lower intensity that activates L-cones above threshold but not rods or 
ipRGCs (Figure 5.7). This stimulus was not able to cause light-induced dopamine release in 
Opn1mwR mice (t-test, p = 0.27), although a positive trend was observed (Figure 5.8). To test 
that light-induced dopamine responses were normal in Opn1mwR mice, I light-pulsed them with 
white bright light causing significant dopamine release (t-test, **p = 0.002). This showed that 
the dopaminergic function of Opn1mwR mice was intact, but activating cone photoreceptors 
above their threshold was not enough to cause full amplitude light-induced dopamine release. 
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Pharmacological modulation in Gnat2A518G mice was the last approach used to test the 
contribution of the different photoreceptor to light-induced dopamine release by blocking 
primary and secondary rod pathways with MFA (Figure 5.9). Intravitreal injections of sham 
saline triggered normal light-inducible responses, but 1mM MFA injection (~100 µM final 
concentration in the eye) significantly reduced light-induced dopamine release compared to 
light sham control (t-test, #p < 0.05). In a similar manner, application of 200 µM MFA in the 
ex vivo preparation caused a reduction in light-induced dopamine compared to light control. 
Therefore, both approaches (in vivo and ex vivo) suggest that rods can signal into dopaminergic 
amacrine cells through a gap junction independent pathway. However, these results may reflect 
an incomplete block, because while application of MFA ex vivo showed a significant increase 
in light-induced dopamine release comparing between MFA-treated retinae (t-test, **p < 0.01). 
That light-induced difference between treated and untreated retinae was not observed in vivo 
(t-test, p = 0.16) although a positive trend was apparent. 
These results suggest that the majority of light-induced dopamine release driven from 
dopaminergic amacrine cells occurs via primary and secondary rod pathway signalling, and a 
minor amount occurs via a rod-driven gap-junction independent pathway. 
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Figure 5.1 Dopamine turnover is suppressed under dim light by rod input. Significant decrease in 
dopamine turnover occurs in dark-adapted mice dissected under dim red light (8.79 log rod photons cm-
2s-1, >650nm) compared to dissection under infrared light (5.82 log rod photons cm-2s-1, >800nm) at 
CT6 in A) Gnat2A518G and B) Opn4-/-, but not in C) Opn1mwR or D) rd/rd (t-test, *p < 0.05, ***p < 0.001, 
mean ± SEM, n ≥ 3 each). No statistical differences were observed between dim red dissections across 
genotypes (including wild-type from Figure 4.1), and under infrared conditions only CT6 wild-type 
statistically differed with rd/rd (one-way ANOVA with Tukey’s multiple comparison test, p = 0.01) 
Opn4Cre/Cre 
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Figure 5.2 Light-induced dopamine release is defined by rod input. A) In an irradiance-response 
curve, significant light-induced dopamine release occurs at the two highest light intensities (>15 log rod 
photons cm-2 s-1) compared to dissection under dim red light in Gnat2A518G and Opn4Cre/Cre (one-way 
ANOVA with Dunnett’s multiple comparison test, ***p < 0.0001, mean ± SEM, n ≥ 5 each) similar to 
the curve from wild-type mice (Figure 4.2). One curve can fit all three datasets (extra sum-of-squares F 
test, p = 0.89; F = 0.44) and no significant differences are observed between equivalent irradiance points 
(one-way ANOVA with Tukey’s multiple comparison test, p ≥ 0.99). Conversely, rd/rd animals do not 
exhibit light-induced dopamine release at any given light intensity and no differences are observed 
between irradiance points (one-way ANOVA with Dunnett’s multiple comparison test, p ≥ 0.99 mean 
± SEM, n ≥ 12 each). B) Similar to in vivo, light-induced dopamine release occurs at the two highest 
light intensities in Gnat2A518G and Opn4Cre/Cre, but not rd/rd retinae (one-way ANOVA with Dunnett’s 
multiple comparison test, ***p < 0.0001, mean ± SEM, n ≥ 5 each). Gnat2A518G retinae present a reduced 
amplitude of dopamine release at the two higher points of the irradiance curve compared to wild-type 
(one-way ANOVA with Tukey’s multiple comparison test, $$$p < 0.0001). Opn4Cre/Cre retinae present a 
reduced amplitude of dopamine release when comparing ~14 log rod photons cm-2 s-1 to wild-type 
equivalent irradiance point (one-way ANOVA with Tukey’s multiple comparison test, $p = 0.047).  
When normalised (not shown in the graph), ex vivo data can fit wild-type, Gnat2A518G and Opn4Cre/Cre 
datasets in a curve (extra sum-of-squares F test, p = 0.71; F = 0.67). Stars indicate comparison between 
dark and light conditions of each genotype, hashtags indicate comparison between rd/rd and the rest of 
cohorts at equivalent irradiance points, and dollar signs indicate comparison between wild-type to 
Gnat2A518G and Opn4Cre/Cre ex vivo. 
$ 
$$$ $$$ 
) 
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Figure 5.3 Rd/rd mice are capable of releasing dopamine. Bars filled with colour represent dark-
adapted retinae, while white-filled, border-coloured bars represent light-pulsed retinae (~16 log rod 
photons cm-2s-1, 15 min). Stars indicate comparison to respective control conditions (dotted lines). 
Regarding inhibitory inputs, no effects are observed after application of strychnine (glycine antagonist), 
but picrotoxin (GABAA/C antagonist) significantly increase dopamine of light-pulsed retinae. Both 
unblock of NMDA receptors in Mg2+-free media and increased spiking with high KCl concentration 
significantly increase dopamine release in both dark and light-pulsed conditions compared to untreated 
controls (t-test, *p < 0.05, ***p < 0.001, mean ± SEM, n = 2 each inhibitory condition and n = 6 each 
spiking dependent condition). 
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Figure 5.4 Aged rd/rd mice have higher basal dopamine turnover levels compared to young 
animals but cannot release dopamine in response to light. Similar to young rd/rd, aged rd/rd mice 
do not release dopamine in response to light. However aged rd/rd mice exhibit higher dopamine 
turnover levels in both dark-adapted and light-pulsed conditions (t-test, **p < 0.01, mean ± SEM, n = 
5 each condition). 
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Figure 5.5 Rd/rd mice lack light-induced dopamine release at all ages during development. No 
significant differences are observed at any tested age from 0 to 26 days of light-induced (~16 log rod 
photons cm-2s-1, 15min) dopamine release compared to the respective points of dark-adapted mice 
dissected under standard dim red light. One-way ANOVA with Tukey’s multiple comparison test (p > 
0.99, mean ± SEM, n = 4 each time point). 
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Figure 5.6 Chemogenetic activation of ipRGCs does not drive dopamine release. Opn4Cre/+ mice 
were infected with virally-introduced hM3Dq in the right eye 6 weeks prior to the experiment. Before 
the experiment, mice were injected with 5 mg/kg CNO to activate the infected ipRGCs. Pupil 
constriction was checked in both eyes (>80% of constriction as selection criteria in the treated eye) 
under infrared light (>950 nm) and dopamine release assessed. No differences in dopamine release 
turnover are found between treated and untreated retinae (paired t-test, p = 0.62, n = 5 each group), 
suggesting ipRGC activation is not sufficient to trigger dopamine release. 
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Figure 5.7 Theoretical chromatic contributions of photoreceptors to light-induced dopamine 
release. The relative activation of different photopigments (rod, melanopsin and UV, M and L cones) 
with the white light-irradiance response curve (obtained in wild-type mice) is presented assuming 
dopamine release is driven by each respective photoreceptor. Overlayed on each graph are the relative 
activation of light pulses delivered in Figure 5.8 for each photoreceptor: dotted red line: medium-
intensity red light, red line: high-intensity red light, blue line: high-intensity blue light.  
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Figure 5.8 Rods are both sufficient and necessary to drive light-induced dopamine release. A) 
Both high-intensity red light that activates rods and cones (above dopamine release threshold, see Figure 
5.5) but not melanopsin, and blue light that activates all photoreceptors result in a significant increase 
in dopamine release (one-way ANOVA with Dunnett’s multiple comparison test, ***p < 0.0001 mean 
± SEM, n = 5 each condition) compared to dark-adapted wild-type mice dissected under dim red light. 
No differences are observed at equivalent irradiance points between wild-type and Gnat2A518G mice 
(one-way ANOVA with Tukey’s multiple comparison test, p > 0.99), whose red light exposure is 
equivalent to rod-only activation. B) Medium-intensity red that activates exclusively cones in Opn1mwR 
(above dopamine threshold) is not enough to cause significant light-induced dopamine release (although 
a trend is observed) whereas a control bright white light exhibits a normal increase (one-way ANOVA 
with Dunnett’s multiple comparison test, **p < 0.001, mean ± SEM, n = 3 each condition).  
 
Med-red 
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Figure 5.9 Dopamine release is driven by gap-junction dependent and independent pathways. A) 
In Gnat2A518G mice significant light-induced (~16 log rod photons cm-2s-1, 15min) dopamine release 
compared to dark-adapted conditions is achieved in intravitreally injected mice with saline. Blocking 
gap junctions with 1 mM MFA significantly reduces, but does not eliminate, light-induced dopamine 
release (t-test, #p < 0.05, **p < 0.001, mean ± SEM, n = 3 each condition). B) Similarly, application of 
200 µM MFA in ex vivo retinae of Gnat2A518G mice significantly reduces light-induced dopamine levels 
and has no effect on dark-adapted retinae. Significant light-induced dopamine release is possible in 
presence of MFA (t-test, # p < 0.05, **p < 0.001, ***p < 0.0001, mean ± SEM, n ≥ 4 each). Stars indicate 
comparison at equivalent light conditions between MFA-treated and control mice, whereas hashtags 
indicate comparison between dark and light treatments within the same condition (control or MFA). 
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5.3. DISCUSSION 
5.3.1. Rods define light-induced dopamine release and set its threshold  
As previously hypothesised in the literature368, data from this chapter suggests that rods are 
(surprisingly) the main photoreceptor responsible for driving light-induced dopamine release 
and setting its absolute release threshold with no need of additional photoreceptors. Also, rods 
alone modulate dopamine turnover under dim light implying that they ultimately control 
dopamine release over a very wide range of light intensities (> 9 log units). More importantly, 
these data indicate that electrophysiological responses from dopaminergic amacrine cells do 
not always correlate with actual dopamine being released. Rods driving, and defining, such a 
high-threshold response may, at first, seem counterintuitive but the idea that rods participate in 
vision at high irradiances has gained acceptance in the recent years22,23,25,598,599. For instance, 
the most recent paper from Tikidji-Hamburyan et al.28 showed that while rod contrast 
sensitivity initially dropped in response to bright light, it progressively recovered with a speed 
proportional to the given light intensity (i.e. occurred faster under brighter backgrounds). 
Bleaching adaptation and gain modulation were suggested as the mechanisms underlying this 
adaptation since rod responses became more robust with increased exposure times and light 
intensities. Thus, it is not hard to believe that rods could be signalling at bright intensities and 
triggering light-induced dopamine release over a wide range of light intensities as suggested 
throughout this thesis. However, the question as to why dopamine is not released at lower 
intensities where rods are robustly active is hard to reconcile. It may be that the answer lies in 
the inhibitory component of rod input that I identified under dim red light. 
Dopamine turnover under dim red light was reduced compared to infrared light dissection in 
wild-type, Gnat2A518G and Opn4Cre/Cre animals, suggesting it is the input of rods alone that 
triggers this decrease. Conversely, no statistical differences were found between the two 
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dissection conditions in Opn1mwR mice which could intuitively lead to the thought of cones 
being involved. However, the lack of significance occurs because in this particular model the 
standard deviation is ~4-fold higher than any other conditions (± 0.18 vs ± 0.04).  Further, a 
power calculation estimates that tripling the n should provide significant differences between 
conditions (inference for means, α = 0.05, ß = 0.8, n = 15). In addition, dopamine turnover 
remained unchanged in both dim red and infrared dissections when rods and cones were absent 
(rd/rd), but dopamine turnover levels matched those from dim red light dissection in wild-type 
mice. The retina of rd/rd animals is known to exhibit spontaneous activity in dark 
conditions600,601, specifically in ON bipolar cells602, which may trigger an equivalent 
suppressive effect as the one driven by rods in wild-type.  
At brighter light intensities, Gnat2A518G mice exhibited equivalent responses as wild-type 
during the whole irradiance curve, suggesting that cones do not play a quantifiable role in light-
induced dopamine release even at bright irradiances. Conversely, the literature showed that 
light-induced activation of cones caused either electrophysiological or c-fos activation of 
dopaminergic amacrine cells330,333. However, as discussed in the previous chapter, 
depolarisation of the soma does not necessarily correlate with depolarisation of the processes 
where dopamine is released. In addition to indirect measurements, dopamine release has been 
measured and suggested to be driven by light-activated cones in Gnat1-/- mice in different 
experimental designs: 1) a bright light pulse (~15 log rod photons cm-2 s-1, 90 min) caused a 
small (~25%) but significant increase in dopamine turnover in  Gnat1-/- mice, although 
significantly reduced compared to wild-type animals368; and 2) a long mesopic light pulse (with 
a non-specified light intensity corresponding to the one of the animal housing from the animal 
facility during 4.5 hours) caused ~30% increase in dopamine turnover in Gnat1-/- Opn4-/- mice. 
Gnat1-/- animals have been reported to retain residual rod responses454,455 and those experiments 
light-pulsed animals for much longer than reported throughout this thesis, either of which could 
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account for the small increases in light-induced dopamine responses. However, Gnat2A518G 
mice too could be an incomplete model of photoreceptor activation where phototransduction 
cascade activates downstream of the mutated transducin454. To overcome this, I showed that 
preferential spectral activation of cones in Opn1mwR mice did not elicit any significant change 
in dopamine turnover, further supporting hypotheses derived from Gnat2A518G results. Only 
when red or blue light wavelengths activated rods above the threshold, dopamine release was 
observed regardless of the mice model used (Figure 5.8). Finally, the role of S-cones in light-
induced dopamine release was not explored in depth with exposure to UV light. However, 
given that the bright red pulse (red solid line, Figure 5.7) can elicit significant dopamine release 
means UV-cones are not necessary to drive this release. Conversely, a very recent paper 
showed light-induced dopamine release in chicks in response to UV light603, suggesting that 
those could play a role. However, bird and mammalian retinae differ significantly in cone 
expression and circuitry, and the influence of UV-cones may be specific to birds. 
Taking advantage of the different degeneration timeline of rods and cones in the developing 
rd/rd retinae, I assessed light-induced dopamine release at different developmental time points 
to elucidate the role of each after or before the disappearance of the other. For example, 
Greferath et al.127  showed that dopaminergic amacrine cells were still activated (c-fos 
expression) by light in rd mice until P20, even when rods had dissapeared127. At P22 only half 
of dopaminergic amacrine cells were activated by light in parallel with degeneration of 
cones127. Therefore, one might think that if cones were driving light-induce dopamine release, 
an increase in dopamine would occur at that point in response to light (as in the wild-type 
developing retina; Figure 4.7). However, this was not the case, showing once more that 
dopaminergic amacrine cell activation does not equal dopamine release. At this stage (~P20), 
bipolar cells from rd/rd mice lose their response to glutamate604, severe morphological changes 
are conspicuous605–608 and rod bipolar cells show an increased sensitivity to inhibitory 
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neurotransmitters592,609, so it is perhaps not surprising that dopaminergic amacrine cells cannot 
release dopamine in response to these altered inputs. 
These results differ from Cameron et al.368 who found that nuclear c-fos was mainly absent in 
adult Gnat1-/- animals  in response to light, although these two animal models differ in their 
rod ablation, in rd/rd mice rods are absent whereas in Gnat1-/- animals rods are present but in 
a permanent dark-adapted state. If a balance of activation of ON and OFF pathways controls 
c-fos activation, one might assume that these two models would produce opposing results.  
Furthermore, Greferath et al.127 examined long term c-fos expression in the rd-FTL mouse as 
opposed to transient c-fos activation after a 90 min light pulse.  
Despite the controversy in the literature regarding c-fos activation of dopaminergic amacrine 
cells, my results show that rd/rd mice were not able to release any dopamine in response to 
bright light at any developmental point. These results suggest that while the circuitry was 
mature enough to drive light-induced release changes in wild-type mice, when rods disappeared 
cone signalling was not able to drive light-induced dopamine release in rd/rd mice. 
The finding that inputs from ipRGCs into dopaminergic amacrine cells327,330,333,339,458,586 did 
not elicit light-induced dopamine release at any given intensity was further evidence that 
electrophysiological response (at the soma) does not necessarily equate to dopamine release 
(Figure 5.2). In Opn4-/- animals, ipRGCs are still present and intact in the retina (although 
lacking melanopsin) and therefore may still be involved in extrinsic signalling due to rod and/or 
cone inputs49,71,79,82,333. Although this activation is not entirely understood, different papers 
suggest classic photoreceptor input via bipolar cells → amacrine cells → ON cone bipolar cells 
→ (via ectopic synapse) ipRGCs65,66,82,100,132,610–612. Therefore, rods and/or cone could signal 
though ipRGCs and pair with conventional rod inputs to elicit dopamine release. Examining 
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dopamine release in animals lacking ipRGCs (instead of just melanopsin; Opn4DTA/DTA) would 
shed more light on this hypothesis. 
Because rd/rd mice were able to release dopamine in high potassium and Mg2+-free media 
(Figure 5.3), the rationale to perform an irradiance response curve was that high irradiances 
may induce depolarisation block in ipRGCs (M1)613 preventing signals from passing to 
dopaminergic amacrine cells. However, no light-induced dopamine release could be observed 
at any intensity in rd/rd animals. Surprisingly, when picrotoxin was applied in the dark 
dopamine release remained the same, but it significantly increased in response to light + 
picrotoxin, suggesting that the GABAergic disinhibition caused by the drug must be paired 
with an excitatory photoreceptive input. The most likely candidate driving this light response 
is ipRGCs, although an input from a small population of cones that do not degenerate at this 
stage could also be responsible129. It is possible that GABAergic inputs prevent spiking in the 
soma of dopaminergic amacrine cells from propagating to the areas, likely dopaminergic 
amacrine cell processes614, where dopamine is released. 
Further, since rd/rd mice have retinal rearrangement during development, I tried an alternative 
method to test the contribution of ipRGCs in non-degenerate retinae by chemogenetically 
inducing activation of ipRGCs. I show that while ipRGCs were consistently active in the dark 
in response to CNO (driving the PLR), no significant release of dopamine occurred (Figure 
5.6). These results mirror the lack of light-induced dopamine release in the rd/rd animals, but 
represent a more physiological state as the Opn4Cre/+ mice that do not show any circuit 
reorganization. This, again, demonstrates that spiking in the soma of dopaminergic amacrine 
cells does not correlate with widespread dopamine release. 
The results from the ex vivo irradiances match the shapes of the in vivo counterparts in 
Gnat2A518G, Opn4Cre/Cre, and rd/rd mice. However, differences in the baseline levels of these 
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measurements can be observed in Figure 5.2 B. Although it is true that in the literature rd/rd 
animals showed smaller concentrations of dopamine compared to wild-type449, the most likely 
explanation for the variability in ex vivo experiments is due to increased number of steps during 
the processing of the retinae and detrimental physiological conditions as happened in the 
previous chapter. While the reduction in amplitude of dopamine turnover in Gnat2A518G and 
Opn4Cre/Cre mice at higher irradiances could indicate a role of cones in light-induced dopamine 
release (via ipRGCs) after rods set the absolute threshold, the conclusions obtained from the 
rest of the experiments performed in this chapter suggest just inter-experimental variability. 
Further, if values are normalised, one curve can fit all values when comparing irradiance 
responses of the dopamine light-inducible genotypes (except rd/rd), meaning the threshold is 
the same regardless of the method used. As discussed in the previous chapter, in vivo and ex 
vivo methods have positive and negative attributes, but overall provided consistent and 
complementary results throughout a wide variety of experimental designs and animal models. 
In summary, a large amount of evidence strongly suggests that rods drive light-induced global 
dopamine release over a wide range of light intensities. Cones and/or ipRGCs may be 
contributing to local dopamine release that cannot be measured with the current used technique, 
but widespread, high amplitude dopamine release is governed exclusively by rod photoreceptor 
input. Very recently, Munteanu et al.615 showed that basal dopamine levels were reduced 
during development when animals were dark reared. Under normal light/dark rearing 
conditions knocking out rods recapitulated the effect of dark rearing but removal of ipRGCs or 
cones had no effect. This model agrees with the results obtained in Gnat2A518G, Opn1mwR, and 
rd/rd mice that neither cone nor melanopsin photoreception has an effect on the retinal 
dopamine system. 
 
 
129 
 
 
 
 
 
Figure 5.10 Widespread light-induced dopamine release is driven by rods. Rods (blue bar) drive 
widespread dopamine release under both very low and very high light intensities using different known 
and suggested pathways discussed throughout Chapter 5. On the other hand, cones (green scalene 
triangle) and ipRGCs (purple circle) provide an electrophysiological input into dopaminergic amacrine 
cells but without eliciting widespread light-induced dopamine release. 
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CHAPTER 6:                                                         
Effect of inflammation on retinal microglia and 
dopamine release 
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6.1. INTRODUCTION 
Inflammation is part of the immune response of the body that protects from infection, injury or 
toxin exposure. Pain, heat and redness occur due to an increase in vascular permeability and 
activation of immune cells at the location of the injury. Once the aberration is eliminated, the 
affected tissue returns to its normal physiology. When this process is quick, effective and 
beneficial it is known as an acute inflammatory episode.  However, when these processes 
persist after the initial insult, it is known as chronic inflammation, and within the nervous 
system it is called chronic neuroinflammation. The most common and studied cases of 
dysregulation and overactivation of resident immune cells in the brain are microglia and 
astrocytes, which are often associated with many neurodegenerative and neurological 
diseases616–622. 
In the retina, chronic neuroinflammation and more specifically activated microglia, are key 
components associated with retinal degenerative diseases that cause visual impairments such 
as macular degeneration, diabetic retinopathy, retinal vein occlusion, retinitis pigmentosa and 
glaucoma623–626. Common observations of these, and many other chronic neuroinflammation-
related pathologies, are overactivation of microglia, excessive release of pro-inflammatory 
mediators and high oxidative stress, which ultimately results in neuronal loss627,628. 
Nonetheless, microglia are necessary for a healthy retina and some of the physiological 
functions of microglia involve several roles in development629,630, blood vessel formation631 
and immunological surveillance during adulthood632; where microglia are highly mobile and 
can be found in different layers, tending to be close to blood vessels633–635.  
I explored microglia in the retinae of GFAP-IL6 mice, a mouse model of chronic 
neuroinflammation where interleukin 6 (IL-6) is constitutively expressed by glial fibrillary 
acidic protein (GFAP) cells. GFAP is an intermediate filament protein expressed in different 
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cells of the central nervous system including astrocytes. IL-6 is a pro-inflammatory cytokine 
that plays a role in the induction of microglial activation636 and its expression is globally altered 
in the retina of wild-type mice in response to stress637. For instance, in glaucoma, it is 
overregulated and found in high concentrations637–640. Under physiological conditions, some 
authors suggest that the increase in IL-6 occurs to stimulate neuritogenesis in retinal ganglion 
cell axons640,641. While the GFAP-IL6 mouse model has been widely used to study chronic 
neuroinflammation in the brain, microglia in the retina has never been examined. Most of the 
literature that describes microglia in the retina covers developmental phases634,642, intravitreal 
injections to mimic or stop acute inflammatory responses643–645 and different animal models of 
retinal diseases646–650.  
Here, I present a yet unexplored mouse model of inflammation (regarding the retina), in which 
I evaluate the impact of increased IL-6 on retinal microglial number and morphology, and how 
this impacts light-induced dopamine release. I characterised retinal microglia populations in 
both wild-type and GFAP-IL6 mice in both young (4 months) and aged animals (24 months), 
with the purpose to further to test if light-induced dopamine release has any correlation with 
microglial numbers and morphology. For instance, prolonged exposure to light causes 
activation of retinal microglia that is suggested to lead to degeneration of photoreceptors651,652. 
Further, microglia express D1 and D2-like dopamine receptors653,654 that are suggested to 
mediate their chemotaxis towards dopaminergic cells in Parkinson’s disease655. Microglia are 
a double-edged sword in that they are beneficial when regulated properly, but can quickly enter 
into a feedback loop of increasingly detrimental inflammation. A good example of this delicate 
state of balance is that sustained microglial depletion results in the degeneration of 
photoreceptor synapses656, while overactivation triggers a sustained release of inflammatory 
factors that contribute to neuronal dysfunction and to pathology657. However, activation of 
microglia during retinal detachment actually protects photoreceptors from degenerating658. 
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Most of the literature evaluating retinal health during neuroinflammation reports ERG 
amplitude and implicit time, however, since both of these parameters have been shown to be 
correlated with dopamine release659 an impact of inflammation on dopamine release itself 
could, in turn, affect ERG parameters.  Certainly, while ERG responses are diminished at 
different points in diabetic retinopathy660, retinal vein occlusion661, retinitis pigmentosa662, 
hypoxia663, macular degeneration664 and glaucoma665; a correlation with changes in dopamine 
release remains to be examined. 
Therefore, in this chapter I aimed to: 
1) Assess if the density and activation state of retinal microglia increase with 
inflammation and age, as it occurs in different regions of the brain. 
2) Assess if an increase in density and activated state microglia cause a decrease in 
basal or light-induced dopamine release due to the disruption of one or more key 
elements involved  
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6.2. RESULTS 
6.2.1. Microglial density increases with age 
Since GFAP-IL6 mice lacked characterisation of their retinal microglia, I performed 
immunohistochemistry against Iba1+ (ionized calcium-binding adapter molecule 1, a common 
marker for microglia) at 4 and 24 months of age in wild-type and GFAP-IL6 mice, and counted 
the density of the stained cells. During youth, GFAP-IL6 mice showed a significant increase 
of ~31% in microglial density (Iba1+ cells/ mm2) compared to wild-type mice (***t-test, p-
value = 0.0004), suggesting that the transgenic model triggers proliferation of microglia (Figure 
6.1). Surprisingly, the differences between GFAP-IL6 and littermate controls is dramatically 
reduced in aged animals with no significant differences between the two groups (t-test, p-value 
= 0.45). However, when comparing the microglial density of young and aged groups to their 
respective genotypes, both are significantly increased: ~48% for wild-type, (***t-test, p-value 
< 0.0001) and ~28% for GFAP-IL6 (**t-test, p-value = 0.0022; Figure 6.1). This suggests that: 
1) microglial proliferation does not reach its maximum during youth regardless of chronic 
exposure to IL-6; and 2) microglial responsiveness to IL-6 may be depleted in aged animals or 
microglial numbers have simply reached their maximum by this age. 
 
6.2.2. Microglia tend towards an inflammatory morphological 
phenotype with inflammation and age 
Activation of microglia is known to correlate with its morphology666–668, with resting microglia 
exhibiting extended dendritic arbours and small somas whereas reactive microglia have 
retracted dendrites and larger somas. Thus, I used different approaches to study morphological 
changes in retinal microglia to determine their state in both wild-type and GFAP-IL6 mice in 
young and aged animals. First, I stained microglia for Iba1 and reconstructed n ≥ 63 cells from 
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each experimental group. Then, 1) I determined the general morphological aspects such as 
soma perimeter and area, convex hull perimeter and area (the perimeter or the area that the cell 
occupies in a 2D space), primary dendrites, branching points and total dendritic length (Figure 
6.2); 2) I performed Sholl analysis to visualise the radial distribution of the quantified 
characteristics, providing information about the spatial arrangement of the dendrites (Figure 
6.3 & 6.5); and 3) I performed bivariate correlations with the different morphological aspects 
quantified in the first aim against convex hull area to find any correlation patterns associated 
with a specific age and/or genotype (Figure 6.6). 
All the commonly tested microglial morphological characteristics across the literature (soma 
area and perimeter, convex area and perimeter, primary dendrites, branching points and 
dendritic length) were analysed in the retinae of wild-type and GFAP-IL6 mice and plotted in 
Figure 6.2. A graphical scheme of the characteristics tested on a reconstructed microglial cell 
is drawn in Figure 6.2 H. From the tested parameters, an increase in the soma size, number of 
primary dendrites and branching points, and a decrease in the convex area, convex perimeter 
and dendritic length are suggestive of microglial activation667. 
I observed an increased soma area and number of primary dendrites, and a reduced convex 
perimeter and area in young GFAP-IL6 animals compared to littermate controls, suggesting 
microglia activation. These results are in agreement with the increase in microglial density at 
4 months of age between GFAP-IL6 and their littermate controls. Conversely, when aged 
GFAP-IL6 animals are compared to aged wild-types, the differences observed between both 
genotypes during youth are abolished. Further, wild-types exhibited the smallest convex 
perimeter and area, actually suggesting a more reactive phenotype than the chronically 
inflamed animals. When young and aged animals from the same genotype are compared, 
GFAP-IL6 mice only differed in an increase of primary dendrites with age. However, aged 
wild-type mice exhibited an increase in soma size and primary dendrites, and a decrease in 
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convex perimeter, area and dendritic length. These results indicate that wild-type mice develop 
increased inflammatory responses with age, however GFAP-IL6 mice do not exhibit this 
increase in neuroinflammatory responses possibly due to a continuous activated state triggered 
by chronic exposure to IL-6.   
 
6.2.3. Aging, but not IL-6 upregulation, causes retraction of microglial 
dendrites 
To study the spatial distribution of the previous quantifications, Sholl analysis data (specific 
morphological characteristic quantified at every radial checkpoint, plotted in X and Y axis 
respectively; “Chapter 2: Materials and Methods”, Figure 2.3) is shown in Figure 6.3. Sholl 
analysis consists of tracing concentric circles that start in the centre of the soma with a fixed 
increased in the radius (in this case 3 µM), and quantification of the amount of a determined 
morphological characteristic (i.e. number of branching points) comprised between two 
successive circles. The morphological characteristics tested were: intersections (of dendrites 
with the concentric circles that start in the centre of the soma), branching points, dendritic 
endings, dendritic length, dendritic area and dendritic volume. From the resulting plots of these 
characteristics I quantified “the shift parameter” (radius at Ymax; Figure 6.3). This analysis 
provides an idea of the overall dendritic complexity (i.e. retracted or expanded) and shift at the 
maximum radii of complexity (distance from the soma). Representative images of microglia 
from each cohort can be visualised in Figure 6.4, where young wild-type microglia display an 
extended dendritic arbour against retracted dendrites in GFAP-IL6 and aged animals. 
Young GFAP-IL6 microglia do not show a shift in complexity compared to littermate controls, 
however in wild-types the complexity shifts towards the soma with age. Aged GFAP-IL6 
microglia, however, do not show this shift in complexity with age. In other words, the dendrites 
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of aged microglia are more retracted than young microglia in wild- type but not in GFAP-IL6 
mice. However, a couple of results such as the reduction in Ymax with age in both dendritic 
volume and branching points of aged GFAP-IL6 microglia does suggest a morphology towards 
an amoeboid shaped form (i.e. fewer branching points near the soma). These results show that 
a retraction of dendrites occurs in normal aging, but not due to upregulation of IL-6, suggesting 
GFAP-IL6 microglia do not display this normal phenotypic change with age. 
 
6.2.4. Bivariate correlations of morphological characteristics with 
convex hull area  
The next analysis tests bivariate correlations of soma perimeter and area, convex perimeter, 
dendritic length, branching points, and primary dendrites against the convex hull area (Figure 
6.6; values for R2 and correlation p-values appear on Table 6.1). Convex hull area is the total 
area the microglia and its dendrites occupies, therefore a change in the correlation between this 
and the morphological characteristics tested, means the cell’s proportions have changed, and a 
phenotypic change may have occurred. Bivariate analysis suggests that young wild-type and 
GFAP-IL6 microglia covering a larger area do not have larger somas, suggesting microglia that 
cover larger areas simply extend their dendrites further. However, microglia from aged mice 
have a positive correlation between soma size and convex hull area suggesting that the larger 
microglia have proportionately larger somas, indicating a phenotypic change with age (Figure 
6.6 A & B). These results suggest a phenotypically different population of microglia that forms 
with age, but not with overexpression of IL-6. As may be expected, convex perimeter, dendritic 
length and number of branching points are strongly correlated with convex area in all groups 
(i.e. the more area the microglia occupy the more perimeter). However, the slopes of the linear 
regression of aged wild-type, and both young and aged GFAP-IL6 microglia between convex 
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perimeter, dendritic length and branching points with the convex area are significantly 
increased, i.e. a more circular than elliptical geometric distribution, compared to young wild-
type (Figure 6.6 C, D & F). Activated microglia generally show a more circular distribution, 
so these data indicate GFAP-IL6 and aging cause a switch to a more activated microglial state. 
Primary dendrites do not show any correlation or slope variation among groups (Figure 6.6 E). 
  WT 4m GFAP-IL6 4m WT 24m GFAP-IL6 24m 
Soma perimeter 
R2 0.05 0 0.06 0.07 
Correlation 0.06 0.9 0.05 0.04 
Soma area 
R2 0.03 0 0.05 0.09 
Correlation 0.13 0.82 0.08 0.02 
Primary dendrites 
R2 0.03 0 0.07 0.01 
Correlation 0.19 0.83 0.05 0.55 
Dendritic length 
R2 0.47 0.72 0.71 0.69 
Correlation <0.0001 <0.0001 <0.0001 <0.0001 
Convex perimeter 
R2 0.67 0.93 0.79 0.94 
Correlation <0.0001 <0.0001 <0.0001 <0.0001 
Branching points 
R2 0.07 0.42 0.47 0.35 
Correlation 0.04 <0.0001 <0.0001 <0.0001 
Table 6.1. R2 values and Pearson r test statistics for bivariate correlations (Figure 6.6). Level of 
significance is expressed with p-value: *p<0.05, ***p<0.0001. WT: wild-type. 
 
6.2.5. Light-induced dopamine release is normal in GFAP-IL6 mice 
After the characterisation of microglia density and reactive-like state in different experimental 
models, I assessed light-induced dopamine release in young wild-type and GFAP-IL6 (Figure 
6.7). Surprisingly, light-induced dopamine release is not impacted by chronic inflammation as 
GFAP-IL6 and wild-type have indistinguishable dark and light-induced dopamine release (one-
way ANOVA with Tukey’s multiple comparison test, p ≤ 0.84). These results suggest that a 
significant increase in numbers, and chronic activation of microglia during 4 months does not 
impair dopaminergic amacrine cell function, or the pre-synaptic circuitry conveying the light 
signal.  
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Figure 6.1 GFAP-IL6 mice have a significantly higher density of microglia compared to wild-type 
mice at 4 but not at 24 months. A significant increase in density occurs in 4 months old GFAP-IL6 
mice compared to 4 months old wild-type mice. Iba1+ density is significantly increased at 24 months in 
both genotypes compared to their respective young genotypes, but there is no statistical difference 
between genotypes in aged animals. One-way ANOVA with Tukey’s multiple comparison test (**p < 
0.001, ***p < 0.0001, mean ± SEM, 4 months, n = 4; 24 months, n = 3). WT: wild-type. 
140 
 
 
Figure 6.2 Microglia from all GFAP-IL6 cohorts and aged wild-type mice present reactive-like 
morphology. Significant differences between 4 months old GFAP-IL6 and wild-type mice are observed in 
A & B) soma, C & D) convex perimeter and area, and E) primary dendrites. F) Branching points remain 
constant across ages and genotypes. Overall, young GFAP-IL6 mice exhibit increased soma sizes, retracted 
dendrites and more primary dendrites. At 24 months, convex perimeter, convex area, and G) dendritic length 
are significantly reduced in wild-type compared to GFAP-IL6, which also remain true when compared to 4 
months old wild-type, in addition to an increased soma area, soma perimeter, and primary dendrites. When 
aged GFAP-IL6 microglia are compared to its young counterpart, only primary dendrites are increased. H) 
Visual schematic of the tested characteristics: branching points (blue) are bifurcations of dendrites, primary 
dendrites (red) contact with the soma, soma perimeter/area (green), dendritic length (black) is the sum of the 
length of all dendrites, and convex hull area and perimeter are the space that the cell occupies (highlighted 
in grey) One-way ANOVA with Tukey’s multiple comparison test (*p < 0.05, **p < 0.001, ***p < 0.0001, 
mean ± SEM, n ≥ 63 each). WT: wild-type. 
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Figure 6.3 Age causes dendritic retraction towards the soma. Sholl analysis consists of overlaying 
concentric circles of an increasing fixed radii on the reconstructed microglia (centre at soma), and tests 
each specific morphological characteristic between two radius checkpoints (every 3 µm). The number 
of morphological characteristics comprised within the distance between the two perimeters of the circles 
is plotted in a XY graph. Tested morphological characteristics are: intersections, branching points, 
endings, dendritic length, area and volume. Aged microglia show an overall trend towards the soma, 
with more severity in wild-type microglia. Representative images of these graphs are presented in Figure 
6.4. WT: wild-type. 
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Figure 6.4 Representative image of microglial retraction with age and inflammation. Visually, 
young wild-type microglia (top left) display spread dendrites and small somas, whereas aged (top right) 
and GFAP-IL6 (young: bottom left; aged: bottom right) microglia exhibit retracted dendrites and large 
somas suggestive of a reactive phenotype. 
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Figure 6.5 Aged microglia retract dendrites. A significant shift to the soma occurs in all dendritic 
characteristics except the number of endings and branching points in aged wild-type microglia 
compared to young. Strong similarities in young and aged GFAP-IL6 microglia are observed, except 
for an increase in dendritic volume and a decrease in branching points in aged animals. One-way 
ANOVA with Tukey’s multiple comparison test (**p > 0.001, ***p < 0.0001, mean ± SEM, n ≥ 63 
each group). WT: wild-type. 
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Figure 6.6 Bivariate morphological correlations to Convex Hull Area in GFAP-IL6 and wild-type 
mice. Strong correlations are found in dendritic length, convex perimeter and branching points in all 
groups. The size of aged somas and primary dendrites correlate with cell size, but not in the young 
groups (Pearson r correlation test, *p < 0.05, ***p < 0.0001). Linear regression of aged wild-type is 
reduced compared to the rest of groups in branching points, dendritic length and convex perimeter, no 
differences are found among any other groups regarding linear regression (Extra-sum-of-squares F test, 
***p < 0.0001 n ≥ 63 each group). WT: wild-type. 
145 
 
 
 
 
 
 
Figure 6.7 Light-induced dopamine release is not altered in GFAP-IL6 mice. A significant increase 
in light-induced (~16 log rod photons cm-2s-1, 15 min) dopamine release occurred in GFAP-IL6 retinae; 
lacking any significant difference compared to wild-type retinae in either light or dark conditions. One-
way ANOVA with Tukey’s multiple comparison test (***p < 0.0001, mean ± SEM, n ≥ 3). WT: wild-
type. 
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6.3. DISCUSSION 
6.3.1. Chronic neuroinflammation diminishes the hallmarks of the 
microglial reactive phenotype in aged GFAP-IL6 mice  
Experiments conducted in this chapter are the first to systematically quantify microglial density 
and morphology in the retina of GFAP-IL6 mice at two different ages. The most relevant 
finding is the similarity of microglial morphology across time in GFAP-IL6 retinae in contrast 
with the overactivated state of wild-type microglia in aged animals, having more activated-like 
phenotype than the chronically inflamed mice at the same age. Previous reports have shown an 
age-dependent increase in microglia density in the retina, and reduction of their dendritic field 
and length632,656,669. These results suggest that chronic activation of microglia throughout life 
may limit this normal age-dependent microglial phenotypic change. Certainly, overactivation 
of microglia has been shown to induce apoptosis in up to 40% of the microglia population670, 
which causes release of even more pro-inflammatory cytokines671. Also, the motility of aged 
microglia has been shown to be significantly reduced compared to young microglia632, which 
raise the question: where does the microglia that replaces the apoptotic casualties migrate from? 
Very recently, Huang et al.672 found that the origin of the repopulated retinal microglia has 
extra-retinal origins (optic nerve and ciliary body), therefore, different microglial subtypes 
might populate the retina of chronically inflamed mice, suggesting further characterisation 
needs to be done to elucidate potential diverse populations. For example, staining of the 
fractalkine receptor CXC3R1 could provide some insight on microglia dynamics, since its 
expression correlates with repopulation673,674. This characterisation of microglia in the retina 
could provide more specific targets for therapeutic interventions in order to limit retinal chronic 
inflammation. 
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Further complementary approaches could be tested using different biomarkers other than Iba1 
staining, such as staining for translocator protein or peripheral benzodiazepine receptor (TSPO) 
to quantify the percentage of microglia that is actually reactive675. Also, it would be interesting 
to test microglial dynamics in living tissue in response to an external insult in both young and 
aged GFAP-IL6 mice, to provide information about physiological responses to harmful stimuli. 
One would expect decreased responses compared to aged wild-type mice if microglia from 
GFAP-IL6 indeed have reduced responses after constant overactivation during a lifetime. This 
would support previous suggestions based on the morphological analysis. Because all the work 
conducted in this chapter to characterise microglia is based on Iba1 staining, the use of other 
indicators such as classical microglia markers (CD11b, CD14, CD68), purinergic receptors 
(P2X4, P2X7, P2Y6, P2Y12), fractalkine receptors (CX3CR1) and cytokines (TGF-ß, IL-1ß, 
TNF-α)676 could determine a more refined profile of the characteristics of the potential changed 
microglial population(s) of GFAP-IL6 animals. For instance, the production of nitric oxide 
(triggered by an external insult) increases the expression of CD11b, and nitric oxide scavengers 
reduce its expression together with the loss of dopaminergic cells in the brain677. Therefore, are 
chronically inflamed retinae more susceptible to retinal damage related with light-induced 
nitric oxide release? This can be answered by quantifying the expression of CD14 and/or CD68, 
which correlate with tissue damage–associated signals678 and lysosomal activity679. Purinergic 
receptors modulate microglial proliferation, activation, cell death and cytokine release680–687. 
Specifically, an increased expression in P2X7 is common in different neuroinflammatory 
conditions and promotes the release of the pro-inflammatory cytokine IL-1ß, which has trophic 
effects on surrounding microglia688 promoting chemokine expression by Müller cells and 
RPE689. In summary, having access to a battery of available microglial markers, much work 
can be done to better characterise and understand the phenotypic change in microglia associated 
with long-term inflammation. 
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During youth, GFAP-IL6 mice showed an increased number of microglia that phenotypically 
seems to be reactive compared to wild-type mice, which provides a first step in the validation 
of the mouse model as chronically inflamed in the retina. However, this difference was 
abolished with aging likely because “normal” ageing in wild-type mice triggers an increase in 
microglia proliferation that ends matching the density of GFAP-IL6 mice. Regardless of the 
differences between their activated-like phenotypes, the similarities in numbers raise the 
question: Is there a maximum (or optimum) number of microglia/mm2 an inflamed retina can 
handle? Lipopolysaccharides could be added in retinal tissue of already inflamed animals or 
aged wild-type (because GFAP-IL6 might have exhausted strong inflammatory responses as 
previously discussed) in an attempt to further increase microglial density. If this was the 
maximum number of microglia an adult retina can handle, future studies could have a good 
absolute reference (microglia/mm2) to evaluate their numbers in response to retinal therapies 
and perhaps establish a scale depending on the severity of the symptoms with its correlation 
with microglial density. Some studies approached similar questions using nearest neighbour 
distance calculations (in the brain), which showed that microglia get closer with increasing age 
without ovelapping690,691, but covering a greater percentage of the retina. 
These results may suggest an IL-6-independent component regarding the increase of cell 
density, since GFAP-IL6 retinae do not reach its maximum density at 4 months of age. 
However, there might be the possibility that young retinae just do not receive as much IL-6 as 
the aged animals. In addition, whether blood circulating IL-6 increases with age is still a matter 
of debate, although most publications report an increase in both rodents and primates692–698 
rather than invariant699 or decreased levels700. An enzyme-linked immunosorbent assay 
(ELISA) could provide further information in the experimental models used701 by quantifying 
retinal, rather than blood-circulating IL-6. 
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The results obtained using bivariate correlations mainly show differences between young wild-
type microglia and other groups. In half of the measurements (convex hull perimeter, dendritic 
length and branching points) both the slope of the linear regression and the R2 are increased 
when the rest of groups are compared to young wild-type. This further suggests that microglia 
in GFAP-IL6 and aged retinae show activated characteristics (i.e. a more circular than elliptical 
shape of dendritic field, and fewer branching points per unit area). Young healthy microglia 
are likely capable of performing surveillance functions in healthy retinae whereas activated 
microglia anchor (or highly reduce their motility) and retract their dendrites in the rest of the 
cohorts, as reported in the literature632,667,702,703. To distinguish between different magnitudes 
of activation, Davis et al.704 established a correlation between soma size and roundness. 
Together with the previous suggested experiments, this could be a good approach to further 
determine the activation profile of microglia in GFAP-IL6 mice. 
Sholl Analysis offers a wide range of analysis depending on what you are specifically looking 
for705. Here, I wanted to test overall differences indicative of reactive-like states, and just by 
looking at the raw data (Figure 6.3) the most obvious is dendritic retraction. Therefore, I 
proposed a measurement I named “shift parameter” (radius at Ymax) to reveal changes at the 
maximum peak of complexity. Indeed, my measurements show an overall retraction of reactive 
microglial dendrites that relate with both age and inflammation. Plus, both dendritic area and 
dendritic volume of aged GFAP-IL6 microglia shift towards the soma compared to young 
GFAP-IL6, suggesting thicker dendrites that resemble to those of a hypertrophic microglia with 
amoeboid-shape706. This might reflect a state of dystrophic microglia deteriorated due to 
independent age-related processes (caused by chronic neuroinflammation) rather than 
enhanced reactivity.  
To conclude, most studies focus on the characterisation of microglia in inflamed or diseased 
conditions, whereas much fewer groups studied microglia in healthy non-aged conditions707–
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712. Due to the initial nature of the experiments to test light-induced dopamine release, no 
further characterisation of microglia beyond individual morphology and total cell density was 
performed for this thesis. Ongoing experiments will further characterise GFAP-IL6 retinae by 
conducting measurements such as microglial spatial distribution713,714 and a complete 
characterisation of astrocytes715,716 and Müller cells717,718, which has been shown to be related 
with microglial pro-inflammatory activation. Also, functional vision tests such as ERG or the 
optokinetic drum test, might reveal more cues about the retinal physiological differences 
between genotypes. However, a big handicap is that most of the microglial studies occur in 
rodent retinae, and the direct translation of these findings to primates should be taken with care 
since the retinal complexity differs and few papers have already reported contradictory results. 
For instance, Owen et al.675 showed that following pro-inflammatory activation, the pro-
inflammatory marker TSPO is upregulated in rodent retinae while in humans it exhibits the 
opposite. Also, microglia density and populations are different in the macula and periphery of 
primate retinae719, and rodents lack any foveal specialisation. 
 
6.3.2. Chronic neuroinflammation does not impair light-induced 
dopamine release 
At a preliminary stage, a significantly increased population of microglia does not seem to 
impact light-induced dopamine release. This data may point to a lack of involvement of 
microglia with any of the key players that mediate light induced dopamine release, or a 
compensatory mechanism at some point(s) of the circuitry to maintain normal dopamine 
release since no differences are observed between wild-type and GFAP-IL6 mice. However, 
using the ex vivo approach and normalising dopamine to sample protein content could provide 
some insight in the absolute variation of dopamine. Interestingly, a link between microglia and 
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dopamine has been suggested in the literature: microglia have dopamine receptors and use them 
to migrate towards its source653,654, and the number of microglia correlates with the number of 
TH+ cells in the brain720. Further, induction of damage that triggers an increase in microglia 
numbers inversely correlates with TH+ cells, suggesting that those play a role in 
phagocytosis721–723. Upstream of dopaminergic amacrine cells, some authors showed 
interaction of microglia with the RPE that might impact on rod integrity  and therefore light-
induced dopamine release724,725. Further, microglia can have a direct impact on rods by active 
phagocytosis, which leads to retinal degeneration726–728. Therefore, much more work is needed 
in order to unravel the interaction between microglia and the circuits that drive light-induced 
dopamine release. Future staining of retinal photoreceptors, second and third order cells, will 
reveal differences in total number or morphology, perhaps suggesting a compensatory 
mechanism (i.e. retinal remodelling as it occurs in rd/rd mice) or no alteration at all because 
neurons might have developed certain resistance to a persistent phagocytic environment729. 
Because the nature of the retinal inflammation project was a collaboration with another group, 
experiments assessing light-induced dopamine release in aged mice have not been performed 
yet. In the literature it is reported that the number of rods in aged wild-type retinae are not 
different to young730 but the number of TH+ cells are reduced with age731. Therefore, it would 
be interesting to measure light-induced dopamine release in aged animals to see if 
dopaminergic amacrine cells have developed a compensatory mechanism that allows them to 
release similar amounts of dopamine as young animals. Further experiments involving the 
staining of key photoresponsive components (i.e. rods, cones and ipRGCs) and ERG 
measurements in GFAP-IL6 mice will provide more information regarding the retinal 
physiology related with chronic neuroinflammation using a novel mouse model approach.  
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CHAPTER 7:                                                      
General Discussion 
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Dopamine plays multiple roles in the healthy physiology of the retina and dopaminergic 
amacrine cells are the only cells in the retina that synthesise dopamine, which is released in 
response to light. Photoreceptors are the neurons that sense light changes and respond with 
biochemical signals that can reach dopaminergic amacrine cells. However, which of these light 
inputs are sufficient and/or necessary to drive dopamine release? To answer that question, I 
optimised an analytical technique routinely used for more than 30 years to be able to measure 
precise variations in retinal dopamine release in a wide variety of mouse models and 
experimental approaches. First, I performed a systematic dissection of each methodological 
step that involves treatment, collection or analysis of retinae, providing critical evidence for 
future experimental designs. These results emphasise the potential differences that can be 
observed in the final amount of dopamine based on common variations of the protocol such as 
use of anaesthesia, intensity, duration and wavelength of light-pulses, techniques for retinal 
dissection (classical dissection or “popping”), illumination during retinal dissection (dim red 
or infrared), solvents for retinal homogenisation, type of quantification (ECD, UV or MS/MS) 
or type of internal standards (deuterated or non-deuterated). Further, I characterised two 
complementary techniques to assess dopamine release in different experimental designs: in 
vivo and ex vivo, and discussed pros and cons of each. An important drawback of these methods 
however is that each measurement only provides a snapshot of the dopamine turnover/release 
after a given amount of time. Alternatively, the use of amperometry319,320,457 (with a carbon 
fibre electrodes) in explanted retinae could provide a continuous temporal measure of 
dopamine release across different light exposures and intensities in each subject. 
Ultimately, all the results from this thesis suggest that dopamine release is controlled by a 
balance between excitatory and inhibitory inputs, and rods are the main mediator for its release 
154 
 
under a wide range of light intensities. The simplest explanation for the mechanism by which 
rods are signalling at such bright intensities seems to be related to bleaching adaptation, since 
recent publications showed that rods can be functional at these bright light intensities26–28. 
Additional experiments can be performed to provide further support to this hypothesis such as 
light-pulsing rod-only mice, that can be obtained crossing models used for the thesis 
(Gnat2A518G x Opn4Cre/Cre). In fact, preliminary results with this model suggest that rods alone 
can drive light-induced dopamine release at the brightest intensity tested. In addition, mice are 
nocturnal and have rod-dominated retinae, but the use of a diurnal retina (cone-dominated) 
would provide valuable information about how, and if, retinal circuitry undergoes adaptation 
in these animals (given that dopamine release is rod-mediated). Can cones mediate dopamine 
release in these animals or is it still mediated by the smaller population of rods? Are the intrinsic 
photoresponsive properties of rods more important than its downstream circuitry? A good 
model to find an answer to some of this questions would be the use of a diurnal mammal with 
a cone rich retina.  
While there is no evidence in this thesis to support the contribution of cones or ipRGCs in the 
normal functioning light-induced dopamine release, their assistance in local modulation cannot 
be entirely ruled out. Certainly, extensive evidence is provided across the literature describing 
inputs from these photoreceptors into dopaminergic amacrine cells at distinct light intensities 
that cause somatic depolarisation of dopaminergic amacrine cells. Such small and localised 
variations in dopamine release could be resolved with a dopamine dye732, or dopamine sensors 
genetically encoded within the cell733,734. However, the sensitivity of those might need to be 
improved to distinguish dopamine concentrations below 1 µM.  
The next obvious question is what is the impact of this large increase in dopamine release at 
bright light intensities on retinal function? This could be investigated by examining the 
modulation of gap junctions in response to bright-light stimulation (above dopamine 
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threshold). Choi et al.735 used a technique called cut-loading, that consists of measuring the 
diffusion of a dye after cutting the retina with a blade. The more diffusion of the dye, the more 
gap junction coupling and vice versa. 
Further, it would be interesting to perform a systematic study of other light-induced 
neuromodulators such as nitric oxide or adenosine. Certainly, nitric oxide and dopamine release 
are suggested to have complicated interactions183,736,737 and its release results in similar overall 
outcomes such as gap junction uncoupling or inhibition of ocular growth. Both nitric oxide and 
adenosine have been shown to modulate the sensitivity of ipRGCs738–740, and perhaps 
pharmacological regulation of these could modify the inputs from ipRGCs to dopaminergic 
amacrine cells causing dopamine release. Also, adenosine (which is released in the dark741) is 
related to circadian rhythms39 and exert noticeable effects on the ERG (increase a and b 
waves)742, suggesting that it may very well having an effect on dopaminergic 
pathways398,743,744. Plus, its analysis would be very similar to dopamine since HPLC methods 
are already established745,746. 
Finally, as a result of a collaborative investigation with another group that studies 
neuroinflammation in the brain, I had the chance to characterise microglia from retinae of 
chronically inflamed animals and relate that with dopamine release. Although chronic 
neuroinflammation does not seem to impair the regulation of retinal pathways involved in 
bright light-induced dopamine release, much work remains to be done to fully characterise the 
impact of microglia on the retina and (specifically for this thesis) the components that 
participate in inputs to dopaminergic amacrine cells that drive light-induced dopamine release. 
Nonetheless, this relation might elucidate novel dopamine-microglia interactions, that have 
been shown to be dysregulated in Parkinson’s disease747,748. Because microglia is suggested to 
be the main contributor of the inflammation in Parkinson’s disease749,750 and has been shown 
to migrate towards dopamine and selectively attack dopaminergic amacrine cells655, perhaps 
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light variations can potentially modify microglial dynamics. Currently, different approaches to 
treat the abnormalities found in GFAP-IL6 animals (i.e. reducing the number of activated 
microglia) to try to reverse the genotype back to a healthy wild-type are being performed in our 
lab. For example, a promising therapy that involves feeding GFAP-IL6 mice with different 
doses of potent antioxidants such as curcumin seem to reduce retinal microglia dose-
dependently, although further physiological characterisation remains to be completed. 
To conclude, I systematically examined the light inputs driving dopamine release in the retina 
and reached the conclusion that rod photoreceptor input defines dopamine release in the retina 
through both excitatory and inhibitory pathways. However, interdisciplinary collaborations and 
much work remains to be done to fully unravel the secrecies of dopamine physiology. 
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